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ABSTRACT
Hindshaker {hsh) is a novel spontaneous murine mutation with autosomal recessive 
inheritance. Homozygous animals of both sexes exhibited a tremor of the hind end 
which commenced at about 2 weeks of age and largely disappeared in animals older 
than 6 weeks. The severity of tremor varied between mice of the same age and a 
small proportion did not develop a phenotype at all. Seizures, infertility and 
premature death were not features of the mutation. There was hypomyelination 
affecting predominantly the spinal cord, although optic nerves and brain were 
involved to a much lesser degree. The defect of thinly myelinated and naked axons 
was maximal at 20 days and largely resolved with time so that in the adult, most 
axons were myelinated. Myelin appeared structurally normal and 
immunocytochemistry indicated the presence of a panel o f myelin proteins.
Although distribution of oligodendrocytes in the spinal cord was similar to normal, 
hypomyelination appeared to be due, at least in part, to a paucity of mature 
oligodendrocytes that was most profound in the spinal cord. The partial resolution 
of the myelin deficit was concomitant with an increase in the number of these cells. 
No ultrastructural abnormalities were found in hsh oligodendrocytes and in vitro 
studies failed to reveal any differences between the differentiation of 0-2A 
progenitors obtained from hsh and control mice. No marked astrocytosis was 
apparent although a microgliosis was detected in older animals. Taken together, the 
evidence suggests that the hsh mutation does not involve a major structural protein 
but more probably perturbs an aspect of oligodendrocyte development.
The first stage of genetic mapping was undertaken using microsatellite markers and 
an intersubspecific (CAST/Ei) and two interstrain backcrosses (C57BL/6J and 
B ALB/cJ). Incomplete penetrance and variation in the expression of the phenotype 
occurred on these genetic backgrounds due to the action of specific alleles at other 
non-disease loci. One such modifying locus was identified on proximal 
chromosome 17. The hsh gene was mapped to a 2cM interval in the middle of 
chromosome 3; three flanking and five intervening microsatellite markers were 
identified on a backcross population of 184 mice. There were no obvious candidate 
genes found on examination of composite genetic maps although Cnp2 apparently 
lies 2cM proximal to the interval of interest and remains an interesting contender. 
Further fine mapping now awaits the generation of vital recombination breakpoints 
to delimit the hsh gene to a sufficiently small interval for positional cloning by 
conti g construction.
To George and Mum
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1. Introduction
1
1.1 General introduction
The elaboration of the myelin sheath by the oligodendrocyte is one of the most 
complex and remarkable features of neural development. A vast amount of lipid 
must be produced by myelinating cells and a precise array of manifold proteins 
correctly inserted into the expanding membrane. The requirement for integration of 
these processes both in development and in subsequent maintenance of the myelin 
sheath is exemplified by inherited and acquired disorders of myelination. The 
failure of normal development or the ensuing loss of myelin lead to devastating 
neurological dysfunction and sometimes death of the organism. Mutant animals in 
which myelination in the central nervous system (CNS) is impaired provide one 
approach to the study of the normal process. The characterisation of the defect may 
shed light on the role of the normal protein in such processes as the division, 
maturation and survival of the oligodendrocyte. A major objective, however, is the 
identification and molecular cloning of the defective gene, to allow causal linkage 
between the gene product and the abnormal developmental process. Even then, the 
final conclusion may prove elusive, either because of complicated pleiotropic effects 
of the gene defect or functional redundancy in the system.
The goals of this project were the description of the phenotype of a novel myelin 
mutant mouse and the genetic mapping of the disease locus. An understanding of 
normal neural development, including the formation of the CNS, the developmental 
biology of the oligodendrocyte and the elaboration and biochemical structure of the 
myelin sheath, is a prerequisite for such a study. A description of these processes is 
therefore provided and a summary of other myelin mutants given. This is followed 
by an account of genetic mapping in the mouse.
1.2 Development in the central nervous system
The murine nervous system is evident at around day 7.5 of prenatal development as 
a thickened plate of ectoderm in the mid-dorsal region of the embryo. The plate 
invaginates to form the neural groove and then progressively closes, creating the 
neural tube (Figure 1, page 3). The broad cranial end of the tube develops three 
dilations destined to become the fore, mid and hindbrain whilst the narrower caudal 
part will constitute the spinal cord (Sadler, 1985).
Initially the neural tube consists of a single layer of germinal neuroepithelial cells. 
The subsequent mitotic activity of these cells gives rise first to progenitor neurons 
and then to glial progenitors which migrate out from the germinal zone. Ultimately,
2
Neural plate
Neurectoderm
N otochord
N eural crest
N eural
groove
G erm inal
neuroepitheliumM arginal/m antle
layers
Floorplate
Figure 1: Development of the neural tube. The notochord can be identified 
lying ventral to the floorplate in the embryonic spinal cord.
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when its proliferative function is exhausted, the germinal layer will form the 
ependymal lining of the ventricular system.
Neuronal development precedes that of glia with the exception of radial glia. For 
example, the formation of motor neurons in the ventral horns of the rat spinal cord 
occurs from embryonic day 11 (Nomes and Das, 1974) whereas the majority of 
oligodendrocytes appear postnatally (Warf et al., 1991). As progenitor neurons, 
called neuroblasts, are generated, they migrate from the germinal layer to form a 
surrounding zone or mantle. The mantle will give rise to the grey matter of the 
spinal cord, the brain stem nuclei and the cerebral cortex. Axons that grow from the 
neuroblasts form the marginal layer, later to become the white matter of the brain 
and spinal cord. The scaffold for the developing CNS is provided by radial glia, a 
transient population of cells that subsequently disappears, perhaps by differentiating 
into another cell type (Choi et al., 1983).
The neuroglia are divided into macroglia and microglia, with the macroglia being 
composed of astrocytes and oligodendrocytes. The macroglia develop from 
progenitor neuroepithelial cells in the late embryonic and early postnatal period of 
rodents, largely after the completion of neurogenesis. Although the precise 
genealogy of these cells is still poorly understood, it may be partly determined by 
the position of their precursors in relation to the notochord and floor plate. The 
notochord is a transient mesodermal structure located ventral to the developing 
neural tube (Placzek et al., 1990) which ultimately gives rise to the nucleus pulposus 
of the intervertebral disc. Where the notochord is in contact with the neural tube, 
the floor plate develops as a midline specialisation of the neuroepithelium. Both 
appear to act as sources of signalling molecules in the embryo (Yamada et al., 1991; 
Placzek, 1995), specifying the fate of ventral neuroepithelial cells. The other class 
of glial cell, the microglia, originates from a population of mononuclear leukocytes 
which penetrate the blood brain barrier in late foetal development (Ling and Wong, 
1993).
Concurrent with early neural tube formation, paired columns of cells located at the 
dorsolateral margins of the neural tube separate to form the neural crests (Figure 1, 
page 3). Neural crest cells give rise to the neurons and glia of the peripheral 
nervous system (PNS), cells of the adrenal medulla and the melanocytes of the 
epidermis as well as contributing to craniofacial structures (Sadler, 1985).
Development in the CNS continues into the postnatal period. By the time of its 
completion, it will constitute the most complex organ in the body, containing many 
billions of neurons and some 10-50 times more glia. The huge cell numbers and
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complexity of their arrangement mean that many features of neural development 
have yet to be elucidated.
1.3 Cells of the CNS
1.3.1 Oligodendrocytes
1.3.1.1 Introduction
The predominant function of the oligodendrocyte is the formation and maintenance 
of CNS myelin. In addition, perineuronal oligodendrocytes may serve to regulate 
the microenvironment around neurons and there is emerging evidence that 
oligodendrocytes have a role in axon growth and maintenance (Rubin et al., 1994). 
Although first regarded as a relatively metabolically inactive cell with little capacity 
for reaction to injury, the oligodendrocyte is proving to be exceedingly varied with a 
complex developmental pattern, a wide range of proteins and lipids which are made 
in enormous quantities and a cell transport system to move these over considerable 
distances.
The origin, migration, proliferation and differentiation of neuroglia in the 
developing CNS are areas of intense study and some contention. Classical studies 
using ultrastructural analysis and autoradiography have shed some light on the 
development of these cells in vivo but cell lineages cannot be deduced from purely 
morphological evidence or from the sequential appearance of different cell types. In 
recent years investigation of oligodendrocyte development has been greatly 
facilitated by the availability of cell type-specific antibodies that can be used to 
identify progenitors, intermediate forms and terminally differentiated cells. 
Although much of this work has been performed in vitro, immunostaining and 
retroviral lineage tracing experiments suggest that a similar developmental 
progression does occur in situ. Some major discrepancies still exist, however, such 
as the in vivo existence of the type 2 astrocyte (see below).
1.3.1.2 Morphology and ultrastructure of the developing oligodendrocyte
The earliest classifications of oligodendrocytes date back to their description by the 
Spanish histologist Del Rio Hortega (Del Rio Hortega, 1921; Del Rio Hortega, 
1922; Del Rio Hortega, 1924) using silver carbonate impregnation. Since that time, 
other techniques have confirmed and enlarged upon these findings (Friedman et al., 
1989; Butt and Ransom, 1989; Remahl and Hildebrand, 1990) but it is still unclear 
how the heterogeneous morphology of oligodendrocytes relates to function.
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Del Rio Hortega grouped oligodendrocytes into four subtypes, which he numbered I 
through IV. Type I cells, the most abundant, possess a small cell body from which 
abundant fine processes emerge directed towards nerve fibres. These cells are 
found throughout the CNS. Type II have a larger soma and fewer, thicker processes 
and are found only in white matter. Type III cells, with three to four processes 
emanating from the cell body and directed towards axons, are localised in cerebral 
and cerebellar peduncles, the medulla oblongata and the spinal cord. Finally, type 
IV oligodendrocytes occur in association with large axons in the spinal cord and 
adhere to their fibre in a manner akin to the PNS Schwann cell. Several studies 
have since supported this classification (Stensaas and Stensaas, 1968; Remahl and 
Hildebrand, 1990).
Traditional in situ studies using microscopic examination and autoradiography have 
also classified oligodendrocytes, this time into three types according to their 
cytoplasmic density and extent of differentiation (Mori and Leblond, 1970). The 
relation between this and types I to IV is not clear. On EM examination, the light 
oligodendrocyte represents the most immature form, having a large pale cytoplasm 
and a light nucleus of 6 to 8.5pm diameter. This contains only slightly clumped 
chromatin and an obvious central nucleolus. Cytoplasmic organelles are abundant, 
particularly free ribosomes arranged as polysomes. The endoplasmic reticulum is 
scanty and usually not stacked and the Golgi apparatus consists of a few stacks of 
small saccules. Fine processes containing microtubules but no ribosomes and few 
mitochondria are characteristic.
These cells mature into medium oligodendrocytes with a smaller, denser nucleus of 
4 to 7pm in diameter and less ample, darker cytoplasm. A few chromatin masses 
are apparent at the nuclear periphery and the nucleolus is less distinct. The rough 
endoplasmic reticulum tends to have longer, stacked cistemae and there are fewer 
free ribosomes. Golgi saccules are more prominent and distended. The fine 
processes now contain fewer microtubules.
Dark oligodendrocytes can be identified with the completion of myelination and full 
maturation of the cell. Cytoplasmic and nuclear volume are further reduced and 
there is rimming of the nuclear membrane by distinct clumps of chromatin. The 
typically dark, spherical nucleus has a diameter of 3.5 to 5.5pm with a small, 
paracentrally located nucleolus. The Golgi apparatus is usually perinuclear and has 
distended saccules. Stacks of long cistemae of rough endoplasmic reticulum often 
have a lumen and surround the Golgi apparatus. The remainder of the cytoplasm is 
filled with ribosomes and mitochondria in an electron-dense matrix. Lamellar
6
bodies can also be identified. Dark oligodendrocytes have only a few processes, 
usually of the same density as the cell cytoplasm.
Some of the criteria used to identify these types of oligodendrocytes can be applied 
to light microscopic examination of semi-thin resin sections (Mori and Leblond, 
1970). The light oligodendrocyte has a large, pale, oval nucleus with few chromatin 
masses and a dark central nucleolus. The pale cytoplasm is voluminous and often 
distributed around the nucleus. As these cells mature into medium 
oligodendrocytes, the nucleus and cytoplasm stain more intensely. The smooth oval 
nucleus is now smaller and contains chromatin clumps around its periphery. The 
density of the cytoplasm may be equal to or darker than the nucleus. In dark 
oligodendrocytes, the nucleus is round or oval and very dark although occasional 
chromatin clumps can still be distinguished. The cytoplasm is even darker and now 
rather scanty, often being eccentrically located in relation to the nucleus.
1.3.1.3 Development of the oligodendrocyte lineage in vitro
Classical ultrastructural and autoradiographic studies were limited in their ability to 
demonstrate the progression of a cell along a particular lineage and relied on 
assumptions based on the sequential appearance of morphologically different cell 
types. The recent demonstration of cell type and stage-specific markers has opened 
up the study of many aspects of oligodendrocyte biology; the morphological 
development, the migration, proliferation and survival and the response to growth 
factors can all be examined and manipulated. This is more easily performed and 
therefore best characterised in vitro, usually using dissociated cultures of rat or 
mouse brain and rat optic nerve. A description of macroglial development in this 
system is given first and its application to the intact CNS discussed later.
In vitro studies have demonstrated three types of macroglial cells; type 1 astrocytes 
from an undefined precursor and type 2 astrocytes and oligodendrocytes from a 
common 0-2A progenitor (Raff et al., 1983; Miller et al., 1985; Raff, 1989). The 
earliest precursor cells stain for the intermediate filament vimentin (Hardy and 
Reynolds, 1991; Gonye et al., 1994) prior to differentiation into proliferative and 
migratory bipolar 0-2A progenitors. These express gangliosides recognised by the 
antibodies against GD3 (Levi et al., 1987) and the A2B5 antibody (Einsenbarth et 
al., 1979) (Figure 2, page 9) and are bipotential in culture, generating either type 2 
astrocytes or oligodendrocytes. The lineage selected depends on environmental 
signals (Raff et al., 1983) but whether this bipotentiality is a feature of in vivo 
development is under debate (Fulton et a l, 1992). 0-2A progenitors proliferate in 
response to a number of growth factors including insulin-like growth factor 1 (IGF-
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l)(McMorris and Dubois-Dalcq, 1988), platelet derived growth factor (PDGF) and 
basic fibroblast growth factor (bFGF) (McKinnon et a l, 1990).
Vimentin and then A2B5 and GD3 staining are lost with progression along the 
oligodendrocyte lineage. Cells become multipolar, less migratory and lose their 
mitogenic response to PDGF (Gard and Pfeiffer, 1990; Warrington et al., 1993) as 
they start to express the pre-oligodendrocyte antigen (POA) detected by 04/A007 
(Bansal et al., 1992b) (Figure 2, page 9). Cells at this stage may still be bipotential 
(Trotter and Schachner, 1989).
Later 04/A007 staining detects two sulphated glycolipids, sulphatide and 
seminolipid (Bansal et a l, 1989). This is followed by Ranscht monoclonal antibody 
(R-mAb) (Bansal and Pfeiffer, 1992a) which binds these two in conjunction with 
galactocerebroside (GalC). The onset of terminal differentiation and commitment to 
the oligodendrocyte lineage is characterised by a decline in proliferation, the 
appearance of 01 staining for GalC (Raff et al., 1978) and the synthesis of 2 ’, 3 ’- 
cyclic nucleotide 3’-phosphodiesterase (CNP). Continued maturation is marked by 
the regulated expression of terminal markers such as myelin basic protein (MBP), 
myelin associated glycoprotein (MAG), proteolipid protein (PLP), 0 10 and O il  and 
the elaboration of myelin membrane (Dubois-Dalcq et a l, 1986; Kuhlmann-Krieg et 
al., 1988) (Figure 2, page 9).
0-2A  progenitor cells have also been identified in adult as well as perinatal optic 
nerves (ffrench-Constant and Raff, 1986; Wolswijk and Noble, 1989). 0 - 2 A ad u lt  
progenitors have a different morphology, antigenic phenotype, cell cycle time, 
differentiation rate and migration rate from those in immature nerves (Wolswijk and 
Noble, 1989). They are thought to arise from a subset of perinatal 0-2A  progenitors 
and seem to have the capacity for self-renewal (Wren et al., 1992).
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1.3.1.4 Comparison of in vivo and in vitro development
Although cell culture systems have facilitated characterisation and analysis of 
discrete populations of cells and modulation of their development by growth factors, 
these systems are inherently limited for several reasons. Cell culture lacks the 
framework of intact tissue and since many cellular interactions during development 
are dependent upon their position, they may not occur in culture. Furthermore, 
artifactual cellular processes may be produced instead. In contrast, a progenitor cell 
in vivo is exposed to a restricted sequence of signals in a local environment that is 
closely regulated temporally and spatially. This may lead to only one or a few 
developmental pathways being followed and hence the generation of a limited range 
of cell types from an individual precursor.
However, a major difficulty in the study of development in vivo has been the lack of 
definitive markers for distinguishing the different cell types and stages. Many 
markers useful in culture are not specific when applied to sections, for example 
A2B5 (Einsenbarth et al., 1979) and GD3 (Wolswijk, 1995). A number of new 
markers appear to label cells in sections that correspond to the 0-2A  progenitor, 
such as NG2 glycoprotein (Levine et a l, 1993) and platelet-derived growth factor a  
receptor (PDGFRa) mRNA (Pringle et al., 1992). Use of these markers combined
with techniques such as retroviral tracing (Levison and Goldman, 1993b) suggests a 
pattern of development in vivo that is similar to that in culture but it has also
highlighted important differences between the two systems. For example, there is 
still no definitive evidence for the in vivo bipotentiality of the 0-2A  progenitor or 
even the existence of type 2 astrocytes (Skoff, 1990; Fulton et al., 1992). 0-2A 
progenitors are therefore regarded as dedicated oligodendrocyte progenitors in 
normal development. Contradictory results have also been obtained when 
examining multipotentiality of early precursors in vivo and in culture; they are often 
multipotential in culture but appear committed to producing one cell type in the 
intact CNS (Luskin et al., 1993; Levison et al., 1993a).
Despite the caution with which in vitro results must be extrapolated to the in vivo 
situation, much of the information on oligodendrocyte biology has come from the 
former system and will doubtless continue to be central to its study.
1.3.1.5 Oligodendrocyte development in vivo
1.3.1.5.1 Origins of oligodendrocyte precursors
Ultimately the macroglia arise from the ventricular layer of the CNS. Two major 
questions posed relate to the precise locations in which the precursors are generated 
and whether they are multipotential at a late stage in the lineage. Early
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morphological and immunocytochemical studies of the spinal cord resulted in 
several hypotheses to explain macroglial genealogy (Gilmore, 1971; Skoff et a l, 
1976b; Choi et al., 1983; Hirano and Goldman, 1988) but it is now generally 
accepted that oligodendrocytes initially arise in ventral subventricular regions of the 
neural tube from a specified precursor (Warf et al., 1991; Noll and Miller, 1993; 
Pringle and Richardson, 1993; Ono et al., 1995; Dickinson et a l, 1996). However, 
some recent studies have contradicted this (Williams and Price, 1995; Cameron- 
Curry and Le Douarin, 1995; Hardy and Friedrich, Jr., 1996) and the issue still 
requires resolution.
Several lines of evidence support the theory of a ventral origin of oligodendrocyte 
precursors. Indirect evidence is provided by the finding that ventral regions of the 
rat spinal cord develop the capacity for oligodendrogenesis in vitro prior to dorsal 
segments (Warf et al., 1991). Also, labelled proliferating cell populations located in 
the ventral ventricular zone dorsal to the floorplate later appear to give rise to 
oligodendrocytes (Noll and Miller, 1993). Although early in vivo studies were 
hindered by the unreliability of markers in sections, the discovery of a number of 
new markers for putative 0-2A progenitors has provided more direct evidence of 
their ventral origin. In situ hybridisation with a probe to PDGFRa mRNA (Pringle 
and Richardson, 1993), thought to be specific for oligodendrocyte precursors in the 
late embryonic rat CNS (Pringle et al., 1992; Yu et a l, 1994) localises cells in the 
embryonic ventral spinal cord. Similar results have been obtained with a probe to 
mRNA for the myelin protein CNP. Immunolabelling with an antibody against 
PDGFRa (Hall et a l, 1996) and, in the chick, 04  antibody (Ono et al., 1995) also 
identifies this ventral population. Under culture conditions, immunoselection with 
an antibody against PDGFRa confirms PDGFRa-labelled cells to be 
oligodendrocyte precursors whilst antibody-mediated complement lysis prevents the 
development of most oligodendrocytes (Hall et al., 1996). Dm20 mRNA and 
protein is also present in some oligodendrocyte precursors in the mouse (Timsit et 
a l, 1995; Dickinson et al., 1996) but in the rat does not appear to colocalise with 
PDGFRa mRNA or Cnp mRNA although it does identify a population of cells in 
the ventral spinal cord. What is not clear is whether all oligodendrocyte precursors 
express detectable PDFGRa mRNA and whether Dm20 mRNA expressing cells 
represent a separate subpopulation of precursors. In the brain, comparable localised 
sources of oligodendrocyte precursors have been identified in the ventral 
diencephalon using the same markers. These appear to migrate and populate more 
dorsal regions (Pringle et al., 1992; Pringle and Richardson, 1993).
The notochord and floor plate appear to have an important regulatory role in the 
specification of the fates of ventral neuroepithelial cells. Signals from these have
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been shown to induce the development of ventrally derived oligodendroglia (Pringle 
et a l , 1996). A strong candidate for the signalling molecule is the product of Sonic 
hedgehog (Shh% a vertebrate homologue of the Drosophila patterning gene 
hedgehog (hh) (Pringle et al., 1996).
In contrast to studies indicating a ventral origin for oligodendrocyte precursors, 
others have produced evidence to the contrary. Chick-quail chimaeric transplant 
experiments seem to show the generation of oligodendrocytes all around the 
dorsoventral axis of the avian spinal cord (Cameron-Curry and Le Douarin, 1995). 
Studies involving the transplantation of labelled embryonic tissue indicate the 
development of oligodendrocytes from tissue obtained prior to the expression of 
PDGFRa mRNA (Hardy and Friedrich, Jr., 1996). It is suggested that PDGFRa 
mRNA expressing cells are not migrating dorsally but represent the temporal and 
spatial differentiation of earlier precursor cells already distributed throughout the 
neural tube (Hardy and Friedrich, Jr., 1996). In addition, retroviral experiments 
performed on cultures of rat cortical cells demonstrated oligodendrocyte clones from 
early embryonic tissue that contained no presumptive PDGFRa*- oligodendrocyte 
precursors (Williams and Price, 1995).
The question of the multipotential nature of early precursors has been studied 
largely using in vivo and culture retroviral technology and has yielded often 
contradictory results. In several studies, only one lineage was produced from a 
single clone (Luskin et al., 1993; Luskin and McDermott, 1994) whereas others 
have shown various combinations of neural cell types being generated from a single 
precursor (Levison et al., 1993a; Levison and Goldman, 1993b; Young and Levison,
1996). Generally, under culture conditions mixed clones are produced, whilst in 
vivo single clones produce only one cell type.
In summary, it seems likely that neuroepithelial cells throughout the entire neuraxis 
have the capacity to give rise to oligodendrocyte precursors during development but 
do so only in certain domains and at specified times. At what stages lineage 
restriction is operative and in which domains remains unclear, with different studies 
often giving contradictory results. The signals controlling the destiny of glial 
progenitors are largely unknown but probably involve factors inherent to the 
individual cell as well as extrinsic signals that are regulated both temporally and 
spatially.
1.3.1.5.2 Migration of oligodendrocyte precursors
Restricted induction of oligodendrocyte precursors necessitates the long range 
migration of cells to myelinate the CNS white matter. The nature of the migratory
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cell and the signalling molecules have been investigated in culture and to some 
extent in vivo. Immature A2B5+ cells are significantly more motile than later 04+ 
cells in vitro (Small et al., 1987) and migrate further in transplant studies 
(Warrington et al., 1993). Little is known about the control of migration of these 
progenitors; in culture PDGF appears to promote migration (Armstrong et al., 1990) 
as does bFGF (Milner et a l, 1997). Migratory roles for integrins which are 
expressed on oligodendrocyte precursors have also been suggested (Milner et a l,
1996). The in vivo migratory pathways and mechanisms are unknown.
1.3.1.5.3 Proliferation and differentiation of oligodendrocyte precursors 
Once oligodendrocyte precursors have migrated into future white matter, their 
numbers must be matched to the number and length of axons requiring myelination. 
In addition, cells must be competent to myelinate fibres at the appropriate time. As 
oligodendrocytes are post-mitotic cells, their final number in a region will depend 
on the number of precursor cells that migrate into it, their proliferative capacity and 
the number of cells that undergo apoptosis (Barres et a l, 1992a). The subsequent
differentiation into myelinating cells involves withdrawal from the cell cycle, the 
induction of myelin gene expression, formation of polarised cytoskeletal networks 
and transport pathways and the extension of cytoplasmic membrane. Co-ordinated 
control of proliferation and differentiation ensures the correct relationships between 
proficient myelinating cells and axons requiring sheaths. A number of mechanisms 
probably operate to regulate these processes, including the intrinsic properties of the 
precursor cells, extracellular signals from other cells and axon-oligodendrocyte 
interactions.
1.3.1.5.3.1 Intrinsic properties controlling proliferation and differentiation 
Oligodendrocyte progenitors in culture continue to divide for a limited time only, 
even in the presence of mitogens. The progeny of an individual cell tend to cease 
dividing at around the same time, suggesting that an intrinsic clock mechanism is 
operating (Temple and Raff, 1986). It is thought this mechanism may consist of two 
elements, a counting component measuring the number of divisions and an effector 
part allowing differentiation. The latter component is dependent on signal 
transduction pathways involving hormones such as thyroid hormone, 
glucocorticoids and retinoic acid (Barres et a l, 1994) and without these 
differentiation does not occur although proliferation ceases. However, in the 
absence of mitogens, precursor cells undergo premature differentiation even when 
not supplied with the effector signals. This suggests these signals are not actually
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necessary for differentiation but act to trigger it once the counting mechanism has 
reached time (Barres et al., 1994).
1.3.1.5.3.2 Extrinsic control o f  proliferation and differentiation 
If oligodendrocyte progenitors are cultured in the absence of mitogens, they 
promptly cease dividing and differentiate into oligodendrocytes (Temple and Raff, 
1985; Barres et al., 1992b), indicating that extrinsic substances are required for 
proliferation. At least four peptide growth factors have been shown to stimulate 
progenitor division in vitro and their presence has been demonstrated in the 
developing CNS. One of the best characterised is PDGF, and it is the only one 
which has been shown to promote DNA synthesis on its own. It triggers several 
divisions of rat optic nerve progenitors before they differentiate, despite the 
continued presence of the growth factor (Noble et al., 1988; Raff et al., 1988).
Basic fibroblast growth factor (bFGF)(McKinnon et al., 1990) also acts as a 
mitogen for 0-2A cells. In contrast to PDGF, bFGF blocks differentiation into 
oligodendrocytes and maintains progenitors in a proliferative state. The 
combination of bFGF and PDGF causes 0-2A progenitors to proliferate for long 
periods without differentiating, apparently over-riding the “intrinsic clock”(Bdgler 
et al., 1990).
Insulin-like growth factors I and II may stimulate the proliferation, differentiation 
and survival of 0-2A progenitors (McMorris and Dubois-Dalcq, 1988). 
Neurotrophin-3 (Barres et al., 1994b) also affects precursor proliferation. Although 
no one of these factors used singly can stimulate sustained proliferation of purified 
precursors in vitro, they can do so in combination (Barres et al., 1994b). NT-3 has 
been shown to have a role in stimulating precursor proliferation in the intact 
developing optic nerve. Antibodies to this peptide given at a critical time result in 
reduced numbers of oligodendrocytes (Barres et al., 1994b).
The sources of these mitogenic substances in vivo is still uncertain although 
astrocytes and neurons are both likely candidates. Astrocyte cultures secrete factors 
that stimulate oligodendrocyte progenitor proliferation in vitro (Raff et al., 1985) 
and produce all these four peptides (Noble and Murray, 1984; Temple and Raff, 
1986; Pringle et al., 1989). Neurons have been shown to produce PDGF in vivo 
(Yeh et a l, 1991; Ellison et a l, 1996) and could serve as another source of this 
mitogen.
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As mentioned above, extrinsic factors likely to have influences on proliferation and 
differentiation of oligodendrocyte precursors include thyroid and steroid hormones 
and retinoic acid (Barres et al., 1994).
Many signal transduction cascades using various second messenger systems are 
likely to be involved in the conveyance of extracellular signals across the 
oligodendrocyte cell membrane during development. Much still remains to be 
learned about these systems, but one of the best studied aspects to date is the role of 
the second messenger 3 ,,5’-cyclic AMP (cAMP). The schedule of oligodendrocyte 
differentiation and the rate of progenitor cell proliferation in vitro are both 
modulated by cAMP. With increased levels of cAMP, differentiation is accelerated 
whereas proliferation is inhibited (Raible and McMorris, 1993). These appear to be 
independent events since the inhibitory effect of cAMP on proliferation is abolished 
by maximal levels of PDGF, while the stimulatory effect on differentiation remains 
(Raible and McMorris, 1993). The extracellular ligands that alter cAMP levels in 
developing oligodendrocytes and the cell type(s) that release those ligands are not 
yet known.
1.3.1.5.3.3 Axonal control o f  oligodendrocyte proliferation
Since oligodendrocyte numbers must be sufficient to myelinate the number and 
length of axons requiring sheaths, axons are likely to have a role in regulating 
precursor proliferation and survival. This appears to be the case in vivo as 
transection of the optic nerve results in a dramatic reduction in the number of 
mitotic precursors (Barres and Raff, 1993). This occurs even without axonal 
degeneration, inferring that electrical activity in axons is a requisite. It is suggested 
that electrical activity normally controls the production and/or release of mitogens 
and support for this comes from studies using tetrodotoxin, a blocker of voltage 
regulated sodium channels. Tetrodoxin has an inhibitory effect on precursor 
proliferation which is countered by the addition of PDGF, an oligodendrocyte 
precursor mitogen (Barres and Raff, 1993). Whether PDGF is normally released 
directly from axons or indirectly from astrocytes is unclear. An axonal role in the 
control of differentiation has also been suggested. It appears that axonal contact is 
necessary for the transformation of a premyelinating oligodendrocyte into a 
myelinating cell (Trapp et a l, 1997).
1.3.1.5.3.4 Autocrine control ofproliferation
As well as being limited by an intrinsic clock mechanism and the absolute levels of 
growth factors and hormones, precursor proliferation may be altered by feedback
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from cells of the same lineage. In vitro studies demonstrate the inhibition of 
precursor proliferation by cells of the same type at high plating densities. This 
appears to mediated either through contact or unidentified local-acting diffusible 
substances (Zhang and Miller, 1996). Transforming growth factor-P, produced by 
oligodendrocytes in culture, has a longer range of effect and also inhibits precursor 
proliferation (McKinnon et a l, 1993). On the other hand, differentiation is hastened 
by the presence of TGFp (McKinnon et al., 1993).
1.3.1.5.4 Survival of oligodendrocyte precursors
Oligodendrocyte numbers are not only dependent on the proliferative capacity of 
immigrant precursors but also on the survival of these and differentiated cells. At 
least 50% of the oligodendrocytes produced in the optic nerve will die within a few 
days of development (Barres et al., 1992a), apparently undergoing apoptosis. 
Several factors affect survival rate, including growth factors from other cells and the 
presence of axons (Trapp et al., 1997).
1.3.1.5.4.1 Role o f  growth factors in survival
Purified oligodendrocytes, or their precursors, rapidly undergo apoptosis if cultured 
in the absence of other cells or exogenous signalling molecules (Barres et al., 
1992a). Several such molecules have been shown to be survival factors, some with 
differing effects on the various developmental stages. In vitro, IGF-1 is a potent 
survival factor for both mature oligodendrocytes and their progenitors whereas 
PDGF only supports survival of progenitors and early oligodendrocytes (Barres et 
al., 1992a). Increasing PDGF levels in the optic nerve through transplantation of 
secreting cells reduces cell death by about 80% (Barres et al., 1992a), leading to a 
doubling of oligodendrocyte numbers with no change in astrocytes. This infers that 
normal oligodendrocyte death is caused by competition for limited trophic factors. 
Other factors that enhance oligodendrocyte survival in vitro include NT-3 (Barres et 
al., 1994b), ciliary neurotrophic factor (CNTF) (Barres and Raff, 1993; Barres et a l, 
1993), leukaemia inhibitory factor (LIF) (Barres and Raff, 1993) and interleukin-6 
(IL6) (Barres and Raff, 1993; Barres et al., 1993).
Optic nerve astrocytes produce PDGF, IGF-1, NT-3 and CNTF and therefore seem 
likely to have a part in supporting the survival of the oligodendrocyte lineage. 
However, axons also have a role to play.
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1.3.1.5.4.2 Axonal control o f  survival
Axons appear to promote survival of oligodendrocyte precursors but by a different 
mechanism to that stimulating proliferation. Transection of the optic nerve followed 
by axonal degeneration results in oligodendrocyte death which can be prevented by 
elevating levels of IGF-1 or CNTF (Barres et al., 1993). However, without axonal
degeneration there is no death and nor does cell death result if  tetrodotoxin is used 
to silence axons. Thus the ability of axons to promote survival is not dependent on 
electrical activity whereas stimulation of proliferation requires functionally active 
axons. Purified neurons, but not neuron conditioned medium, increase survival of 
purified oligodendrocytes in vitro (Barres and Raff, 1994a), which is again 
suggestive of an axonal role in the survival of these cells.
Eventually the elaborately interwoven processes of migration, proliferation and cell 
survival will culminate in a sufficient number of competent myelinating cells. This 
involves a huge increase in oligodendrocyte cell numbers that occurs largely in the 
postnatal period. It has been estimated that in the rat brain, the number of 
progenitors expands from about 5 x 105 at birth to a terminal population of 60 x 106 
mature oligodendrocytes in adults (Pfeiffer et a l, 1993). Perturbation at any stage
of this development may presumably lead to a deficit in cell numbers and, if this is 
severe enough, consequent hypomyelination.
1.3.2 Astrocytes
Approximately 50% of the glial cell population in the brain consists of astrocytes 
which are up to ten times more numerous than neurons in the mammalian CNS. 
Astrocytes constitute a heterogeneous class of cells in terms of structural and 
functional properties. Morphologically they are process-bearing stellate cells with a 
pale cytoplasm and a pale oval nucleus. Traditionally they are split into 
protoplasmic and fibrous types based on their morphology and distribution, with 
fibrous dominating in white matter and protoplasmic astrocytes largely in grey 
matter (Peters et al., 1976). A second classification of astrocytes divides them into
type 1 and type 2, thought to develop from different progenitors and proposed to be 
analogous to protoplasmic and fibrous classes respectively (Miller and Raff, 1984; 
Miller et al., 1985). The progenitor cell for type 1 astrocytes is believed to be 
committed to this lineage, whereas the type 2 cell is thought to derive from the 
bipotential 0-2A cell although there is still much controversy regarding this. The 
most distinctive ultrastructural feature of astrocytes is the presence of intermediate 
filaments filling the cytoplasm. The major component of these is glial fibrillary acid 
protein (GFAP) which is relatively specific for astrocytes in the CNS and employed 
as an astrocyte marker (Bignami et al., 1972). Organelles such as mitochondria,
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endoplasmic reticulum and Golgi apparatus are sparse in mature astrocytes. 
Glycogen particles, dense inclusion bodies and fatty droplets are identified in the 
cytoplasm. Major astrocytic functions include guidance during neuronal migration 
in development, maintenance of the neural microenvironment and modulation of the 
immune response.
1.3.3 Microglia
This is the least frequent of the three classes of glial cells (Ling and Leblond, 1973). 
The outline of microglia is often irregular as the cells conform to the contours of the 
surrounding neuropil. The nucleus is electron-dense with large clumps of chromatin 
and the cytoplasm is light to moderate-staining, darker than astrocytes but less dense 
than oligodendrocytes. It contains no microtubules or filaments but includes dense 
core vesicles and large amounts of closely packed cistemae of the Golgi apparatus 
(Skoff et al., 1976a; Skoff, 1990). It is considered to be a mobile phagocytic
mesodermal cell that is activated in various pathological conditions (Perry and 
Gordon, 1988).
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1.4 Formation and morphology of the myelin 
sheath
A major function of the mature oligodendrocyte is the production of vast amounts of 
membranous extension, the myelin sheath. The membrane forms multilamellar 
sheaths around neuronal axons, resulting in axons with high resistance and low 
capacitance. This dramatically increases nerve conduction velocities and reduces 
energy and space utilisation. At the onset of myelination, a newly differentiated 
oligodendrocyte gives rise to long, slender processes which associate with the 
surfaces of scattered axons. Each process elongates to form a cup around the axonal 
segment and then, with one lip insinuating under the other, spirally wraps this 
segment. Wrapping may occur in a clockwise or anticlockwise direction (Skoff et 
a l , 1980) and initally the layers remain separated by an extracellular space called
the mesaxon. As further layers are added, compaction of the membrane occurs 
(Peters et al., 1976). The major dense line (MDL) results from the extrusion of 
cytoplasm from the myelinating process and the fusion of the cytoplasmic surfaces. 
The intraperiod line (IPL) forms as the mesaxon compacts by the apposition of the 
extracellular membrane faces. In the spinal and cerebral white matter of the cat this 
transition from a simple cytoplasmic sheath to compact myelin occurs after 
formation of no more than 3 lamellae (Remahl and Hildebrand, 1990). When 
mature, the sheath will contain cytoplasm only within the inner and outer loops of 
the spiralling process and in connecting channels. Deposition of myelin starts at 
several discrete sites along the entire length of an axon (Skoff et al., 1980) with 
intemodes extending towards one another until only a small gap, the node of 
Ranvier, separates adjacent intemodes. Some of the early short cytoplasmic sheaths 
will be eliminated as there is insufficient axonal space for them all to elongate 
(Remahl and Hildebrand, 1990). This conforms with the idea that some glial units 
shift from a polyaxonal to a monoaxonal relation before formation of compact 
myelin (Remahl and Hildebrand, 1990).
Axons in the CNS become myelinated within a diameter range of 0.2-0.8pm, with 
large diameter fibres acquiring a sheath first. The oligodendrocytes responsible for 
this form at an early developmental stage and produce just one or a few intemodes 
(Remahl and Hildebrand, 1990). Cells destined to enwrap small axons appear later 
in development and produce up to 40 sheaths. The diameter range within which 
axons undergo primary ensheathment differs for prospective large and small CNS 
axons. Large axons must reach a greater diameter before ensheathment; as 
development proceeds and small fibres become myelinated, so the minimum 
diameter required decreases (Matthews and Duncan, 1971). There is, however,
19
considerable overlap in diameter ranges for unmyelinated, ensheathed and 
myelinated fibres at any one stage (Remahl and Hildebrand, 1982).
Both the radial and longitudinal dimensions of the mature myelin sheath are coupled 
to axon diameter (Murray and Blakemore, 1980; Friede and Bischhausen, 1982) 
although the precise relation varies between regions of the CNS and the species. 
The family of axons/sheaths related to an individual oligodendrocyte appears to be 
relatively uniform in terms of axon diameter and sheath thickness (Remahl and 
Hildebrand, 1990). Differences in the biochemical composition of thick and thin 
sheaths (Hartman et a l , 1982) make it unlikely that an individual oligodendrocyte 
would be capable of supporting sheaths of various sizes. It is unknown whether 
oligodendrocyte heterogeneity in terms of cell morphology, number of sheaths 
produced and the dimensions and structure of these is intrinsic or related to local 
factors such as axonal contact. Transplantation studies suggest the latter; optic 
nerve oligodendrocytes, which usually myelinate only small diameter axons, are 
capable of producing sheaths for much larger fibres in the spinal cord (Fanarraga et 
a l , 1997).
Eventually the majority of CNS axons, unlike those of the PNS, will acquire a 
myelin sheath (Remahl and Hildebrand, 1982). The fibres that remain unmyelinated 
are small diameter although the size spectra of myelinated and unmyelinated axons 
overlap considerably (Remahl and Hildebrand, 1982; Hildebrand and Waxman, 
1984).
20
1.5 Myelinogenesis
The onset and completion of myelination varies between species and within 
different areas of the nervous system but several general trends exist. Myelination 
of the peripheral nervous system always precedes that of the CNS; in laboratory 
rodents this is by a period of several days. Within the CNS, the spinal cord 
myelinates before the brain (Langworthy, 1928; Langworthy, 1933; Fox et a l , 1967; 
Schwab and Schnell, 1989). The cervical spinal cord is the first area in which 
myelinated axons are detected prior to their appearance more caudally in the cord 
and rostrally in the hindbrain. Within the cord, there is a set pattern o f myelination 
of tracts at any one level, with the ventral columns being myelinated first, followed 
by the cuneate, ventrolateral, gracile, rubrospinal and finally the corticospinal tracts 
(Langworthy, 1933; Matthews and Duncan, 1971; Baron et a l , 1993). In the brain, 
myelination spreads from the medulla to the pons, midbrain and then the 
telencephalon. Optic nerve myelination begins at several sites along the nerve and 
progresses in a general rostral to caudal direction from retina to the chiasm (Black et 
a l , 1982; Hildebrand and Waxman, 1984; Remahl and Hildebrand, 1990; Colello et 
a l , 1995). The time scale varies between species but in the rat, myelin sheaths can 
first be demonstrated in the ventral columns just before birth at E l9, in the optic 
nerve by P6 but not until P12 in the corpus callosum (Bjartmar et a l , 1994). 
Myelination in this species is largely completed by 2 months of age.
Although these general statements can be made, the process of myelination is 
remarkably complex. There appear to be waves of rapid myelination (Ionasescu et 
a l, 1993) preceded by periods of oligodendrocyte proliferation (Matthews and 
Duncan, 1971; Skoff et al., 1976a; Skoff et al., 1976b) and rates of progression vary 
such that one system may be surpassed by another, later-starting, group (Ionasescu 
et al., 1993). In individual early fibres, there may be a chaotic mixture of naked 
portions, portions invested by cytoplasmic sheaths, mixed uncompacted and 
compacted sheaths and compact myelin sheaths (Skoff et al., 1980). Nodes may or 
may not be established. Apparently the move from a completely unmyelinated to 
myelinated state is gradual and non-uniform.
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1.6 Molecular biology of the myelin sheath
1.6.1 Lipids
Lipids constitute about 70% of the dry weight of myelin and account for its 
insulating property but there is no known myelin-specific lipid. One distinguishing 
feature is a high content of the sphingolipids, galactocerebroside and sulphatide, 
which together account for about 65% of total lipid (Norton and Cammer, 1984). 
Galactocerebroside is restricted almost exclusively to myelin and oligodendrocytes 
and is used as an oligodendrocyte marker (Raff et al., 1978). Myelin is also 
enriched in cholesterol and ethanolamine phosphoglycerides.
1.6.2 Proteins
The genes specific to myelination can be grouped according to their roles. Their 
protein products may be involved in the induction of myelination, in the contact and 
initial ensheathment of target axons or in the formation and compaction of the 
sheath. This last task requires structural myelin proteins as well as transport and 
assembly proteins. Although genes have been isolated in each of these categories, 
most progress has been made in terms of characterisation of the abundantly 
expressed genes of compact myelin and the axon-glial adhesion molecules.
1.6.2.1 Proteolipid protein (PLP)
Proteolipid protein (PLP) is the major integral membrane protein of myelin in the 
CNS and together with its isoform DM20, comprises 50% of the myelin protein 
mass (Nave and Milner, 1989). The gene is located on the X chromosome (Willard 
and Riordan, 1985) and contains 7 exons within 17kb. The open reading frame 
encodes for the PLP isoform of 276 amino acids. DM20 is generated by the use of 
an alternative splice site in exon 3 with deletion of exon 3B from the mature 
transcript. Consequently DM20 protein lacks 35 residues (amino acids 116 to 150) 
but is otherwise identical to PLP (Macklin et a l , 1987). Remarkable conservation 
of the gene across species is found with complete homology between man and 
mouse at the amino acid level. Sequence similarities with other molecules such as 
the neuron-specific M6 has led to the suggestion of the existence of a PLP/DM20 
gene family (Yan et a l , 1993).
Both Pip and Dm20 mRNAs are developmentally regulated, with Pip mRNA 
expression detected postnatally in the mouse CNS (Timsit et a l , 1992) where its 
levels parallel myelination. Dm20 mRNA has been detected earlier in the 
developing CNS, prior to myelination (Timsit et al., 1992; Yu et al., 1994; 
Dickinson et a l , 1996). The ratio of PLP/DM20 changes during myelination with
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DM20 as the major protein isoform prior to and during early myelination and PLP 
predominating in the adult (Van Dorsselaer et a l, 1987). The gene is also expressed
at a lower level in Schwann cells but the products are barely detectable in PNS 
myelin (Puckett et a l, 1987). Dm20 mRNA has also been localised in non-nervous 
tissue such as cardiac muscle and spleen (Campagnoni et a l, 1992).
Pip and Dm20 mRNAs are translated on membrane bound ribosomes and undergo
vesicular transport through the Golgi apparatus and on to the plasma membrane. 
Insertion into the membrane depends on correct association with lipids (Pasquini et 
a l, 1989) and in some cell lines also requires suitable proportions of DM20 and 
PLP (Sinoway et a l, 1994). PLP is a hydrophobic membrane protein consisting of a 
276-residue polypeptide chain with four hydrophobic domains linked by highly 
charged hydrophilic regions. Several models for the membrane orientation of the 
proteins exist (Popot et a l, 1991; Weimbs and Stoffel, 1992) although most recent
studies suggest that both the N- and C-termini lie on the cytoplasmic surface and the 
two loop regions of PLP are exposed to the extracellular surface (Weimbs and 
Stoffel, 1992; Gow et a l, 1997). The sequence deleted in DM20 is relatively 
hydrophilic and is likely to lie on the cytoplasmic side of the membrane.
The functions of PLP and DM20 are not known and there are a number of 
hypotheses, largely based on abnormalities seen in mutants. The abundance of PLP 
in the adult CNS, its localisation to compact myelin and the abnormal periodicity 
seen in the PLP-deficient mutants suggests a structural role in maintaining the 
closely apposed double intraperiod line (Duncan et a l, 1987). The strong
conservation of the protein’s primary sequence has led to the suggestion that 
PLP/DM20 are involved in either homotypic or heterotypic protein-protein 
interactions within the membrane (Helynck et a l, 1983; Sinoway et al., 1994). 
Further evidence for a role in membrane adhesion comes from the accumulation of 
proteolipids at cell-cell interfaces in some cotransfected cells (Sinoway et al., 1994). 
Possibly the proteolipids assemble into complexes in myelin, forming pores with 
adhesive properties between adjacent myelin lamellae (Sinoway et al., 1994).
DM20 is present prior to PLP and not correlated with myelination, is distributed in 
central and peripheral glia (Griffiths et a l, 1995) and achieves higher levels than 
PLP in the least severe PLP mutants. These features have led to the proposition of a 
role in glial cell development for this isoform.
1.6.2.2 Myelin basic protein (MBP)
MBP refers to a group of small positively charged molecules, specific to myelin, 
that are derived by alternative patterns of mRNA splicing. MBPs are abundant in
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compacted myelin (30-40% by mass in the CNS, 10-20% in PNS) in which they are 
membrane associated, presumably by electrostatic interactions with the negatively 
charged phosphate groups of the lipid bilayer. They are thought to be important in 
maintaining the fusion of the major dense line in the compact myelin sheath. The 
Mbp gene lies on mouse chromosome 18 and comprises 7 exons spanning 32 kb 
(Takahashi et a l,  1985). At least 6 isoforms, ranging in size from 14kDa to 21kDa,
differ by the presence or absence of internal peptides which are encoded by exons 2, 
5 and 6 (de Ferra et al., 1985). A functional difference between the various MBP
isoforms is not known but the evidence that the exon-2-containing proteins (17 kDa, 
21kDa) appear earlier in development (Carson et al., 1983) and are targeted to the 
nucleus at this time (Pedraza et al., 1997) has led to the suggestion that they may
subserve a regulatory function in implementing the myelination programme 
(Pedraza et al., 1997). Once oligodendrocytes have differentiated into fully 
myelinating cells, however, Mbp mRNAs are selectively transported to intracellular 
regions where myelin compaction is occurring (Trapp et a l, 1987; Verity and
Campagnoni, 1988). This spatial segregation of mRNA occurs in association with 
microtubules (Ainger et al., 1993; Bassell and Singer, 1997) and presumably 
functions to target these reactive proteins precisely to myelin, preventing adhesion 
via electrostatic interaction to inappropriate intracellular components.
More recently it was shown that the organisation of the Mbp gene is even more 
complex. The Mbp transcripts active in myelinating cells (including the glial cell 
specific promoter) are contained within a larger gene, the gene-of-oligodendrocyte- 
lineage (Golli-mbp) (Pribyl et al., 1993). This gene includes 5 additional exons and 
generates, by alternative RNA splicing, several MBP-related polypeptides, the 
functions of which are still unknown. Golli-mbp transcripts are expressed with a 
different developmental time course from myelin Mbp mRNA in glial cells. It is 
conceivable that the myelin-specific Mbp gene has evolved as a secondary 
transcription unit by acquisition of an intragenic transcription start site, thereby 
recruiting MBP as a novel structural protein.
1.6.2.3 Myelin-associated oligodendrocytic basic protein (MOBP)
MOBP, a recently characterised myelin protein specific to the CNS, appears to be a 
relatively abundant myelin component (Yamamoto et al., 1994; Montague et a l,
1997). The protein shares several characteristics with MBP, being small, 
hydrophilic, basic and localised within compact myelin. Several isoforms, 
generated by alternative splicing, show different developmental expressions and 
associations with microtubules and the karyoplasm (Montague et a l,  1997). The 
late developmental expression of some of the isoforms and their localisation to
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compact myelin suggest that MOBP acts at a late stage of myelin formation, perhaps 
in myelin compaction and sheath maintenance (Holz et al., 1996). The Mobp gene 
maps to chromosome 9 in the mouse (McCallion et a l, 1996).
1.6.2.4 V , 3’-cyclic nucleotide 3’-phosphodiesterase (CNP)
CNP represents about 5% of the total CNS myelin protein and consists of two 
peptides with apparent molecular weights of 46kD and 48kD (Sprinkle et al., 1978). 
Two genetic loci have been reported on mouse chromosomes 3 and 11 (Bernier et 
al., 1988) but the locus on chromosome 11 appears to contain all the DNA 
sequences necessary to encode the alternatively spliced Cnp mRNAs (Monoh et al., 
1989; Kurihara et al., 1990; Thompson, 1992). It is not yet clear whether the locus 
on chromosome 3 gives rise to Cnp mRNAs, perhaps in different tissues, or if it is a 
pseudogene. The gene on chromosome 11 is about 6kb in length and contains 4 
exons. Two transcription sites are utilised, at the beginning of the first (exon 0) and 
second (exon 1) exons, that appear to give rise to the two mRNAs. The mRNA 
produced from the upstream transcription site is the smaller one (2.4kb) because the 
first exon splices into the interior of the second (Kurihara et al., 1990). The 
additional splicing event adds 60 base pairs of coding sequence (Kurihara et al., 
1990; Thompson, 1992), resulting in the longer protein product. The larger protein, 
CNP2, is therefore identical to CNP1 except for an additional 20 amino acids at its 
N-terminus (Bernier et al., 1987). CNP1 is generated from the longer mRNA of 
2.8kb.
In the CNS, CNP is unique to oligodendrocytes. It is also found in the PNS in lower 
abundance and in a number of non-neural tissues at very low levels of activity. In 
the adult CNS, it is localised in the plasma membrane and processes, and in 
cytoplasm-containing compartments of the myelin sheath but is excluded from 
compact myelin (Trapp et al., 1988). Embryonic expression in oligodendrocyte 
precursors has been reported in vivo (Yu et al., 1994; Scherer et al., 1994), and 
specifically Cnp2 mRNA expression has been described in oligodendrocyte 
precursors in vitro (Scherer et al., 1994). At the time of oligodendrocyte 
differentiation, both mRNAs are induced (Scherer et al., 1994). The functional 
significance of the enzymatic activity displayed by CNP remains to be elucidated 
but since it appears to be the first myelin-related protein detected during 
development, it may have a crucial role in the early stages of myelination (Trapp,
1990). As well as possessing membrane-association properties, CNP binds to the 
actin-based cytoskeleton (Gillespie et al., 1989; De Angelis and Braun, 1996) and it 
has been suggested that it may have a role in signal transduction cascades 
(Thompson, 1992). Isoprenylation of the protein at its C-terminal may have a role in
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CNP function since transfection studies have shown that only isoprenlyated protein 
causes cells to extend filopodia and processes (De Angelis and Braun, 1994). 
Isoprenylation does not affect the ability of the protein to interact with the 
cytoskeleton (De Angelis and Braun, 1996).
1.6.2.5 Myelin associated glycoprotein (MAG)
MAG, a minor component of myelin, constitutes about 1% of CNS myelin protein. 
It is an integral membrane glycoprotein with an amino terminal extracellular 
domain, a single transmembrane region and a cytoplasmic carboxy terminal domain. 
The extracellular domain can be divided into 5 regions with structural features 
similar to immunoglobulin domains and MAG is therefore considered to be a 
member of the immununoglobulin gene superfamily (Salzer and Colman, 1989). 
The protein localises to the periaxonal regions in the CNS but is excluded from 
compact myelin (Trapp et a l, 1989), and it has been suggested that it is involved in 
contact between the myelin forming cell and the axon (Owens et a l, 1990; Trapp, 
1990; Quarles et a l, 1992). The two isoforms, L-MAG and S-MAG, are generated 
by alternative splicing (Salzer et a l, 1987) of a single gene on mouse chromosome 7 
and differ only in their C-termini. Their apparent molecular weights are 72 and 
67kDa respectively before glycosylation, and lOOkDa when glycosylated (Owens et 
al., 1990; Quarles et al., 1992). L-MAG is prominent during early CNS myelination 
whereas both forms are present in nearly equal amounts in mature CNS myelin 
(Trapp, 1990). Phosphorylation of L-MAG occurs on the cytoplasmic domain 
(Edwards et a l , 1989; Afar et a l, 1990; Bambrick and Braun, 1991) and may be 
related to the differential expression and possibly a different function from S-MAG. 
It has been proposed that the interaction of L-MAG with its ligand generates a 
signal involving activation of Fyn tyrosine kinase (Fyn) at the the beginning of 
myelination (Umemori et a l,  1994). Fyn apparently acts downstream of L-MAG as 
a signalling molecule, and indeed, ^ -k n o ck o u t mice show impaired myelination 
(Umemori et al., 1994).
1.6.2.6 Minor CNS proteins
Several other CNS myelin proteins have been documented including 
myelin/oligodendrocyte glycoprotein (MOG) (Linington et a l,  1984), mapping to 
chromosome 17, myelin oligodendrocyte specific protein (MOSP) (Dyer et a l,
1991), oligodendrocyte-myelin glycoprotein (OMgp) (Mikol et a l, 1993), myelin 
and lymphocyte protein (MAL) (Magyar et a l, 1997) and oligodendrocyte specific 
protein (OSP) which maps to chromosome 3 (Bronstein et a l , 1996). The 
functional significance of these proteins is not yet known.
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1.7 Review of CNS myelin mutants
1.7.1 Introduction
Myelin mutants have contributed greatly to our understanding of the assembly and 
maintenance of the myelin sheath and its functional importance in the nervous 
system. A diverse group of spontaneous mutants in several species has recently 
been joined by engineered genetic variants characterised by defects of myelin 
formation. Both structural and regulatory genes may be altered, shedding light on 
the normal function of the gene through correlation with the resultant phenotype. 
Unfortunately, however, the pathogenesis of disease does not often appear as simple 
as lack of a functional protein. As well as yielding functional information, mutants 
may also be models for human neurological diseases or may act as recipients for 
glial cell transplantation studies. Most of the mutations involve genes encoding 
structural myelin proteins. Other genes encoding transcription factors, proteins for 
signal-transduction, enzymes of lipid metabolism, and cytoskeletal elements are as 
important as structural myelin proteins for myelin formation, but little genetic 
information is currently available. Although many of the spontaneous mutations 
still remain uncharacterised, the major developments in gene mapping and cloning 
make their future definition a real possibility. This will hopefully allow further 
access to the complex processes involved in the formation of the myelin sheath.
1.7.2 shiverer and myelin-deficient
The spontaneous shiverer (Mbpfihi) mutant was the first myelin mutant characterised 
at the molecular-genetic level, arising from the deletion of exons 3-7 of the Mbp 
gene on chromosome 18 (Roach et al., 1983; Roach et al., 1985). Homozygous 
mice are unable to synthesise any of the MBP isoforms and thus provide a model 
system in which to investigate myelination in the complete absence of these 
proteins. Animals develop a generalised body tremor during the third postnatal 
week and adults suffer from tonic seizures, with most dying before 6 months of age 
(Chemoff, 1981).
Hypomyelination is most apparent in the CNS where axons are surrounded by very 
thin sheaths or remain naked (Rosenbluth, 1980; Carson et al., 1983). Myelin 
compaction is variable and the intracellular surfaces of two myelin membranes 
frequently remain separated (Privat et al., 1979). This absence of the major dense 
line suggests a role for MBP in its formation. However, occasional sheaths do 
demonstrate a MDL so it may be that other proteins can also contribute to this 
structure (Rosenbluth, 1980).
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In contrast, PNS myelin shows very little alteration, with normal periodicity and 
only subtle alterations in thickness (Panagopoulos et a l, 1989; Gould et a l, 1995).
The double mutant P0-/MBP- confirms the suggestion that P0 substitutes for MBP in 
the formation of the PNS major dense line (Martini et a l, 1995).
Transgenic complementation of Mbpshi mice with a wild-type Mbp gene results in a 
partial phenotypic rescue (Readhead et a l, 1987) with restoration of the MDL, 
confirming the putative role of the protein in myelin compaction. The amount of 
myelin produced is gradually restored by increasing levels of MBP in mutant 
animals, which indicates that MBP synthesis is a rate-limiting step of myelin 
assembly (Readhead et al., 1987; Popko et a l, 1987). Intriguingly, shiverer mice 
crossed with Pip-/- knock-out mice show amelioration of the phenotype and have a
normal lifespan. They also produce more myelin than shiverer mice, although the 
myelin periodicity is abnormal (Stoffel et a l, 1997).
Allelic to shiverer is the mutant myelin deficient (Mbpshi~mld), in which there is 
duplication of the entire Mbp gene and an inversion of the duplicated region 
between exon 2 and the 3y end (Okano et a l, 1988). This results in the formation of 
endogenous antisense RNA (Tosic et a l, 1990; Fremeau, Jr. and Popko, 1990) 
which interferes with Mbp mRNA. The phenotype is slightly milder (Popko et a l, 
1988), presumably because a small amount of residual MBP is incorporated into the 
myelin sheath.
1.7.3 quaking
The murine mutation quaking (<qk) is inherited as an autosomal recessive trait. 
Homozygous mice show hypomyelination of the CNS and a less marked deficit in 
the PNS. Tonic seizures occur in these animals although they have a normal 
lifespan. Affected females breed normally but affected males are sterile.
Oligodendrocyte density is increased and there are often vacuoles in the cytoplasm 
suggestive of defective incorporation (Greenfield et a l, 1977) and degradation of 
myelin proteins (Watanabe and Bingle, 1972). This mutation is associated with a 
deletion on chromosome 17 (Ebersole et a l, 1992). Initial characterisation of the 
locus indicates that several protein isoforms are produced, some abundant in brain, 
lung, heart and testis (Ebersole et a l,  1996). The gene product is predicted to have 
both signal-transducing and RNA-binding properties, perhaps having a role in the 
regulation of myelin gene expression (Ebersole et al., 1996).
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1.7.4 Pip mutants
The largest group of known myelin mutations involves the Pip gene and is inherited 
in an X-linked manner. The normal myelination process is impaired in these 
mutants, leading to severe neurological dysfunction and, in most cases, early death 
of the animal. Mutations occur in several species including mouse, man, rat, dog 
and pig and in some, several allelic forms are present. The majority of the mutations 
across the species are point mutations within the coding region, leading to amino 
acid substitutions (Gow et a l, 1994). The gene appears intolerant of any change so 
that even conservative substitutions result in gross phenotypic changes.
1.7.4.1 P tfp
The CNS of Pl]Jp mice shows a severe reduction of myelin and a high rate of 
oligodendrocyte cell death. The resulting lack of mature oligodendrocytes is 
accompanied by an increase in the numbers of mitotic precursors (Skoff, 1982; 
Knapp et al., 1986) which show an abnormal cell cycle (Knapp and Skoff, 1987). A 
small percentage of oligodendrocytes escape cell death and differentiate to a myelin- 
producing stage. Their myelin shows slightly reduced spacing of the intraperiod 
line, suggesting that PLP is not required for extracellular membrane adhesion but 
may act as a strut-like spacer (Duncan et a l, 1989). An astrocytosis is present and 
defects in astrocyte cell cycle and metabolism are reported (Knapp and Skoff, 1993).
The cellular mechanisms underlying oligodendrocyte death have not been 
determined. The two common hypotheses are the lack of a functional protein or the 
gain of a toxic function due to structural misfolding of the altered protein. There is 
evidence to support both theories. For example, knock-out and transgenic studies 
suggest that cell death is not due to a simple absence of PLP/DM20. Transgenic 
Plp/P/Y  mice are not successfully “rescued” (Nadon et a l, 1994; Schneider et a l,
1995) whilst knock-out mice deficient in both isoforms do not develop the lethal 
phenotype associated with Pip mutations (Boison and Stoffel, 1994; Boison et a l, 
1995; Klugmann et a l, 1997). Conversely, evidence against a “toxic” theory 
includes the prolonged survival of PljJp oligodendrocytes when transplanted into 
shiverer tissue (Lachapelle, 1995) and their increased lifespan in vitro when cultured 
in astrocyte conditioned medium (Knapp et a l, 1996). If it is the case that loss of 
oligodendrocytes is due to abnormal conformations or toxic effects of mutant 
proteins, it is not clear whether this is a non-specific cytotoxicity or interference 
with a specific glial protein function. Arrest of transport of abnormal PLP/DM20 
through the ER and secretory pathways may be involved (Gow et al., 1994). 
Unexpectedly, transgenic mice over-expressing Pip and Dm20 have been found to
29
develop a phenotype similar to Plp/P (Readhead et a l , 1994; Kagawa et a l , 1994), 
indicating that myelination is very sensitive to any alteration in Pip gene dosage.
1.7.4.2 Plpip~rsh
The viable Plp/P'rsh mouse, characterised by a single amino acid substitution 
(isoleucine186 -^threonine) in exon 4, differs from most other Pip mutants in that it 
shows dysmyelination associated with a normal complement of oligodendrocytes 
and little cell death (Schneider et al., 1992). Also, affected males and homozygous 
females show normal fecundity and lifespan (Fanarraga et a l, 1991). Seizures are 
not a feature and the hindlimb tremor reduces with time (Griffiths et a l, 1990). 
Heterozygous females appear clinically normal.
Hypomyelination of the CNS is present but the deficit is not as severe as in other 
Pip mutants such as PlpJP, the md rat or sh pup. Differences are identified between 
the pattern of myelination in the spinal cord and the optic nerve (Fanarraga et a l,
1992) such that many optic nerve axons remain unmyelinated whilst myelination 
continues to progress in the cord. Eventually many of the smaller spinal cord axons 
acquire almost normal myelin sheaths although larger ones remain hypomyelinated. 
Well-compacted sheaths of normal periodicity are not uncommon (Griffiths et al., 
1990). PLP protein levels are severely decreased but the amount o f the DM20 
isoprotein is normal (Mitchell et a l, 1992) and myelin sheaths stain intensely with 
antibodies recognising both isoproteins. A unique characteristic of Plp/P'rsh with 
respect to other Pip mutants is the presence of normal, or even increased, 
oligodendrocyte numbers at the time of myelination (Fanarraga et al., 1992). Also, 
death of oligodendrocytes does not appear to be a major feature of this mutation 
(Griffiths et al., 1990). This is intriguing in that it uncouples the two major 
phenotypic characteristics of Pip mutants, hypomyelination and cell death, and 
suggests a connection between DM20 and glial cell development and survival.
1.7.4.3 Other Pip mutants
1.7.4.3.1 Plp)P-4j and Plpip-™d
A new murine mutant, with a single nucleotide substitution in exon 2 of the Pip 
gene, has been identified and termed Plp/P'4j (Billings-Gagliardi et a l,  1995).
Affected animals show a tremor, seizures and death before weaning. The number of 
myelin sheaths is even fewer than in PlpJp, glial cell counts are increased and dead 
cells are prominent. Plp/P'msd is a lethal allele defined by the conservative
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substitition a l a n i n e 2 4 2 _ > v a i i n e  jn iast transmembrane domain of the PLP/DM20 
(Gencic and Hudson, 1990; Macklin et al., 1991).
1.7.4.3.2 Rat, dog, rabbit, pig and man
Other mutations in the Pip gene include the myelin deficient rat {md-rat) (Boison 
and Stoffel, 1989), shaking pup {sh-pup) (Nadon et al., 1990), paralytic tremor 
rabbit (pt), type AIII Landrace pig (Blakemore et al., 1974a) and Pelizaeus 
Merzbacher disease (PMD) and forms of spastic paraplegia in man (Seitelberger, 
1995). Although there are differences in severity and age of onset between species 
and allelic forms, the general phenotype of the Pip mutants is similar with 
hypomyelination, generalised tremors, seizures and early death, prior to adulthood, 
in hemizygous males. The degree of hypomyelination varies, being very severe in 
the md-rat (Duncan et al., 1987), for example, and less marked in the sh-pup 
(Griffiths et al., 1981). Less severely hypomyelinated mutants, such as Plplp'rsh and 
sh pup, tend to have longer lifespans. Any myelin which is formed is usually 
disproportionately thin, poorly compacted and fails to stain for PLP protein (Duncan 
et al., 1987). Mitotic rates of immature glia are increased and in some mutants, 
oligodendrocytes show marked distension of the rough endoplasmic reticulum (Gow 
et al., 1994). This swelling may indicate a failure of normal transport o f proteins 
from the RER to the Golgi, perhaps due to abnormal protein folding. An 
astrocytosis is a common feature (Knapp and Skoff, 1993) and is most severe in the 
mutants with least myelin. Physiological abnormalities such as an increased pH 
have been seen in cultured mutant astrocytes (Knapp et al., 1993). Microglia are 
increased, especially at the time of maximum oligodendrocyte death (Knapp et al.,
1993).
Female heterozygotes show a variable phenotype but the extent of hypomyelination 
is always considerably less than the 50% predicted by random X-inactivation 
(Duncan et al., 1986; Duncan et al., 1993). This suggests that there is either 
preferential inactivation of the mutant allele or increased survival of those cells with 
a wild type allele
1.7.4.4 Uncharacterised CNS dysmyelinating mutants
With advances in gene mapping and cloning being extended to other species, the 
possibility of cloning genes on the basis of mutant phenotypes is becoming more 
likely. Some of the myelin mutants will reveal novel genes or those with a 
previously unrecognised function in myelination. Several examples are given here 
although this is not exhaustive.
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The taiep (tremor, ataxia, immobility, epilepsy, paralysis) rat is a CNS 
hypomyelinating and demyelinating mutation inherited in an autosomal recessive 
fashion. A unique feature is massive accumulations of microtubules in 
oligodendrocytes (Duncan et a l, 1992) so this mutation may offer insights into the 
role of the cytoskeleton in myelination. Another rat, the zitter rat (Kondo et a l, 
1991; Kondo et a l, 1992), shows pronounced hypomyelination in the spinal cord 
and accumulation of abnormal membranous structures in oligodendrocytes, in 
conjunction with distension of the RER, perinuclear structures and Golgi apparatus. 
These changes may indicate a defect in membrane biosynthesis.
Two strains of Syrian hamsters have been reported with a hypomyelinating disorder 
of the CNS, inherited as an autosomal recessive trait. In the first strain (Nunoya et 
a l, 1985) there is persistence of the tremor throughout life, but the second shows 
recovery by 100 days (Kunishita et a l, 1986). The myelin, although reduced in 
amount, appears structurally normal and no qualitative or quantitative 
oligodendrocyte abnormalities were found (Nunoya et al., 1985).
Two breeds of dog, the Chow Chow and Weimaraner, show an unusual distribution 
of CNS hypomyelination. Both conditions are autosomal recessive traits (Komegay 
et a l, 1987; Lunn et a l, 1995) although it is not known if the same gene is involved 
in each. The hypomyelination, most marked in young dogs, involves mainly the 
peripheral margins of the spinal cord white matter and shows some recovery with 
age (Lunn et al., 1995). The brains are only mildly affected. The susceptibility of 
the periphery of the spinal cord white matter may relate to the migration of 
oligodendrocyte precursors and the pattern of myelination.
Larger species may also suffer from CNS dysmyelination. For example, a 
dysmyelinating condition has been reported in Charolais cattle in which myelin 
compaction appears impaired, with hypertrophied tongues of oligodendrocyte 
cytoplasm surrounding axons at the paranodes (Palmer et a l, 1972; Blakemore et 
a l, 1974b).
1.7.4.5 Transgenic mice
As well as spontaneous mutants or those created in radiation/mutagenesis 
experiments, it is now possible to create mice with targeted null mutations or 
random transgene insertions for virtually any cloned gene. The phenotype resulting 
from complete loss of a gene can yield much information on the normal functioning 
of that gene. The over-expression of a particular protein can also shed light on its 
function as well as acting to “rescue” mutant phenotypes. The resultant phenotype 
of “knock-out” mice is often surprisingly mild, perhaps due to redundancy of
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function of some genes. Several myelin genes have been studied in this way and 
some examples are given. This is not a comprehensive list, however, and new 
models are being created at a fast rate.
Null alleles have been created for several myelin genes including Mag, Pip and 
UDP-glucuronosyltransferase 8 (Ugt8). MAG-deficient mice are almost normally 
myelinated in the CNS and PNS with only subtle abnormalities of the periaxonal 
region and redundant myelin sheaths (Li et a l , 1994; Montag et al., 1994). 
Targeted disruption of the Plp/Dm20 gene results in surprisingly mild clinical signs 
and the production of large amounts of myelin, although this displays abnormal 
periodicity (Boison and Stoffel, 1994; Rosenbluth et a l , 1996; Klugmann et a l ,
1997). Mice lacking UGT8 do not synthesise the major myelin glycolipids 
galactocerebroside and its sulfated derivative sulfatide, but instead substitute 
glucocerebroside into myelin. They form compact myelin with sheaths of virtually 
normal thickness but still exhibit severe generalised tremoring and mild ataxia. It 
seems likely that the compositional change in myelin lipids is responsible for the 
phenotype.
Transgenic Pip and Cnp mice with extra gene copies have also been created. Extra 
copies of Cnp lead to mild CNS hypomyelination, redundant myelin membrane with 
intramyelinic vacuoles and lack of cytoplasmic compaction. The oligodendrocytes 
appear to mature earlier in development, resulting in earlier maximum gene 
expression for Mbp and Pip, suggesting that CNP is an early regulator of cellular 
events leading to CNS myelination (Gravel et a l , 1996). Mice expressing Pip 
mRNA at only twice normal levels develop a dysmyelinating phenotype, 
demonstrating that the Pip gene is dosage sensitive (Readhead et a l , 1994; Kagawa 
et a l, 1994; Griffiths et a l, 1995).
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1.8 Genetic mapping in the mouse
1.8.1 Introduction
Interest in mouse breeding began several hundred years ago when the Chinese and 
Japanese imperial courts were entertained by mice with unusual coat-colours or 
behaviour (Tokuda, 1935). Phenotypic variants continued to be of value to 
collectors throughout the centuries and in 1915, the genetic mapping of these 
mutants got underway with the reported linkage of two coat colour mutations, albino 
and pink-eyed dilution (Haldane et al., 1915). Conceptually mouse mapping altered 
little until the 1970s and consisted primarily of linkage analysis of phenotypic 
deviants. This changed with the advent of recombinant DNA technology and the 
discoveries of polymorphic genetic markers (Botstein et a l , 1980) and interspecific 
crosses (Avner et al., 1988) which gave tremendous impetus to the production of 
mouse genetic maps. Amongst mammalian species, the mouse genetic map is now 
the second most sophisticated and serves many functions, from studies on genome 
evolution to the analysis of disease models and complex traits that may be 
applicable to man. As the only species where it is possible to rapidly perform high 
resolution mapping, positional cloning and genetic engineering leading to targeted 
alterations, it is obvious that the mouse has no equivalent as a mammalian model.
1.8.2 Mouse taxonomy
1.8.2.1 Systematics of the Mus species
Since genetic mapping in the mouse often exploits allelic differences between 
strains and species of mice, an understanding of the taxonomy is vital to any 
mapping project. Mouse systematics are complex and as more information is 
gained, so the classification of and within species may alter. Currently, within the 
sub genus Mus there are nine species of mice including the house mouse Mus 
musculus, some of which can be bred to produce fertile hybrids (Figure 3, page 36 ). 
The house mouse is made up of four populations or subspecies, namely M. musculus 
musculus, M. musculus domesticus, M. musculus castaneus and M. musculus 
bactrianus (Bonhomme and Guenet, 1989). These groups can be distinguished 
morphologically and genetically and inhabit non-overlapping ranges but can 
interbreed readily. A question still remains about whether they are simply 
subspecies or in fact should be classified as separate species (Bonhomme and 
Guenet, 1989).
The three closest relatives of Mus musculus are the species Mus spretus, Mus 
spicilegus and Mus macedonicus. These do not breed with Mus musculus in the
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wild although they can be induced to do so in the laboratory (Bonhomme et al., 
1984). The genetic divergence between the Mus species and subspecies, and their 
ability to interbreed with laboratory strains to produce fertile offspring have been 
exploited to great effect, playing an important role in the development of genetic 
maps. In particular, crosses between inbred laboratory strains and Mus spretus or 
Mus musculus castaneus have proved invaluable.
1.8.2.2 Origin of inbred laboratory strains
Mice that result from the process of at least 20 sequential brother-sister matings are 
considered to be inbred. There are now hundreds of inbred laboratory strains and 
substrains available to the researcher but the recent common ancestry of many of the 
traditional strains has limited their genetic diversity. Their history dates back to the 
19th century, when the house mouse became an object of fancy in Europe and many 
variant strains were imported, particularly from the Far East. By the beginning of 
this century, European and American fanciers were familiar with numerous 
phenotypically distinct lines (Morse, 1981). A critical connection between these 
mouse fanciers and early geneticists was Miss Abbie Lathrop, a retired 
schoolteacher in Massechussetts who began to breed mice for sale as pets in the 
early part of this century (Morse, 1978). She supplied the geneticists with a constant 
source of variant mice obtained from fanciers and many of the common inbred 
strains used today such as C57BL/6 and C57BL/10 are derived entirely from her 
mice. Their mixed origins mean that none of the traditional inbred strains are truly 
representative of any one Mus musculus subspecies, but it is suggested that the most 
prominent component of the mosaic is Mus musculus domesticus (Bonhomme et al., 
1987). Despite this multi-faceted origin, limited polymorphism exists between the 
strains due to their shared recent ancestry. In fact, all the classical inbred strains 
have been found to carry the same domesticus mitochondrial DNA derived from a 
single female (Ferris et a l , 1982; Ferris et al., 1983) and many carry an 
indistinguishable musculus Y chromosome (Tucker et al., 1992). The absence of 
sufficient interstrain variation has limited mapping using DNA polymorphisms and 
brought about the shift to interspecific and intersubspecific crosses (see Interspecific 
crosses, page 41). In this situation, inbred laboratory strains are bred with Mus 
spretus or Mus musculus castaneus to exploit the much larger genetic divergence 
and more frequent occurrence of DNA polymorphisms. However, the great 
variation in microsatellite markers, even between inbred strains, has reversed this 
somewhat, enabling the use of interstrain crosses for linkage analysis.
35
M
. 
m
us
cu
lu
s
a.
9
2
M
36
Fi
gu
re
 
3: 
Sy
st
em
at
ic
s 
of 
the
 
M
us
 
su
bg
en
us
. 
D
om
es
tic
us
, 
m
us
cu
lu
s, 
ca
sta
ne
us
 
an
d 
ba
ct
ria
nu
s 
ar
e 
all
 
su
bs
pe
ci
es
 
wi
th
in
 
the
 
M
. 
m
us
cu
lu
s 
gr
ou
p.
 
O
th
er
 
lin
es
 
re
pr
es
en
t 
w
el
l-d
ef
in
ed
 
sp
ec
ie
s. 
Th
e 
in
di
ca
te
d 
tim
es
 
of 
di
ve
rg
en
ce
 
be
tw
ee
n 
su
bs
pe
ci
es
 
ar
e 
in 
m
ill
io
ns
 
of
 
ye
ar
s 
be
fo
re
 
pr
es
en
t 
(m
yr
 
bp
).
1.8.3 The mouse genome and mutant loci
The mouse genome represents a total haploid length of three billion base pairs 
spanning 20 chromosomes. Large genomic sequences have been conserved between 
mice and humans and it has been suggested that by simply breaking the mouse 
genome into about 180 pieces and re-ordering them, the human genome could be 
reproduced (Copeland et al., 1993). Currently, about 2/3 of the mouse map is made 
up of such segments where both synteny and gene order have been conserved. At 
the time of writing, over 6000 microsatellites (see Microsatellite markers, page 40 
for definition) and 5554 genes have been mapped in the mouse with 1900 genes 
common to both man and mouse.
There have been 958 deleterious murine mutations recorded, of which more than 
700 have been localised on the genetic map. The spontaneous mutation rate in mice 
is about 5 x 10'6 to 10‘5 for recessive alleles although some loci are highly mutable 
compared to others. About two thirds of mutations are in a previously unknown 
locus and one third define an already known locus. Variant mice carrying mutations 
provide a vital means of accessing the genome. With the recent technological 
advances in mapping, it should be possible to clone virtually any mouse mutation on 
the basis of its phenotype and its position in the genome. This should permit 
identification of the gene and the study of its protein product, its normal biological 
function and its role in disease states. The large number of conserved linkage 
groups also enables the identification of homologous human genetic disorders and 
the use of the mouse as a disease model.
1.8.4 Linkage mapping in the mouse
1.8.4.1 Types of genetic maps
A genetic map is a representation of the distribution of a set of loci within the 
genome. Mapping can be accomplished at many different levels of resolution and 
several types of maps exist. The linkage map was the first to be developed and can 
be constructed only for those loci that occur in two or more heritable alleles. 
Offspring are counted that receive either parental or recombinant allele 
combinations from a parent heterozygous at two or more loci. Linkage between loci 
can be determined and the relative distances between them calculated on the basis of 
recombination rates. Distances are measured in centimorgans (cM), where one 
centimorgan is equivalent to a recombination rate of 1%, ie. one in a hundred 
offspring has the non-parental combination of alleles. In the mouse, the genome is 
considered to be 1600cM in length.
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The chromosome map is based on the number and banding pattern of mouse 
chromosomes and is defined by microscopic examination. Resolution is therefore 
not high compared to linkage and physical maps. Somatic cell hybrid analysis and 
in situ hybridisation, techniques used to develop chromosome maps, have been
limited in their application to the mouse genome (see Historical perspectives of 
linkage mapping in the mouse, page 38) and mapping in this species has tended to 
rely on classical linkage analysis.
Physical maps involve the direct analysis of DNA and distances between loci are 
measured in base pairs. Eventually, the goal of the mouse genome project is the 
development of a complete physical map where the entire DNA sequence is known. 
In theory, linkage, chromosomal and physical maps should all provide the same 
information on chromosomal assignment and order of loci but in fact, the relative 
distances within each map can be quite different. Only the physical map provides an 
accurate measurement of the actual length of DNA between two loci. Chromosomal 
maps are modified according to the packing of DNA molecules in different 
chromosomal regions and linkage distances are influenced by the bias of different 
DNA regions to undergo recombination. Genetic maps tend to be a combination of 
all these map types although the greatest bulk of information comes from linkage 
analysis. Thus, the centimorgan is the genetic unit of measurement at present but it 
is likely that accumulation of physical mapping data will lead to the megabase 
becoming the established unit.
1.8.4.2 Historical perspectives of linkage mapping in the mouse
The mouse has appealed to geneticists for far longer than the relatively recent leaps 
in mapping technology. Early geneticists found the mouse attractive for the 
investigation of Mendel’s laws of inheritance for several reasons. A short 
generation time, large litter sizes and an immediate post-partum oestrus permitted 
the breeding of large numbers of mice relatively quickly. The availability of inbred 
and wild-derived strains, the existence of naturally occurring variants and the ability 
to perform controlled matings meant that the inheritance of phenotypically obvious 
traits could be followed (Avner et al., 1988; Cote et a l, 1994). Vaginal plugs 
allowing accurate identification of mating times, the male’s tolerance of young 
offspring and the ease of handling were also advantageous. Despite these inherent 
advantages, studies in other species such as Drosophila and Caenorhabditis greatly 
overshadowed early mouse genetics. It took the recent discoveries of interspecific 
crosses (Avner et al., 1988), new types of genetic markers (Botstein et al., 1980)
and large numbers of conserved regions between human and mouse genomes (Cote 
et al., 1994) to move mouse genetics from backwater to forefront. It is now a vital
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model for the Human Genome Project and substantial emphasis has been placed on 
the genetic and physical mapping of the mouse genome worldwide (Brown, 1992).
Early classical linkage mapping was founded on localising the genes responsible for 
phenotypic variants and until the 1980s, the vast majority of mapped loci were 
defined by mutations that had been painstakingly incorporated into the genome map. 
Progress was slow because it was technically difficult to arrange crosses in which 
more than a few visible markers were segregating. Each new mutation had to be 
bred into a strain with other phenotypic markers and then further breeding pursued 
to test for linkage to any of these other markers. This had to be repeated with 
different groups of phenotypic markers until linkage was established. Chromosomal 
mapping using in situ hybridisation and somatic cell hybrids, powerful tools in the 
mapping of human disorders, were less successful in the mouse. In the case of in 
situ hybridisation, this was due to the acrocentric nature of mouse chromosomes 
which makes it difficult to differentiate cytologically between individual 
chromosomes. Somatic cell hybrids carrying single mouse chromosomes, or 
chromosomes with deletions or translocations, were not as widely available in 
mouse genetics as in the human field (Copeland et al., 1993). Also, it was usually 
possible in mice to find a variant that could be used for linkage mapping, obviating 
the need for other techniques.
Genetic mapping in the mouse was revolutionised by DNA cloning technology, the 
interspecific backcross and new DNA markers. Recombinant DNA techniques 
allowed the identification of numerous restriction fragment length polymorphisms 
(RFLPs) between strains of mice. RFLPs are DNA variations that affect the 
distance between restriction sites, usually as a result of a nucleotide change that 
creates or eliminates a site. The different fragment sizes generated after enzyme 
digestion can then be detected with labelled cloned probes on Southern blots. 
Theoretically, thousands of cloned loci could be mapped in a single cross. 
However, attempts to identify RFLPs between different inbred laboratory strains 
often met with limited success even after testing with large numbers of enzymes. In 
one study, RFLPs were identified at only 30% of the single copy loci tested with 22 
different restriction enzymes (Knight and Dyson, 1990). The use of interspecific 
crosses overcame the limitations imposed by the low degree of allelic variation 
among traditional strains. RFLPs could be identified for nearly every cloned locus 
tested on the spretus backcross (LeRoy et a l, 1992). This breeding strategy was 
incredibly important because it provided the first complete linkage map of the 
mouse genome based on DNA markers and because it created mapping panels that
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could be used to rapidly map essentially any new locus that was defined at the DNA 
level.
However, although the capacity to type RFLPs changed the face of genetics, it was 
not a panacea. Limitations included the difficulty in finding polymorphism in a 
cloned region, the often di-allelic nature of the polymorphism and the labour- 
intensive nature of typing large numbers of RFLP loci by Southern blotting. More 
recently, highly polymorphic microsatellite markers distinguishable by PCR have 
been developed which are technically easier and faster to map than RFLPs. There is 
no need for these loci to represent actual genes because their only purpose is to mark 
particular points along each chromosome, acting as anchor loci. Most new loci are 
now mapped in interspecific or intersubspecific crosses using microsatellite markers 
as positional anchors to establish linkage.
1.8.4.3 Microsatellite markers
Microsatellite markers, also termed simple sequence length polymorphisms 
(SSLPs), are now the most abundant class of marker on the mouse map. These are 
di-, tri- and tetranucleotide sequences repeated multiple times in series and were 
first developed as human genetic markers (Weber and May, 1989) before being 
applied to the mouse (Love et a l , 1990; Comall et a l, 1991). The commonest 
microsatellites in the mouse genome are dinucleotide repeats, the most frequent 
being (CA)n which occurs in about 100,000 locations (Hamada et a l, 1982). Perfect 
microsatellites are those with a single uninterrupted repeat element whilst imperfect 
loci contain two or more runs of the same sequence broken up by short stretches of 
other sequences. Many microsatellites are imperfect and also a mixture of distinct 
runs of two or more different repeat units. The length of the repeat run varies 
among individuals in a species and between different inbred strains o f mice, 
apparently due to slippage during replication with a mutation rate estimated to be 
around 10'4 per locus per generation (Dietrich et a l, 1992). Microsatellite markers 
can be easily typed by PCR using unique sequences on each side for primer 
production and show polymorphism rates of about 50% among inbred laboratory 
mouse strains (Dietrich et al., 1992). The vast majority have been developed by the 
Whitehead Institute/Massachusetts Institute of Technology Centre for Genome 
Research (Copeland et al., 1993), from which the term Mit, used in naming 
individual markers, is derived. Each marker has been analysed for polymorphism on 
a panel of 12 commonly used laboratory strains. At the time of writing, there are 
over 6500 microsatellite markers spread across the genome, allowing fine mapping 
to a very small interval.
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1.8.4.4 Interspecific crosses
Until the mid 1980s, mouse gene assignment relied on two- or three-point crosses 
between laboratory strains or recombinant inbred strains. This was limited by the 
low degree of allelic variation among laboratory strains and as only a small number 
of genes were informative in each cross, a composite map could only be deduced 
indirectly. The introduction of the interspecific cross overcame this limitation, 
initially using Mus spretus and inbred laboratory strains to produce fertile F 1 hybrid 
females (Avner et al., 1988). The genetic divergence that exists between these two 
species is such that RFLPs can be identified for nearly every locus that is tested. 
There are, however, disadvantages in using Mus spretus as the wild mouse species 
in an interspecific cross, the main one being that the FI males are infertile, thus 
preventing the study of male meiosis and slowing down the generation of sufficient 
backcross progeny. Also, the wide divergence may have permitted the accumulation 
of chromosomal inversions that could suppress recombination and hamper fine 
mapping (Hammer et al., 1989). For these reasons, Mus musculus castaneus is 
often used instead and although more closely related, the degree of polymorphism is 
still high and both sexes of the FI generation are fertile. With the advent of 
microsatellite markers, the need to use highly divergent mice in backcrosses has 
diminished and it is in fact possible, although more difficult, to map genes in crosses 
between laboratory strains.
1.8.4.5 Approach to mapping of a novel mutation
In mouse genetics, the search for a gene responsible for a mutant phenotype with an 
unknown basis begins with consideration of potentially related, previously 
characterised loci. These candidates may be genes in which mutations cause a 
similar phenotype or those suggested by biochemical or molecular analysis of the 
phenotype. If efforts to map the novel phenotype by association fail, it is necessary 
to move to a positional cloning exercise where the cloning of a gene is based solely 
on pinpointing its position in the genome (Collins, 1992; Collins, 1995). This is a 
two stage process that involves the identification of close flanking DNA markers 
followed by cloning across the region and characterisation of the mutated gene. For 
the first stage, a new mapping cross must be established in which DNA markers 
from across the genome can be tested for linkage. A detailed linkage map is 
accomplished by following the segregation of the mutant locus, defined by the 
phenotype, and the DNA markers, usually microsatellite markers. For recessive 
genes, an interspecific or intersubspecific backcross is utilised to generate the 
progeny for mapping. Markers that have been finely mapped and ordered via the 
backcross serve as a scaffold onto which overlapping clones from large insert 
genomic libraries can be positioned relative to each other and the mutant locus.
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This set of contiguous clones covering the region of interest is termed a “contig”. 
The generation of a contig is achieved by using the ends of previously obtained 
clones to rescreen the library in a technique known as “chromosome walking”. A 
number of systems for generating large insert libraries have been described 
including, most importantly, the yeast artificial chromosome (YAC) (Kusumi et a l , 
1993), but also the bacterial artificial chromosome (BAC) (Collins, 1995) and phage 
1 (PI) (Pierce and Sternberg, 1992a; Pierce et a l , 1992b). Once clones covering the 
critical region have been obtained, the gene of interest must be identified apart from 
all other genes and non-genic sequences within this region.
However, to some extent, high resolution mapping can reduce the guesswork 
involved in the candidate gene approach and expedite the search since genes that 
recombine outwith a defined interval can be excluded. This combination of 
positional cloning and candidate gene identification (the “positional candidate” 
approach) is increasingly successful as the genetic map becomes ever denser, and 
will soon become the predominant approach to identification of a novel mutant 
locus (Collins, 1995).
1.8.5 Modifiers of spontaneous mutants
It has long been known that mouse mutants can show considerable variation in both 
penetrance and expressivity despite a common genotype. Incomplete penetrance 
describes the failure of some animals with a mutant genotype to express the 
associated mutant phenotype. Variable expressivity occurs when multiple 
individuals all express a particular trait but in a quantitatively distinguishable 
manner. Both phenomena may become apparent when the mutation is crossed onto 
different genetic backgrounds and are due to the influence of alleles at other non­
disease (modifier) loci. For example, curly tail (ct), a murine model for human 
neural tube defects, shows incomplete penetrance and variable expressivity on 
several different backgrounds. The disease locus has been mapped to distal 
chromosome 4 and several strong candidates for modifier loci have been identified 
by backcrosses to recombinant and inbred strains (Neumann et a l , 1994; Letts et a l ,
1995). It is likely that modifiers achieve alteration of the phenotype by suppressing 
or enhancing the expression of other involved genes. Several possible mechanisms 
have been suggested. They may alter transcription rates, mRNA stability or modify 
the degree of DNA methylation (Wilkins, 1990). Alternatively they may change the 
phenotype by increasing or decreasing the activity of a redundant gene as occurs 
with the mouse model for cystic fibrosis on the C57BL/6J background (Rozmahel,
1996). Exploring modifying genes is particularly attractive, allowing the 
identification of further genes involved in the pathophysiological pathway. They
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may also provide an expanded array of potential therapeutic targets in complex and 
polygenic traits.
1.9 Aims of thesis
Myelination within the CNS depends on a successful series of interactions between 
oligodendrocytes and their target axons. Oligodendrocytes develop from precursors 
through a complex differentiation pathway, including proliferation and migration, 
under the influence of various growth factors, cell to cell interactions and soluble 
molecules. The regulation of this sequence of events is poorly understood. Natural 
myelin mutants provide one method of studying the processes involved; correlation 
of a particular phenotype with mutation in a specific gene may provide clues as to 
the normal function of that gene.
It was the aim of this study to evaluate a new myelin mutant mouse, hindshaker 
(hsh), in which there was CNS hypomyelination which gradually reduced with age. 
Initial studies had shown that the myelin deficit was most marked in the spinal cord 
and in mice up to two months of age. No obvious oligodendrocyte pathology had 
been observed. Preliminary immunostaining demonstrated the presence of major 
myelin proteins. The mutation was inherited in an autosomal recessive manner and 
linkage tests showed it was not an allele of quaking. The genetic and morphological 
studies therefore indicated that this was a novel mutation not involving a major 
structural gene but more probably affecting the biology of the oligodendrocytes. 
The postulated defect could have perturbed cell migration, proliferation, 
differentiation or the ability to elaborate membrane. The goals of the study were 
twofold. Firstly, the effect of the mutation on glial cell development and myelin 
formation was to be further evaluated using established histological and molecular 
techniques including morphometry, glial cell quantification, immunostaining and in 
situ hybridisation. The ability of oligodendrocytes to undergo differentiation in 
vitro was to be assessed with cell culture techniques. Secondly, genetic mapping of 
the mutant locus was to be carried out. Initial mapping using visible phenotypic 
markers was to be undertaken at Harwell to establish a chromosomal assignment. 
Fine mapping of the chromosomal locus with microsatellite markers and an 
interspecific backcross would be initiated as part of the project if  this was 
successful. Evaluation of candidate genes using techniques such as 
immunostaining, Western blotting and in situ hybridisation would be undertaken as 
appropriate. Definition of the hsh phenotype and identification of the gene may 
provide new information on the complex process of myelination, defining the role of 
another critical factor in oligodendrocyte biology.
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2. Materials and Methods
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The details of the preparation of solutions etc, and of processing and staining 
techniques are given in the appendix. The page reference is provided as necessary.
2.1 Tissue fixation
2.1.1 Fixatives
2.1.1.1 Buffered neutral formaldehyde (BNF) (4%)
BNF was the fixative employed for tissues destined for paraffin-embedding (see 
Buffered neutral formaldehyde, 4% (BNF), page 213). Sections were cut for 
haematoxylin and eosin staining (H&E) and immunocytochemistry.
2.1.1.2 Strong fixative (paraformaldehyde/glutaraldehyde 4%/5%)
Tissues removed from mice perfused with “strong fix” were resin-embedded and 
sections used for light and electron microscopy and immunocytochemistry (see 
“Strong fix” (paraformaldehyde/glutaraldehyde 4%/5%), page 213).
2.1.1.3 Periodate-lysine-paraformaldehyde (PLP) fixative
This fixative was used for preservation of tissue to be stained with the macrophage 
specific F4/80 antibody (see Periodate-lysine-paraformaldehyde, page 213).
2.1.2 Fixation techniques
2.1.2.1 Intracardiac perfusion
2.1.2.1.1 Technique
All perfusions were performed in a fume hood. Mice were euthanased with either 
carbon dioxide or halothane overdose and then pinned in dorsal recumbency. 
Following creation of a thoracotomy site, the right auricle was identified and a nick 
made through the full thickness of its wall. A 23-27 gauge needle, depending on the 
size of animal, was placed through the wall of the left ventricle to lie within its 
lumen. After initial exsanguination by flushing with 0.85% sodium chloride (NaCl), 
perfusion was initiated with either BNF, strong fix or PLP fix. The amount of 
fixative required depended on the weight of the animal and varied from 10 to 120 
ml; rigidity was used to assess fixation. In the case of BNF and strong fix, animals 
were then wrapped in fixative-soaked tissue and stored in containers at 4°C for 24 
hours prior to dissection. Tissue not immediately processed following dissection 
was stored in the appropriate fixative at 4°C. Tissue perfused with PLP fix was 
dissected immediately and placed in the same fix for 4-6 hours before transfer to
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20% sucrose in 0.1 M phosphate buffer overnight. Blocks were then frozen in OTC 
as described (Cryopreservation and sectioning, page 47).
2.1.2.1.2 Dissection of tissue
Tissues were dissected using a low power microscope and microsurgical 
instruments. Skin and muscle overlying the head and dorsum was incised 
longitudinally and reflected to reveal the skull and spine. Starting rostrally, the 
calvarium was elevated with forceps, exposing the cerebral hemispheres and 
cerebellum. Individual vertebral arches were removed until the cord was visible; 
meninges and nerve roots were severed at this point, allowing elevation of the cord 
from the caudal end forward. The entire brain was freed by cutting the cranial 
nerves except for the optic nerves, which were sectioned only if required for resin- 
embedding. Other samples such as sciatic nerve were obtained by dissection of 
overlying skin and muscle and careful excision of the tissue.
2.2 Tissue processing and cutting
2.2.1 Paraffin processing and sectioning
Following their removal from mice perfused with BNF, whole brains and spinal 
cords were wrapped in filter paper, placed in processing biopsy cassettes and loaded 
in a basket of a Shandon Elliot automatic processor (Histokinette). Passage through 
dehydrating solutions and infiltration with wax (Paraffin wax processing, page 214) 
was followed by embedding in wax at 60°C. Paraffin sections for routine staining 
and immunostaining were cut at 6pm using a Biocut 2035 microtome (Leica) and 
left overnight in a 56°C oven to ensure adherence to the slide.
2.2.2 Resin processing and sectioning
Tissue required for resin embedding was obtained from mice which had been 
perfused with strong fix. Samples were processed using a Lynx microscopy tissue 
processor (Leica) (Resin processing, page 214) and placed in resin filled rubber 
moulds for polymerisation at 60°C overnight. Blocks were cut on a Reichert-Jung E 
ultratome at 1pm (thick sections) for light microscopy and 70 nm (thin sections) for 
electron microscopy. Thick sections were cut using a glass knife and those for 
immunostaining were placed on APES coated slides (see In situ hybridisation, page 
60 for preparation). The 70 nm sections were cut with a diamond knife and 
mounted on 200 mesh-3.06 mm diameter copper grids.
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2.2.3 Cryopreservation and sectioning
Cryopreservation was used for tissues destined for immunofluoresent 
immunocytochemistry, in situ hybridisation and F4/80 staining for microglia. Fresh 
tissue was dissected immediately following euthanasia and suspended in “Tissue- 
Tek” OCT compound (Miles Inc.) in small foil boats. These were held in 
isopentane cooled to below -70°C in liquid nitrogen until the OCT was completely 
frozen. The foil was rapidly removed, the frozen block wrapped twice in “Sealon 
film” (Fuji) to limit dehydration and stored at -20°C. Spinal cords from animals 
perfused with periodate-lysine-paraformaldehyde were also cryopreserved after 
cryoprotection in 20% sucrose. All sections were cut at 15 pm using an OTF 
cryostat (Bright Instrument Company) and mounted on APES coated slides.
2.3 Staining techniques
2.3.1 Light microscopy
2.3.1.1 Haematoxylin and eosin stain for paraffin sections
Sections were routinely stained with H&E (Haematoxylin and eosin, page 216) to 
assess tissue quality and to give an overview of tissue morphology in various organs 
at the onset of the study. Counterstaining with haematoxylin alone for nuclear detail 
was carried on sections used for in situ hybridisation and F4/80 staining.
2.3.1.2 Methylene blue/azur II for resin sections
Resin sections for light microscopy were routinely stained with methylene blue/azur 
II (Methylene blue/azur II, page 218). Slides were heated on a hot plate to 60°C and 
flooded with stain for 10-30 secs followed by rinsing in running tap water. After 
drying overnight on the hot plate, they were mounted in DPX (BDH).
2.3.2 Electron microscopy
Thin sections of resin embedded tissue destined for EM examination were stained 
with uranyl acetate and lead citrate using standard techniques (Staining o f tissues for 
electron microscopy, page 217).
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2.4 Morphological studies
2.4.1 Quantification of glia
Quantification of glia was performed on lpm  resin sections of cervical cord (C2- 
C3) stained with methylene blue/azur II. Cells were counted within an area of the 
white matter adjacent to the ventromedian fissure and along the ventral aspect of the 
cord. A 6.3x eyepiece with a lOOx oil immersion lens were used to visualise cells 
within a 100 square graticule (Graticules Ltd.). Four fields, 2 to each side of the 
fissure, were examined and the glial cell nuclei identified as oligodendrocytes, 
astrocytes, microglia or unclassifiable using morphological criteria. Endothelial 
cells were excluded. A second section, 12pm caudal to the first to ensure nuclei did 
not appear twice, was counted in a similar manner. A total of 400 to 600 cells, 
depending on age and status, were examined per animal.
The length of glial cell nuclei was measured in longitudinal thoracic cord sections 
using a calibrated eyepiece. Both astrocytes and oligodendrocytes were measured 
and the mean length of 30 nuclei was calculated. This figure was used in 
calculations of glial cell numbers and density.
Areas of whole spinal cord and spinal grey matter were calculated from Polaroid 
micrographs using Sigma Scan/Image measurement software (Jandel Scientific 
Software) and SummaSketch III graphics tablet (Summagraphics). Corrected total 
glial cell counts and densities were calculated using Abercrombie's formula as 
discussed by Sturrock (Sturrock, 1983) and from these the specific glial cell 
numbers were estimated. Three to six animals of mutant and wild type genotype 
were counted at each age and the results were plotted using Graphpad Prism 
software (Graphpad Software Inc.).
2.4.2 Dead cell density
The dead cell density was estimated by counting pyknotic nuclei distributed 
throughout dorsal, lateral and ventral white matter of the same cord sections used 
for counting. Although the cell type cannot be ascertained, it is recognised that 
during development of the CNS a large proportion of such dead cells represent glial 
cells of which the majority are oligodendrocytes (Barres et al., 1992b).
2.4.3 Myelin volume
Thin resin sections were obtained from the cervical spinal cord and optic nerves of 
at least three mutant and three wild type mice at several ages. These were 
photographed at approximately 5000 and 7500 times magnification for cord and
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optic nerve respectively and printed at two times magnification. A diffraction 
grating with 2160 lines per mm was photographed at the same time for calibration.
Myelin volume was measured using a method described by Williams (1977). A 
ruled transparency with squares 2 cm by 2 cm was placed over each micrograph and 
intercepts coincident with either axon or myelin were recorded. At least ten to 
twelve photographs were counted for each area per animal. Results were expressed 
as a ratio of actual to possible contacts to give an arbitrary measure of myelin 
volume.
2.4.4 Morphometry
The same electron micrographs were used for morphometric analysis of a smaller 
range of ages. Using a graphics pad, about 150 myelinated fibres were outlined for 
each cord to generate the total areas of axon plus myelin and axon alone 
(software/hardware as above). In younger mutant mice, all myelinated axons were 
measured if  this totalled fewer than 150. Results were used to derive diameters of 
circles with equivalent areas and the notional myelin thickness (Excel 5, Microsoft). 
The derived myelin thickness and equivalent axonal diameter allowed the 
calculation of the g  ratio, which is defined as the ratio of axon diameter to that of the 
axon plus sheath.
Axon diameter ranges for both myelinated and unmyelinated fibres were calculated 
with the same software in younger mutant animals and compared to axonal 
diameters in normal mice.
2.4.5 Classification of fibre type
The spinal cord sections of 30 day old mutant animals were rephotographed at 7000 
times magnification to permit easier identification of the stage of myelination. 
Fibres were then classified as unmyelinated, ensheathed or myelinated. At least one 
lamella of compacted myelin constituted a myelinated fibre. Percentages of each 
group were calculated for each animal.
2.4.6 Statistical analysis
In general, the results for experimental groups were demonstrated graphically by 
separate data points. In some cases, the small group size limited the applicability of 
complex statistical analyses but by presenting individual data points, general trends 
can be illustrated. Experimental groups with sufficient data points were compared 
using the non-parametric two tailed Mann-Whitney test. This ranks the data points 
and makes a statement on the significance of the mixing of the distributions of
49
ranked values from the two groups. Statistical significance was set at the 5% level 
(P<0.05). In some areas of the study, sample sizes were large enough for the 
illustration of the mean values for mutant and wild type animals.
2.5 Immunocytochemistry
2.5.1 Peroxidase-anti-peroxidase (PAP) immunostaining
2.5.1.1 Description of antibodies
The PAP technique was performed on paraffin and/or resin-embedded sections of 
spinal cord, brain, optic and sciatic nerves of mutant and wild type animals. 
Staining for PLP and MBP, the two major CNS myelin proteins, was used to 
examine their assembly into the myelin sheath and the degree of myelination. Anti- 
PLP 226 antiserum (ProfN.P. Groome, Oxford) was used at 1:600 with a goat-anti- 
rabbit link (1:10) and a rabbit PAP complex (1:400). Anti-MBP (Dr J.M. Matthieu, 
Lausanne) was used at 1:1000 (paraffin sections) and 1:750 (resin sections) with the 
same link and PAP complex as for PLP.
GFAP, an astrocyte-specific marker in the CNS, was used to investigate numbers of 
these cells as an astrocytosis is commonly observed in the spontaneous myelin 
mutants (Baumann et a l , 1986). GFAP was detected using a polyclonal antibody 
(1:750) from DAKO. The same link and PAP complex was used as above. 
Negative controls with the primary antibody omitted were included for each 
experiment. Non-specific immunoreactivity was never detected.
2.5.1.2 Technique
Paraffin-embedded sections were first passed through the following hydration 
solutions;
1. Xylene 2 min;
2. Absolute alcohol 2 min;
3. Methylene 2 min;
4. Water 2 min;
5. Iodine 1 min;
6. Water 2 min;
7. Sodium thiosulphate 1 min;
8. Water 2 min.
50
Resin embedded tissue was treated by immersion in sodium ethoxide solution for 30 
min using a basket rotor, washing 6 times in absolute alcohol over a 30 min period 
and washing in running water for 30 min. Removal of resin was checked 
microscopically before proceeding to the wash stages.
Endogenous peroxidase activity was blocked by the submergence of the slides in a 
3% hydrogen peroxide solution for 30 min. This was made up in absolute alcohol 
for paraffin sections and in water for resin sections. The slides were next washed in 
running water for 30 min. A 10% solution of normal goat serum made up in PBS 
was pipetted onto the sections to block non-specific binding sites. This was tapped 
off after 2 hrs and the slides dried around the sections with tissue. Primary 
antibodies were made in 1% normal goat serum/PBS and placed over the sections. 
These were incubated overnight at 4°C in a moisture chamber. Control sections had 
normal rabbit serum applied at the same dilutions as the test sections.
The following day, the slides were brought to room temperature over 30 min before 
being washed in PBS 6x. The secondary antibody was diluted to 1:10 with 1% 
normal goat serum/PBS and incubated with the sections for 1 hour. After washing 
6x with PBS, the excess liquid was wiped off and sections were covered with PAP 
complex diluted with 1% normal goat serum/PBS. The slides were again washed 6x 
in PBS and then with 0.2M phosphate buffer for 2 min. A 100 ml solution of 
3,4,3’,4’-tetramino-biphenyl hydrochloride (DAB) was made with 50mg of DAB in 
50 ml of distilled water, made up to 100ml with 0.1M phosphate buffer. 330pl of 
30% aqueous hydrogen peroxide was added to the DAB solution and the sections 
placed in it until the required colour intensity had been achieved (30s to 5 min). 
Slides were then washed in 0.2M phosphate buffer for 2 min and running water for 
5 min before counterstaining. Paraffin sections were counterstained with haemalum 
(Haematoxylin, page 216) whilst resin sections were immersed in 1% 
osmium/caccodylate buffer for 2 min before washing. All sections were then 
cleared and mounted in DPX.
2.5.2 Immunofluorescence
2.5.2.1 Description of antibodies
A number of oligodendrocyte-specific antibodies were tested on cryosections of 
cervical spinal cord of 10 and 20 day old mutant and wild type animals. This was 
both to examine the absolute presence of protein in the search for a candidate gene 
prior to molecular mapping, and/or to correlate levels of each protein in normal and 
mutant mice. Methods of fixation and antibody binding times varied but each was 
used as a single label and detected with a fluoroscein isothiocyanate (FITC) or
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Texas Red (TXR)-labelled secondary. FITC absorbs light of wavelength 495nm 
and emits at 525nm and can therefore be visualised as green light using a blue filter. 
The Texas red labelled conjugate absorbs light at 596nm and emits at 620nm and 
can be viewed as red light with a green filter.
Primary
antibody
Dilution Source Secondary
anti-MOG clone Y10 1:50 S. Piddledson Goat-anti-mouse IgGl FITC 1:80
anti-MAG 253 1:500 N. Groome (Oxford, UK) Goat-anti-rabbit IgG FITC 1:80
anti-MOBP clone 32 1:80 N. Groome Goat-anti-mouse IgGl FITC 1:80
anti-CNP 1:300 Sigma Goat-anti-mouse IgGl FITC 1:80
anti-GFAP 1:1000 Dako Goat-anti-rabbit IgG TXR 1:200
Table 1: Antibodies, secondaries, dilutions and sources used in
immunofluorescence on cryosections. All secondaries were obtained from 
Southern Biotech.
2.5.2.2 Techniques
2.5.2.2.1 CNP, MOG, MAG and GFAP.
Sections were first thawed and dried before washing in PBS for 10 min. Those for 
MOG and CNP staining were fixed with 4% paraformaldehyde at room temperature 
for 20 min, washed in PBS for 5 min 3x and covered in primary antibody for 1 hour 
in a humidity chamber on the bench. MAG and GFAP sections were treated 
likewise but also received a 10 min fixation in methanol at -20°C after 
paraformaldehyde. The primaries were removed by washing 3x in PBS and 
secondary antibodies applied for about 30 min. Sections were washed in PBS for 5 
min 3x, water for 5 min and then mounted in Citifluor antifade mountant (UKC 
Chem Lab). Negative controls with the primary omitted were run with each 
experiment.
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2.5.2.2.2 MOBP
Cryosections to be stained for MOBP were fixed in 5% acetic acid/95% ethanol for 
5 min at room temperature. After washing, the primary antibody was applied 
overnight at 4°C. The following day, sections were washed in PBS for 5 min 3x 
and covered in secondary antibody for 30 min. Washing and mounting were as 
described.
2.5.3 F4/80 immunocytochemistry
F4/80 staining for microglia was performed using the ABC technique (Vector Labs 
Ltd) on 15 pm cryosections of spinal cord fixed in periodate-lysine- 
paraformaldehyde. The antibody binds to an unknown macrophage antigen and is 
used as a microglial-specific antibody in the CNS. Sections were allowed to air dry 
before washing in PBS for 10 min to remove embedding medium. All subsequent 
incubations were carried out in a humidity chamber and at room temperature. 
Firstly, sections were incubated with 1% normal rabbit serum for 30 min and then 
covered in F4/80 antibody (Serotec) at 1:20 in PBS for 1 hr after removal of excess 
serum. Two 10 min washes in PBS were followed by incubation in biotinylated 
rabbit anti-rat IgG (Vector Labs Ltd) at 1:100 in PBS. After two further washes, 
endogenous peroxidase activity was quenched by placing sections in 0.3% hydrogen 
peroxide in 96% alcohol for 20 min. Slides were again washed and then incubated 
for 45 min with Elite ABC, made up according to manufacturer’s instructions. Post­
washing, peroxidase was visualised with the chromagen 3 ’-3’-diaminobenzamine 
(DAB) by dissolving 125mg DAB in 250ml 0.1M phosphate buffer and adding 
125pi 30% hydrogen peroxide just before use. The DAB reaction was intensified 
by incubation in 0.01% osmium tetroxide in 0.1M phosphate buffer for about 30 
sec, followed by careful washing. Counterstaining with haematoxylin was 
performed (Haematoxylin, page 216) and slides mounted in DPX (BDH).
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2.6 Preparation of DNA for riboprobe production
2.6.1 Core techniques
2.6.1.1 Nucleic acid electrophoresis
Electrophoresis of DNA was performed using 1-1.5% regular agarose gels of ultra 
pure electrophoresis grade agarose (Gibco BRL). Gels were cast by melting the 
agarose in the presence of lx  Tris acetate EDTA (TAE) buffer (see Tris acetate 
EDTA buffer xlO, page 219) with a final concentration of 0.04M Tris acetate and 
0.001M EDTA. Ethidium bromide (lOmg/ml) was added after cooling of the 
agarose to 60°C, at a concentration of 0.5pg/ml. Samples were loaded with 6x TAE 
gel loading buffer (see Loading dye, page 219) and the gels then run in lx  TAE 
buffer. A “Fotoprep I” ultraviolet transilluminator (Fotodyne Inc) was used to view 
gels which were then photographed using a Polaroid MP4 land camera (Polaroid), a 
T2201 transilluminator (Sigma), a Wratten 22A filter (Kodak) and Polaroid 667 
(ASA 3000) film.
2.6.1.2 Restriction enzymes
Restriction enzymes were supplied by Gibco BRL, Promega and New England 
Biolabs and used with the appropriate buffer according to manufacturer’s 
instructions. Linearised vectors containing sequence for proteolipid protein {PLP) 
and UDP-glucuronosyltransferase 8 (UGT8) were generated by digesting the 
appropriate plasmid in the presence of suitable enzyme. Plasmid details are given in 
Figure 4, page 56 and the following digests performed;
Insert Vector Digest Promoter Probe
PLP pGEM-4 EcoR l T7 antisense
Hind III SP6 sense
UGT8 pGEM-3Z E coR l SP6 antisense
Hind III T7 sense
Table 2: Restriction digests carried out to linearise vectors containing inserts. 
Sense probes were generated as negative controls.
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10jug digests were usually performed for about 2 hours and a small aliquot run on a 
1% gel to ensure complete digest. Samples were then stored at -20°C prior to probe 
production.
2.6.1.3 Ethanol precipitation
DNA was routinely precipitated in the presence of 0.3M sodium acetate pH5.2 and 
3x ice cold ethanol. Amounts of less than lpg  were precipitated at -70°C overnight 
while larger amounts were precipitated at -20°C for not less than 2 hours. RNA 
probes were precipitated in the presence of 0.75M ammonium acetate. Samples 
were centrifuged at 4°C and 12000 rpm for 15-30 min to pellet the nucleic acid. 
After removal of the supernatant, the pellet was washed in 70% ethanol/sterile 
distilled water (SDW) for DNA or 75% ethanol/DEPC SDW (see In situ 
hybridisation, page 60 for preparation of DEPC/SDW) for RNA and air dried for 5- 
10 min. DNA was reconstituted in the appropriate amount o f SDW and RNA in 
DEPC SDW.
2.6.1.4 Phenolichloroform extraction
Removal of protein from samples containing nucleic acid was performed using 
phenol:chloroform:isoamyl alcohol in a ratio of 25:24:1. The combination of two 
organic solvents is more efficient than one used individually. An equal volume of 
phenol:chloroform was added to the nucleic acid sample, mixed thoroughly and 
centrifuged at 12000 rpm for 2 min. The aqueous phase, containing the nucleic 
acid, was harvested and ethanol precipitation performed as described.
2.6.2 Subcloning for riboprobe production
2.6.2.1 DNA fragment isolation
DNA fragment isolation was made from a 1% agarose gel following enzymatic 
liberation from the original vector. A gel slice containing the fragment was excised 
whilst viewed with a UV transilluminator and the fragment then isolated using a 
Qiaex gel extraction kit (Qiagen). The gel slice was incubated in 3x its volume in 
buffer QX1 at 50°C in the presence of lOpl of QiaexII silica beads for 10 min, with 
frequent vortexing. Nucleic acids are selectively absorbed onto the QiaexII beads 
whilst the agarose melts. The beads were pelleted by centrifugation and the 
supernatant removed. The beads were then vortexed for 30 sec in a further 500pi of 
QX1 to remove any remaining agarose. Two washes in 500pl buffer PE, a high 
salt/ethanol buffer, were performed to remove final traces of salts. The beads were 
then pelleted, air dried for 10 min and the DNA eluted by vortexing in SDW for 30
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rT7 PLP1 836 bp SP6
Hind ill Pst I Bam HI Eco Rl
^  ANTISENSE SENSE ^
875 bp ^ SENSE TRANSCRIPT
ANTISENSE TRANSCRIPT ^  880 bp
Eco Rl Sst I Hind III 
ANTISENSE ^^  SENSE
SP6T7 UGT8 340 bp
363 bp ^
SENSE TRANSCRIPT
ANTISENSE TRANSCRIPT
^  355 bp
Figure 4: Schematic diagram of vectors, inserts, insertion and restriction sites 
used in riboprobe production.
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sec. After the beads were once again pelleted, the supernatant containing the 
nucleic acid was harvested.
The yield was calculated by comparison of aliquots of isolated fragment with 
parallel fragment digests of known amounts.
2.6.2.2 Enzymatic manipulation
2.6.2.2.1 Alkaline Phosphatase
The vector to be used for riboprobe production was dephosphorylated (CIP treated) 
prior to insert ligation. This was to prevent reannealing of the linearised plasmid 
and was performed using calf intestinal alkaline phosphatase (CIAP) (Gibco BRL). 
5pg of linearised vector was dephosphorylated in the presence of 50mM Tris-HCl 
pH8.5 and O.lmM EDTA using 0.1U CIAP at 37°C for 30 min. This was followed 
by the addition of a further 0.1U CIAP and another 30 min incubation. The enzyme 
was inactivated by heating at 75°C for 15 min and denatured by two 
phenol/chloroform extractions. The remaining CIP-treated vector was precipated 
and reconstitution in SDW was at 250pg/ml.
2.6.2.2.2 Ligase
Ligation was catalysed by T4 DNA ligase (Gibco BRL) at 15°C overnight in a 20pl 
volume in the presence of 0.25U enzyme, 0.05mM Tris-HCl pH7.6, lOmM MgCl2, 
ImM ATP, ImMDTT, 25% (w/v) polyethylene glycol-800 and 250ng (lfil) CIAP 
treated linearised vector. Reactions containing vector:fragment ratios o f 1:1, 2:1 
and 1:2 were established and the following control reactions were also set up;
a) pGEM4z + ligase
b) Linearised vector 
(non-CIP) - ligase
c) Linearised vector 
(non-CIP) + ligase
d) Linearised vector 
(CIP) + ligase
- to assess transformation efficiency
- to assess efficiency of vector digest
- to assess ligation efficiency
- to assess CIP efficiency
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2.6.2.3 Transformations
Transformations were performed in sterile 40ml polypropylene tubes pre-chilled on 
ice. About 150ng of DNA from each ligase reaction was taken and made up to a 
final volume of 1 O O jllI  with Tris EDTA buffer pH8.0. Available competent cells 
(JM101 Escherichia coli) were thawed and a 100pi aliquot added to the DNA, 
mixed gently and incubated on ice for 30 min. The mixture was then heat-shocked 
at 42°C for 45 sec and transferred to ice for 2 min. After the addition of 800pl of 
SOC medium (SOC medium, page 220), cultures were incubated at 37°C and 100 
rpm for 1 hour in an orbital incubator. Duplicate plates of each culture were made 
by plating out 200pl aliquots onto Luria-Bertrani agar indicator plates using a sterile 
bent glass rod. Once all the liquid had been absorbed, the plates were inverted and 
incubated at 37°C overnight. Colonies on test and control plates were counted to 
gauge the efficiency of ligation and transformation. A number of single white 
colonies were then selected from the test plates for individual small scale culture 
prior to miniprep plasmid DNA extraction. These cultures were performed at 37°C 
in an orbital incubator overnight, in 5ml Luria Bertram medium (Luria-Bertani 
medium, page 219) in the presence of lOOpg/ml ampicillin.
2.6.2.4 Plasmid preparation
2.6.2.4.1 Minipreps
Plasmid DNA was isolated from bacterial cells from 1.5ml of each culture using the 
W i z a r d T M  miniprep DNA purification system (Promega). The remainder (3.5ml of 
broth) was retained. The miniprep system is based on the alkaline lysis procedure 
with lysis of bacteria using sodium dodecyl sulphate (SDS) and sodium hydroxide 
(NaOH). SDS denatures bacterial proteins whilst NaOH denatures both 
chromosomal and plasmid DNA. Neutralisation with potassium acetate causes the 
covalently closed plasmid DNA to reanneal rapidly but most of the chromosomal 
DNA precipitates with bacterial proteins and is removed by centrifugation. Further 
purification of plasmid DNA is achieved by passage through a proprietary 
chromatography column before elution with Tris EDTA buffer. Test digests were 
performed and run on a 1% agarose gel to check for the presence of fragment before 
setting up a large scale culture.
2.6.2.4.2 Maxipreps
One of the cultures was selected to start a 200ml culture. lOOpl of the retained 
broth was added to 200ml LB broth and cultured as described for the smaller
58
preparations. The W i z a r d T M  maxiprep DNA purification system was used to 
isolate plasmid DNA according to manufacturer’s instructions.
2.6.2.5 DNA quantification
DNA samples were quantified using a GeneQuant RNA/DNA calculator (Pharmacia 
Biotech). A spectrophotometer cell with a minimum volume of 70pl was used to 
ensure the minumum amount of nucleic acid was discarded during quantification.
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2.7 In situ hybridisation
2.7.1 Materials and solutions
To minimise RNase activity, all solutions were made using diethyl pyrocarbonate 
(DEPC) treated SDW. This was prepared by treating distilled water with 0.01% 
DEPC overnight and sterilising by autoclaving at 151b/in^ for 15 min. Glassware 
was cleaned by soaking in 6% sulphuric acid/6% potassium dichromate overnight 
before soaking in DEPC SDW and sterilisation by baking at 180°C. Plastics were 
treated by soaking in DEPC SDW and autoclaving at 151b/in2 for 15 min. Sections 
were cut onto 3-aminopropyltriethoxy-silane (APES) coated slides to ensure 
adherence. Slides were prepared by soaking in 5% Decon 90 (Decon Labs Ltd) 
overnight, washing and oven drying. They were then soaked in 0.25%  APES 
(Sigma) in methylated spirit for 2 min in a fume hood, rinsed in DEPC SDW for the 
same time and oven-dried wrapped in foil. The coverslips used to cover sections 
during hybridisation were soaked in 1M hydrochloric acid for 30 min, rinsed 3x in 
distilled water and air dried. Cleaned coverslips were immersed in Repelcot (BDH) 
for 20 min, rinsed 2x in distilled water and baked at 130°C for 90 min. The 
siliconisation with Repelcot was included to reduce non-specific probe binding.
2.7.2 Preparation of 35S labelled riboprobes
Sense and antisense 35g riboprobes were generated using an SP6/T7 transcription 
kit (Boehringer Mannheim). The reaction was carried out on 2pg of linearised 
plasmid DNA in a 20pl reaction volume containing 0.5mM ATP, 0.5mM GTP, 
0.5mM UTP, 50pCi 35g_cTp (specific activity 37TBq/mM; <1000Ci/mM; 
Amersham), 20U RNase inhibitior, 20U SP6 or T7 RNA polymerase, transcription 
buffer and DEPC SDW. The mixture was incubated at 37°C for 30 min before the 
addition of a further 20U of enzyme and incubation for the same period. The DNA 
template was removed by incubating for 15 min at 37°C with 20U of RNase free 
DNase. To remove contaminating protein, an equal volume of phenol/chloroform 
was added to the sample and vortexed for 10 sec, centrifuged at 13000 rpm for 3 
min and the aqueous layer removed to a fresh DEPC treated eppendorf. The solvent 
was then back extracted by adding an equal volume of DEPC SDW, repeating 
centrifugation and adding the aqueous layer to that previously harvested. RNA was 
precipated from this aqueous solution with 0.75M ammonium acetate and 2.5x 
volume of cold ethanol for 3 hr at -20°C. A 5pi aliquot was removed prior to 
centrifugation and placed in 5ml “Ecoscint” in a scintillation vial. This represented 
the total amount of isotope present.
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Following precipitation, RNA was spun at 13000 rpm for 30 min at 4°C and 5jlx1 of 
the supernatant removed as before; this represented unincorporated isotope. The 
remaining supernatant was discarded and the pellet resuspended in lOOpl of DEPC 
SDW. A final 5 pi was removed and added to “Ecoscint” as a measure of 
incorporated isotope. The three scintillation vials were counted on a Beckman LS 
1801 scintillation counter and the percentage of incorporated isotope calculated.
RNA was reprecipitated overnight as described. The solution was then centrifuged 
at 13000 rpm at 4°C for 30 min, the pellet washed with 70% ethanol/DEPC SDW, 
briefly air dried and resuspended in DEPC SDW with lOmM DTT at lng/pl/kb. 
Probes were stored at -20°C and used within 6-8 weeks.
2.7.3 In situ hybridisation technique
2.7.3.1 Pretreatment of sections
The procedure was performed as described by Cox et al (1984) and modified by 
Wilkinson et al (1987). Pretreatment of the tissue rendered the target mRNA 
accessible to the probe without disrupting the morphology of the tissue. 
Hybridisation was undertaken in low stringency conditions to favour hybrid 
formation with the unbound probe removed by the higher stringency washes. An 
RNase step was included to remove single stranded RNA.
Frozen cord and brain sections on APES slides were allowed to air dry before 
rinsing in PBS and fixation in 4% paraformaldehyde for 20 min. After rinsing in 
PBS, sections were placed in a solution of 0.1M triethanolamine and 0.25% acetic 
anhydride for 5 min. A further addition of 0.25% acetic anhydride was made and 
solutions left for another 5 min. This acetylation step reduces the non-specific 
binding of probe to the proteins via electrostatic interactions. Sections were next 
passed through 5 min washes in PBS, 0.85% saline and methylated spirits and 
dehydrated in absolute alcohol ( 2 x 5  min).
2.7.3.2 Hybridisation
The required volume of probe was calculated on the basis of number and size of 
sections and the dilution factor of the probe. Brain sections took 6 ul and spinal 
cord half as much. Generally probe dilution was 1:10 and was made up in 
hybridisation buffer (50% formamide, 10% dextran sulphate, IX Denhardt’s, 20mM 
Tris Hcl pH8, 0.3M NaCl, 5mM EDTA, lOmM NaPOz^ pH8 and 0.5mg/ml yeast 
tRNA) with 1% 1M dithiothreitol added to the final mixture.
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After denaturation of the diluted probe by heating at 80°C for 2 min and cooling on 
ice, it was applied to the sections and covered with siliconised coverslips. Slides 
were placed horizontally into a holding box containing tissue paper soaked in 50% 
formamide and 5 x SSC. This was sealed with tape and placed inside three vacuum 
sealed bags before immersion in a 50°C waterbath for overnight hybridisation.
2.7.3.3 Post hybridisation treatment
After removal of the slides from the bags and container, the following washes were 
performed to remove unbound or non-specifically hybridised probe:
1) wash 1 5xSSC/0.01M DTT 50°C 30 min
2) wash 2 2xSSC in 50% formamide/ 
0.1MDTT
65°C 20 min
3) wash 3 0.5M sodium chloride/ 
0.005M EDTA/0.01M 
Tris-HCL (pH7.5)
37°C 10 min (x3)
4) wash 3 0.02mg/ml RNaseA in 
lOmM sodium acetate
370C 30 min
5) wash3 370C 30 min
6) wash 2 65°C 20min
7) wash 4 2xSSC room temperature 15 min
8) wash 5 O.lxSSC room temperature 15 min
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followed by dehydration in the following solutions:
1) 75ml ethanol, 162.5ml DW, 12.5ml 
6M ammonium acetate
2 min
2) 150ml ethanol, 87.5ml DW, 12.5ml 
6M ammonium acetate
2 min
3) 200ml ethanol, 37.5ml DW, 12.5ml 
6M ammonium acetate
2 min
4) 237.5ml ethanol, 12.5ml 6M 
ammonium acetate
2 min
Slides were rinsed in absolute alcohol for 2 min, air dried and positioned in a 
radiographic cassette for overnight exposure. This was to give an indication of 
exposure times after dipping.
2.8 Autoradiography
2.8.1 Slide dipping
Slides were dipped in a solution of Ilford emulsion K5 mixed in a 1:1 ratio with 
distilled water containing 1% glycerol to provide a thin layer over the specimen. 
Emulsion temperature was 42°C. After wiping the backs of the slides, they were 
placed in a plastic box with silica gel to air dry for 4 to 6 hours. They were then 
transferred to a light tight box containing a sachet of silica gel; the box was tape- 
sealed and wrapped in a black plastic bag prior to storage at 4°C for a time 
determined by the exposure against the radiographic film.
2.8.2 Developing
This was carried out in undiluted Kodak D19 developer at room temperature under 
safelight conditions. Slides were immersed for between 3 and 4 min and then 
placed for 1 min in a 1% acetic acid/1% glycerol solution in water to halt 
development. Next they were transferred to a 30% sodium thiosulphate solution for 
3 min to fix the autoradiograms before final washing in water in the dark for 30 min. 
After air drying, sections were counterstained with haematoxylin and mounted using 
DPX mountant.
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2.9 Cell culture
2.9.1 Tissue preparation
2.9.1.1 Spinal cord cell dissociation
Mutant and wild type mice of the same age were selected from litters o f similar 
sizes to ensure that they were at a similar developmental stage. Test and control 
cultures were set up within 24 hours of one another using the same media, and 
antibody staining was carried out simultaneously where possible, with the same 
antibody batches. Spinal cords were obtained from 2 mice for each culture. All 
manipulations were carried out in a tissue culture hood except for the initial 
dissection. The cords were dissected into Hanks Balanced Salt Solution 
( H B S S ) (C a 2 + /M g 2 +  free to prevent enzyme inactivation) and the meninges and 
nerve roots stripped. Cords were then minced on the inside of a petri dish lid using 
a No. 10 scalpel blade and transferred into a sterile bijou by adding and sucking back 
about 1ml of antibiotic enriched HBSS. The same volume of trypsin 0.25% and 100 
pi of 1% collagenase (lOmg/ml) were added to this and incubated at 37°C for 30 
min. The addition of the same amount of each solution was repeated and a further 
30 min incubation performed. 1 ml of SD solution (SD solution, page 220) was 
added and the solution allowed to stand for about 5 min to halt enzymatic activity 
and reduce cell clumping.
Mechanical dissociation was performed by very slowly triturating through a 21G 
needle (5x) and a 23G (3x). The suspension was transferred to a centrifuge tube, 
about 5 ml of Dulbecco’s modified eagle medium (DMEM)/10% foetal calf serum 
(FCS) added and then spun at 1000 rpm for 10 min. The supernatant was removed 
and the pellet reconstituted in 1.4 ml of DMEM/10% FCS.
2.9.1.2 Plating out
Cell density was calculated using a regular Levy counting chamber with a Neubauer 
ruling by counting the four large ruled squares in the comers (lmm^ = 16  squares). 
Cell numbers were adjusted to 2-300,000/ml with the same medium. Plating of 
50pl per poly-L-lysine coated coverslip (Poly-L lysine coverslips, page 221) 
ensured about 15,000 cells per coverslip. The coverslips had previously been placed 
in FLOW 24 well plates which were now put in an incubator at 37°C, 5% CO2 for 
30-40 min to permit cell attachment. After this, the cultures were fed with 500pi of 
SATO/0.1% FCS (SATO medium, page 220) and maintained in the incubator until 
immunofluorescence was carried out.
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All solutions used in cell dissociation were warmed to 37°C prior to use.
2.9.2 Immiinofluorescent staining
2.9.2.1 Antibodies
All antibodies were diluted in DMEM unless otherwise stated. Immunostaining was 
performed to assess the in vitro antigenic development and the morphology of 
mutant oligodendrocytes. Several antibodies were tested on both wild type and 
mutant cultures; counts were carried out on those that gave strong fluorescence 
without high background. Details are given below. CNP and MOG did not give a 
strong enough signal to be confident of identifying positive staining above 
background.
Primary Dilution Source Secondary
anti-PLP 226 1:600 N.P. Groome (Oxford, UK) Goat anti-rabbit IgG FITC 1:80
anti-MBP 1:1000 N.P. Groome Goat anti-rat IgG FITC 1:50
0 4 1:5 I. Sommer (Glasgow, UK) Goat anti-mouse IgM TXR 1:50
Ol 1:5 I. Sommer Goat anti-mouse IgM FITC 1:50
Table 3: Details of antibodies used for immunostaining in cell culture.
1.9.2.2 Technique
All coverslips were used for double immunostaining. For surface markers, 
coverslips were incubated with 20pi of the primary antibody for 20 min at room 
temperature, washed for 5 min in DMEM and then incubated with the secondary for 
the same length of time. The same procedure was repeated if the second 
immunostain was also a surface marker. After washing for 5 min in DMEM, cells 
were fixed with 2% paraformaldehyde in DMEM applied for 30 min at room 
temperature. Nuclear staining was achieved with 4 ’,6-diamidino-2-phenylindole 
(DAPI) (6pg/ml) for 30 sec and coverslips mounted in Citifluor antifade mountant 
(UKC Chem Lab).
For immunostaining with a cytoplasmic marker following a surface marker, Gow’s 
technique was instituted post-fixation. Blocking buffer (Blocking buffer, page 221) 
was applied for at least 30 min before being removed with a tissue without washing.
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The primary antibody was applied overnight at 4°C in the same blocking buffer but 
with 0.02% saponin. The following day, sections were washed in TBS for 20 min 
(3x) and the secondary antibody, diluted as detailed, applied for 20 min. Coverslips 
were then washed, stained and mounted as described above.
An Olympus 1X70 inverted microscope was used to view and photograph 
coverslips. Three coverslips were counted for each antibody combination at 24, 48 
and 72 hours for both mutant and wild type animals. About 300 cells were counted 
per coverslip. The experiment was repeated three times.
2.10 Western blotting
2.10.1.1 Isolation of protein from tissue
Protein was isolated from whole spinal cords by homogenisation in 0.1M Tris (pH 
6.8) and ImM Na-p- tosyl-l-lysine chloro-methyl ketone (TLCK) to which 2% SDS 
was added and the samples then boiled for 5 min. After centrifugation at 13000 rpm 
for 5 min at 4°C, the supernatant was harvested and stored at -20°C. Total protein 
concentration was measured using the BCA assay (Pierce). DTT was added to give 
a final concentration of 40mM.
2.10.1.2 SDS-polyacrylamide gel electrophoresis
Protein analysis was performed using a vertical sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) gel produced by polymerisation of 
the acrylamide polymer cross-linked by N,N’-methylene bisacrylamide. The 
accelerator for the reaction was N,N,N,N’,-tetramethylethylenediamine (TEMED) 
and the catalyst was ammonium persulphate.
To prepare the gel, a 5% solution of acrylamide-bisacrylamide 
(Acrylamide/bisacrylamide solution, page 221) was placed in one well of a Biorad 
mode 385 gradient former and a 20% solution (Acrylamide/bisacrylamide solution, 
page 222) in the other well which also contained a magnetic stirrer. The outlet from 
the gradient former passed through a peristaltic pump (LKB Bromma 2120 
Varioperpex II pump) and into the glass plate sandwich. The gradient former 
delivered the most concentrated acrylamide into the sandwich first and as the level 
of this rose, then the concentration of the acrylamide decreased. The rate of 
delivery was 3.0 ml/min. This produced a gel that was 17.5% at the bottom and 5% 
at the top. A 2.5% bis-acrylamide stacking gel (Stacking gel, page 222) was layered 
over the resolving gel once this had polymerised. The stacking gel had minimal
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sieving effect on the proteins because of its large pore size. It thereby concentrated 
them into a relatively narrow band at the stacking/resolving gel interface.
Aliquots of protein samples were prepared for electrophoresis by adding lOOpl of 
SDS-PAGE sample buffer (Sample buffer, page 222) and boiling for 5 min to 
denature the polypeptides. The SDS bound to the denatued polypeptides in a 
constant weight ratio so that they had an essentially similar charge and migrated 
through the gel according to size. Samples were cooled and electrophoresed 
through a vertical LKB electrophoresis apparatus at 35mA for about 4 hours.
A discontinuous buffer system was used such that the gel buffer and the tank buffer 
were different (Discontinuous buffers, page 222). This helped to concentrate the 
proteins prior to their entry into the resolving gel.
2.10.1.3 Immunodetection
Electrophoretic transfer of the separated proteins onto Hybond ECL nitrocellulose 
membrane (Amersham Life Sciences) was performed at 200mA for 4 hours at 4°C 
in a transblot cell (Bio-Rad). Immunodetection was carried out using enhanced 
chemiluminescence (ECL). Non-specific binding was blocked by overnight 
treatment with Tris buffered saline (pH 7.6) containing 5% dried milk, 0.2% gelatin 
and 0.1% Tween 20. The ECL nitrocellulose membrane was treated with the 
primary antibody, polyclonal CNP (Prof P.J. Brophy) at 1:300 for 1 hour at room 
temperature followed by extensive washing in the blocking buffer. The membrane 
was incubated in the secondary antibody, anti-rabbit IgG conjugated with 
peroxidase, at 1:80 for 1 hour followed by thorough washing with blocking buffer 
and a final TBS rinse. The membrane was incubated in equal volumes of luminol 
enhancer solution and stable peroxide solution (Pierce Chemical Co.) for 5 min at 
room temperature. The membrane was wrapped in Saran wrap and exposed to X- 
omat imaging film (Kodak) in a cassette for 30 sec. The film was developed using 
an automatic processor (Dupont Cronex CX-130).
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2.11 Mouse breeding
2.11.1 Homozygous stock
2.11.1.1 Breeding
Homozygous hsh stock was donated by the MRC Mammalian Genetics Unit, 
Harwell for establishment of breeding stock at the Parasitology Mouse House, part 
of the Veterinary Research Facility, Glasgow. Individual males were permanently 
housed with one or two females and a variable number of litters, usually in the 
region of 6-8, obtained from each pair. Brother-sister matings were avoided. Only 
severely affected mice were used in the phenotypic studies or retained as parents for 
subsequent generations. Wild type C3H/101 mice were already maintained at 
Glasgow and were housed under the same conditions.
2.11.1.2 Phenotypic measurements
Mice were aged taking the day of birth as PI. Phenotypic severity was classified at 
several ages by assessment of the tremor. The body weight of at least 50 wild type 
and 50 mutant mice was measured at several time points during development and 
mean values calculated. Small litters and very large litters were excluded from this 
study and those litters from which pups were removed prior to weaning were 
eliminated after that time. This was to ensure a representative growth pattern for the 
two phenotypes. Litter sizes were also recorded for both wild type and mutants.
2.11.2 Intersubspecific backcross
2.11.2.1 Choice of breeding strategy
To map a mutationally defined locus, it is necessary to generate a special panel of 
samples in which segregation of the mutant and wild type alleles can be followed 
phenotypically prior to DNA preparation for marker locus typing. For hindshaker, a 
two generation cross, the outcross-backcross, was adopted. In the outcross, hsh 
mice were bred with non-mutant mice from a different genetic background to 
generate first generation offspring (FI). FI mice, heterozygous at all loci and 
therefore phenotypically normal, were backcrossed to homozygous hsh mice. The 
resultant F2 offspring were either homozygous or heterozygous at any given locus 
(Figure 5, page 69). Mice were typed phenotypically for homo- or heterozygosity at 
the hsh locus and then DNA extracted for typing with a number of microsatellite 
markers.
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OUTCROSS
BACKCROSS
F2 PROGENY
UNRECOMBINED RECOMBINED
Figure 5: Generation of F2 mice in outcross-backcross. WT mice from a 
different genetic background are outcrossed to hsh to generate FI mice, 
heterozygous at all loci. Recombination may occur during formation of gametes 
in these mice. F2 mice are produced by backcrossing with hsh. All F2 mice 
inherit one chromosome in a pair from the C3H/101 hsh parent, and one from 
the FI parent. This FI chromosome may be intact (WT or hsh) or recombinant. 
The closer a marker is positioned to the hsh locus, the less probability of 
recombination between the two loci. Mice with a trem or will therefore tend to 
be homozygous for microsatellite markers close to that locus.
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2.11.2.2 Choice of parental strain
The parental strain carrying the mutant locus was on a mixed C3H/101 background. 
The choice of the second parental strain for use in the outcross was based on 
considerations of genetic distance (the more distant the strain, the greater chance of 
polymorphisms at DNA marker loci) and the ability to generate offspring in which 
segregation of the mutant allele could be observed. As Mus spretus is the most 
distant species from Mus musculus that still allows the production of fertile FI 
hybrids (females only), outcrosses with this will provide the highest level of 
polymorphism that is theoretically obtainable for the purpose of mapping (about 
90%) (Love et al., 1990; Dietrich et al., 1992). For this reason, the original 
mapping was initiated with two M. spretus males (B and K Universal) individually 
paired with C3H/101 mutant females. These failed to breed over a period of several 
weeks despite careful management and so an intersubspecific cross using Mus 
musculus castaneus was begun. Although the degree of polymorphism is less than 
that with M. spretus (about 77%) (Dietrich et al., 1992), it is still much greater than 
that between laboratory strains, and offspring of both sexes are fertile. The first 17 
hsh x M. m. castaneus FI mice were generated at Harwell until M. m. castaneus 
(CAST/Ei) stock was available commercially. FI mice were then bred on site. 
C3H/101 females were mated to M. m. castaneus males for the production of larger 
and more frequent litters from the hybrid female. All F2 backcross mice were 
generated on site. Both male and female FI parents were backcrossed to C3H/101 
mutants. Breeding stock were kept in permanent groups of one male with one or 
two females and generally produced 7-10 litters before being replaced with young 
stock. The F2 offspring were phenotypically graded at about twenty days and were 
classified as hsh or unaffected.
2.11.3 Interstrain backcross
In order to examine the penetrance of the hsh mutation on different genetic 
backgrounds, two interstrain outcross-backcross breeding regimes were established. 
C57BL/6J and BALB/cJ inbred strains were obtained (B and K Universal) as a male 
and female of each, and outcrossed to hsh C3H/101 mice as for M. m. castaneus. 
The FI mice of both sexes were backcrossed to hsh stock and the offspring 
classified as hsh or unaffected. Although there is even less polymorphism between 
classical inbred laboratory strains, which are largely derived from M. m. domesticus, 
it is estimated that about 50% of microsatellite markers show interstrain 
polymorphisms (Dietrich et al., 1992). It was therefore possible to utilise the 
phenotypically affected mice for DNA marker analysis in addition to the F2 mice 
from the M. m. castaneus cross.
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2.12 General principles of linkage analysis
The fundamental principle underlying linkage analysis is recombination in the FI 
parent. Closely linked genes or markers will tend to undergo few recombination 
events in FI mice and will be inherited together. Unlinked loci will assort randomly 
and hence have a recombination rate of 50%. The method for analysing the 
frequency of recombination is the examination of the inheritance of polymorphic 
genes and markers in the F2 offspring. However, it must be remembered that F2 
mice are only a means to analyse recombination and it is genetic events in FI 
parents that are pivotal to linkage detection.
In an outcross-backcross using C3H/101 hsh mice, FI hybrid mice are heterozygous 
at all loci, inheriting one chromosome in a pair from the hsh parent and the other 
from the tester strain. Thus, all FI mice carry only a single hsh allele and are 
phenotypically wild type. F2 mice inherit one intact C3H/101 chromosome in a pair 
from the hsh backcross parent. The other chromosome in the pair comes from the 
FI hybrid and may be intact wild type or hsh, or may represent a combination of 
genetic material from both strains (Figure 5, page 69). Half of the F2 mice will 
carry two hsh alleles and should express a shaky phenotype. The other half inherit 
the wild type allele from the FI hybrid and are heterozygous for hsh. These mice 
will be phenotypically normal.
Similarly, for any other locus, half of all mice will be heterozygous, inheriting the 
tester strain allele from the FI parent, and half will be homozygous, having received 
the C3H/101 allele. A C3H/101 allele is always inherited from the hsh parent. If  a 
particular marker locus shows no linkage to hsh, random assortment occurs and half 
of the homozygous hsh F2 mice will be heterozygous and half homozygous for the 
marker locus. This gives a recombination rate of 50% between the marker and hsh. 
The same proportions will be derived for the wild type group, which are all 
heterozygous at the hsh locus. With a linked marker {i.e. in close physical 
proximity to hsh), few recombination events will have occurred between hsh and the 
marker in the F 1 parent, such that a greater proportion of phenotypic hsh F2 mice 
will inherit the C3H/101 allele for the marker and hence be homozygous. Similarly, 
more wild type mice will be heterozygous for the marker, having inherited a tester 
strain allele at both loci. The recombination rate thus reduces from 50%. For a 
marker positioned very close to hsh, few recombination events will occur and the 
vast majority of shaky mice will be homozygous for the marker, with the reciprocal 
change in the wild type population. The aim in linkage analysis is the identification
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of those marker loci which fail to recombine with hsh; since the positions of the 
markers are known, the map location of the hsh locus can be inferred.
2.13 Genome-wide linkage analysis
Markers were chosen on the basis that the typing of 50 mice for a marker permits 
detection of linkage in a region extending 15cM proximally and distally from this 
marker (Silver, 1995a). Coverage of the genome using these criteria necessitates 2- 
4 markers, appropriately spaced, per chromosome. As described above, an unlinked 
marker will recombine with hsh at a rate of 50% i.e. half of the mice will be 
homozygous for the marker and half will be heterozygous. With markers closer to 
hsh, this rate will reduce as more mice become homozygous. Eventually complete 
concordance will be found with very close markers. Under the conditions of 50 
mice being typed for markers detecting linkage within a radius of 15cM, a 
recombination fraction of less than 26% demonstrates linkage at p<0.001. 
Therefore 26% was taken as the value below which linkage had been identified.
Once a recombination fraction of less than 26% for a marker had been found, tighter 
linkage was sought to other markers on that chromosome. Markers showing tight 
linkage, called flanking markers, were next tested against all available samples. 
Only the recombinant mice were then typed for intervening markers and haplotypes 
for these mice were created. New samples were run against the flanking markers 
and only further tested if recombinant for one of these.
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2.14 Statistical analysis
Map distances were measured in centimorgans (cM) where a centimorgan is the 
distance between two genes that will recombine with a frequency of 1%, i.e. 1 
mouse in 100 will have a recombination event between those two genes. In the 
mouse, this is roughly equivalent to 2000 kb pairs. Standard errors were calculated 
with the following formula;
S.E. =VRF[(100-RF)/n]
where RF = recombination fraction 
and n = total number of samples
The cut-off values for statistical significance of recombination rates between hsh 
and microsatellite markers were derived from a Bayesian corrected test (Silver, 
1995a) and p<0.001 was taken as demonstration of linkage. This ensures that only 1 
in 20 cases of positive demonstration of linkage is likely to be false. With a p value 
of 0.05, one will conclude that linkage exists in 1 of every 20 experiments 
conducted on loci that are in fact unlinked. Since true linkage exists only for a very 
small number of microsatellite markers (about 3/100 with the strategy employed 
here), the expected number of false positives would exceed the number of truly 
linked markers. Thus, the probability of linkage would actually be considerably less 
than 95% (about 40% in this case). A p value of 0.001 sets a limit for accepting less 
than 1 false positive for every 20 true positives, i.e.demonstration of linkage with a 
95% probability.
Logarithm of odds (LOD) scores were calculated where necessary using the Map 
Manager programme available at http://mcbio.med.buffalo.edu/mapmgr.html and an 
Apple Mac computer. A LOD score of 3 or greater was taken as significant, as 
discussed by previous authors (Lander and Kruglyak, 1995).
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2.15 Genetic maps
About 12 different mouse genetic maps can be accessed through the World Wide 
Web (WWW), either directly or through the Mouse Genome Database (MGD) at the 
Jackson Laboratory. The uniform resource locator (URL) for this resource is 
http://www.informatics.jax.org. Two of the maps are microsatellite linkage maps 
that serve only to indicate the position of microsatellite markers across the genome. 
The Whitehead/MIT map (http://www-genome.wi.mit.edu) shows the position of 
over 6000 microsatellite markers based on their results from an intersubspecific 
intercross using C57BL/6J-ob and CAST/Ei mice. Since only 98 meiotic events 
have been typed, markers have only been mapped to about 1.1 cM and many are 
listed together in linkage groups called “bins”. About 3200 of these markers have 
been mapped more precisely by the European Collaborative Interspecific Backcross 
(EUCIB) mapping project (European Backcross Collaborative Group, 1994) on a 
C57BL/6 x Mus spretus backcross of 983 mice 
(http://www.hgmp.mrc.ac.uk/MBx/MBxHomepage.htmI), which has allowed 
mapping to an interval of 0.1 cM. Genetic distances for markers differ between the 
two maps due recombination frequency differences in the strains of mice used for 
the crosses.
In an attempt to combine data from all maps, two integrated maps, the Mouse 
Genome Database (MGD) and the Chromosome Committee maps can be accessed 
at the MGD. Data of mouse/man gene homology were accessed through the MGD 
(http://WWW.informatics.jax.org/homology.html) to allow examination of the 
syntenic regions in man. The human gene maps were accessed through the WWW 
server maintained by the National Center for Biotechnology (NCBI) which is the 
location of the GenBank database. The URL for this is 
http://www.ncbi.nlm.nih.gov/.
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2.16 Preparation of genomic DNA
2.16.1 Collection of tissue
After identification of hsh and wild type phenotypes, F2 mice from the mapping 
backcross were euthanased with carbon dioxide and their tails and spleens 
harvested. Fresh gloves and scalpel blades were used for each mouse to minimise 
the possibility of sample contamination. Spleens were placed in cryotubes and tails 
in eppendorfs before both were frozen in liquid nitrogen. Splenic samples were then 
transferred to liquid nitrogen for long term storage while tails were kept at -70°C. 
Tails were used for extraction of genomic DNA in the first instance; spleens were 
utilised if tail tissue became exhausted.
2.16.2 Technique
The procedure adopted for routine gDNA extraction was influenced by throughput, 
reproducibility and ease of performance. At the onset of mapping using the 
intersubspecific backcross, only small numbers of samples were being processed 
simultaneously. The traditional method of cell lysis and deproteination by 
phenol/chloroform extraction was used. About 0.5cm of tail was incubated at 55°C 
in 700pl of buffer based on sodium dodecyl sulphate (SDS), which causes lysis of 
cell membranes. Proteinase K (0.4mg/ml) was included to denature protein. After 3 
hours, 20pl of RNaseA (0.35|Lig/ml) was added and the mixture incubated for a 
further 2 hours. Debris was removed by centrifugation at 13000 rpm for 5 min and 
an equal volume of phenol/chloroform added to the supernatant. After shaking for 3 
min, the cloudy solution was spun for 5 min at 13000 rpm and the upper aqueous 
layer harvested. This was repeated a total of 3 times. The gDNA was precipitated 
routinely, air dried for no more than 10 min and dissolved in 1 OOjllI of SDW 
overnight. Yields of about 20pg were achieved. Samples were stored at 4°C.
A commercial kit, the QIAamp Tissue kit (Qiagen), was assessed later in the study 
and was found to give consistently high yields with reduced manipulations. This 
technique was therefore sometimes used for ease and reliability when large numbers 
of samples were being processed simultaneously. The system is based on a patented 
spin column system in which gDNA is first absorbed onto a membrane, allowing the 
removal of protein in the flow-through. The gDNA is then eluted by the addition of 
a different buffer. Manufacturer’s instructions were followed. Yields, when 
quantified, were generally in excess of 40pg.
Quantification of DNA was necessary for the preparation of “pooled” samples for 
use as described by Ben Taylor (Taylor et al., 1994). This is described in DNA
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quantification, page 59. These samples were also run on 0.7% agarose gels to check 
both the integrity and the quantification of DNA. Samples extracted using the 
Qiagen kit were not usually quantified or run on a gel and gave very satisfactory 
PCR results when used directly.
2.16.3 Preparation of pooled DNA samples
DNA samples were standardised to 0.5 mg/ml in SDW or TE and aliquots of 3pi 
were mixed and diluted 10-fold to give a final concentration of 50pg/ml.
2.17 Microsatellite primer pairs
Primer pairs were obtained from Research Genetics Inc, Huntsville, Alabama at a 
concentration of 6.6pM. Selection of an individual primer pair was based on the 
position of the microsatellite marker in the genome and polymorphism between 
C3H and the subspecies or strain (test strain) used in the backcross. At least a 10 
base pair difference was required, depending on the size of the PCR product. The 
101 strain fragment lengths had not been characterised by the Whitehead 
Institute/Massachusetts Institute of Technology (Whitehead/MIT), and as this 
constituted part of the hybrid hsh background, it was necessary to test each new 
primer pair with DNA from C3H, 101 and the test strain to ensure all were 
polymorphic. If  the 101 band was too close to the test strain, that primer pair was 
abandoned. A pooled sample of C3H/test strain was also tested to check for 
preferential priming of one strand over the other. Again, the markers that showed 
this phenomenon were not used.
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2.18 Polymerase chain reaction
Several PCR programmes were tested but there proved to be little difference in 
terms of intensity and specificity of product. In light of this, the final choice was 
largely based on duration of PCR reaction time and the fastest programme was 
adopted. If  a primer pair failed to give satisfactory product with this programme, 
other protocols were attempted that used a different annealing temperature or cycle 
number. However, this was found to make no substantial difference in the majority 
of cases. A Perkin-Elmer or Hybaid Omnigene DNA thermal cycler was used for 
the amplification.
1) Initial cycle 94°C 2 min
55°C 40 sec
72°C 2 min
2) Step cycle (35 cycles) 93 °C 20 sec
55°C 40 sec
72°C 15 sec
3) Final cycle 93°C 2 min
55°C 40 sec
72°C 1 min
Reactions were carried out in 0.5ml eppendorfs in a 25pl volume containing 1.5pl 
of target (approximately lOOng) and 1 unit of Taq DNA polymerase (Bioline). 
Manufacturer’s buffer was used with ImM dNTP (Bioline), 2.25mM MgCl2 and 
0.2pM each primer. Formamide was added at 0.2pi per reaction to reduce non­
specific primer binding if a large number of spurious bands were produced. Q 
solution (Qiagen) was tried with primer pairs that gave very weak or no product. 
Both these are reported to decrease the melting temperature of DNA and therefore 
reduce the tendency for non-specific priming by disrupting these weaker bonds. 
Reagents were covered with 25pi mineral oil to prevent evaporation.
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2.19 Analysis of PCR products
2.19.1 Agarose gel electrophoresis
Most PCR products could be separated on 3% Nusieve GTG agarose gels. This is a 
high resolution agarose that challenges polyacrylamide and can be used to separate 
fragments that differ by as little as 2%. To prepare gels, agarose was sprinkled on 
top of the appropriate volume of 0.5x TBE (Tris borate EDTA buffer x5, page 219), 
mixed well and left for 15 min. The solution was microwaved on “medium” for 1-2 
min, mixed again and left to rest for 2 min. It was then microwaved on high for 1 
min whilst the agarose boiled. After allowing to cool to about 60°C, ethidium 
bromide (lOmg/ml) was added to a concentration of 0.5ng/ml and the gel cast. 
Once set, it was placed at 4°C for 20 min prior to use to obtain the optimum 
resolving and handling qualities.
6x TAE loading dye was added to each sample prior to loading. Samples were 
loaded onto a dry gel which was then placed in an Electro-4 gel tank containing 0.5x 
TBE. Gels were run at 75-100V for at least 45 min, depending on the size of the 
fragments and the degree of polymorphism between them.
2.19.2 Gel photography
Gels were photographed using one of the following camera set-ups;
a) Polaroid MP4 land camera (Polaroid), a T2201 transilluminator (Sigma), a 
Wratten 22A filter (Kodak) and Polaroid 667 (ASA 3000) film).
b) Kaiser RA1 CCD camera, a Herolab UVT-28M transilluminator and a Sony UP- 
890CE video graphic printer.
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3. Study of the hindshaker phenotype
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3.1 Background to the hsh mutation
The spontaneous hindshaker (hsh) mutation was first recognised at the MRC 
Mammalian Genetics Unit, Harwell in 1992. The original hsh mouse was a single 
male in a litter of mice carrying the downless (dl) and Steel contrasted (Mgfil-00?1) 
mutations (see below). The phenotype was described as a marked quivering of the 
hindquarters that occurred during locomotion and was less evident at rest (Beechey, 
1993). The behaviour was very reminiscent of rumpshaker (Cattanach and Beechey, 
1991) but differed in that the quivering decreased rapidly with age in hsh and 
disappeared by 50 days of age. Homozygous hsh stock was established at the MRC 
Mammalian Genetics Unit by breeding the mutation onto the C3H/101 hybrid 
background for several generations; hybrid mice were created by crossing 
C3H/HEH females with 101/H males. This background gives improved vigour and 
fecundity and is routinely used for maintenance of mutant stocks at Harwell. 
Breeding studies conducted at this time indicated an autosomal recessive inheritance 
and proved that hsh was not an allele of quaking (Beechey, 1993)
Fifteen homozygous hsh mice were donated to Prof I.R. Griffiths at the Applied 
Neurobiology Group, Glasgow in 1994 to set up a breeding colony for investigation 
of the phenotype. All mice were heterozygous for the dl mutation and 8 were 
known to be heterozygous for M gfil'00?1. The recessive dl mutation, found on 
chromosome 10, is a spontaneous coat variant first recognised in 1958 in the A/H 
strain. Mice are characterised by a thin haircoat with shiny, bald patches behind the 
ears and a bald tail. Incisor teeth may be abnormal or absent and molars are 
abnormal. M g fl'00*1, also on chromosome 10, is a semidominant mutation that 
gives a silver haircoat and resulted from a neutron irradiation experiment in 1963; 
the original mice used in this experiment were on C3H/101 (female) and SN (male) 
backgrounds. The A/H and SN strains are no longer in existence. It is not known 
what contribution the founding strains made to the genetic makeup of the original 
hsh male. Since the stock maintaining the dl and M gftl'00?1 mutations has been 
crossed several times with C3H/101 hybrids in the last three decades (C. Beechey, 
personal communication) and one original parent was also C3H/101, these two 
strains must have made a sizeable contribution. Presumably there may also have 
been some genetic material from the A/H and SN strains still present in the stock.
Preliminary morphological studies carried out by I.R. Griffiths showed that the most 
obvious feature of hsh mice was hypomyelination in the CNS, most prominently in 
the spinal cord of young animals. Numerous naked and thinly sheathed axons were 
present in spinal cord white matter of immature mice; myelin debris and 
macrophages were absent and axons appeared normal. Immunostaining
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demonstrated the presence of the major myelin proteins in these sheaths. No 
obvious glial cell abnormalities were found. By 4 months of age, the majority of 
axons were myelinated, although many sheaths appeared disproportionately thin.
3.2 Aims of the hsh phenotypic studies
The description of the phenotypic consequences of a mutation in a specific gene is 
an important part in elucidating its role in the normal animal. The aim of the hsh 
phenotypic study was to develop a detailed account of the effects of the hsh 
mutation and thus to shed light on the putative role of the gene in normal 
myelination. This chapter will present the account in four separate sections; the 
behavioural phenotype, the nature and development of the myelin defect, glial cell 
analyses and in vitro development of hsh oligodendrocytes.
Genetic mapping of the disease locus was also initiated as part of my project, the 
findings of which are presented in the subsequent chapter (Linkage mapping of the 
hsh mutation, page 162). On the basis of the results, a small number of candidate 
genes were suggested for further investigation. For continuity, these studies will be 
presented in the final section of this chapter as part of the phenotypic results.
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3.3 Phenotypic studies
3.3.1 Introduction
The most obvious aspect of a mutation is usually its effect on the physical or 
behavioural characteristics of the organism. These changes may indicate the body 
system that is involved and therefore direct subsequent detailed analyses of the 
phenotype. Although the tremor exhibited by hsh mice had suggested neurological 
dysfunction, the behavioural phenotype had not been fully characterised in our 
laboratory. Also, it had not been established whether other physiological functions 
were impaired. Thus, a study of the behavioural signs, growth rate and fecundity 
was undertaken to investigate the phenotype more fully.
3.3.2 Methods
3.3.2.1 Tremor study
To describe the development of the phenotype, twenty-six litters of mutant animals 
were examined daily for the presence of a tremor between P10 and P25 and then at 
P30, 35, 40, 50, 60, 75 and P100. Mice were assigned one of four grades; “0” for 
mice with no tremor, “ 1” for animals with a slight gait abnormality and straight tail, 
“2” for those with an obvious tremor when ambulating and “3” for mice with a 
tremor at rest. The general behaviour and viability of these mice was also observed.
3.3.2.2 Weight study
To evaluate growth, at least 50 mutant and 50 wild type animals were weighed at 
PI, 5, 10, 15, 20, 30, 50, 75 and P I00 and the mean weight at each age calculated as 
described in Phenotypic measurements, page 68. Mice homozygous for the dl 
mutation were smaller than their littermates from about P10 and were not used for 
phenotypic studies or breeding. Mice with silver haircoats were also rejected from 
the study.
3.3.2.3 Litter sizes
Fecundity was assessed by recording the number of newborn pups in hsh and wild 
type litters and evaluating the percentage distribution of mice per litter.
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3.3.3 Results
3.3.3.1 General phenotypic description
Homozygous mice of both sexes developed a tremor of the rump (lumbar region and 
hindlegs) and tail at about P I2, at the onset of ambulation. In general, this was 
apparent only during locomotion and disappeared at rest. Shaking increased in 
intensity over the next 1-2 weeks, reaching maximum severity between P20 and 
P30. After this time, mice gradually improved and few exhibited a shake beyond 
P40, although an abnormal tail carriage persisted in some older mice.
Notwithstanding this general pattern, the severity of the shake and rate of its 
disappearance varied quite considerably. This was most evident at the start of the 
project when some mice were grade 3 by P20 and remained so for 10-14 days before 
slowly improving, others reached only grade 1 and appeared normal by P25, and a 
small number of mice (about 10%) did not shake at all. Even the most severely 
affected mice exhibited a gradual improvement to grade 1 by P50. As the study 
continued, deliberate selection of only markedly shaky mice (grade 3 at P20) for 
breeding stock led to the majority of offspring exhibiting a grade 2 to 3 tremor by 
P20, remaining markedly shaky for about 10 days and slowly improving to grade 0 
or 1 by P40 to P50. Littermates appeared to develop a similar degree of tremor, 
although this was not always the case. The very occasional severely affected animal 
suffered spontaneous seizures but this was a rare occurrence.
Viability of mice appeared to be normal; the number of mice bom in a particular 
litter was generally equivalent to the number weaned at P20 and the longevity of 
adult mice did not appear different from wild type animals. The activity and agility 
of mutants also appeared unaltered.
3.3.3.2 Weight study
No observable differences were found between the body weights of hsh and wild 
type animals at any age (Figure 6, page 86).
3.3.3.3 Breeding study
In total, the numbers of newborn pups were recorded for 156 hsh and 189 wild type 
litters. No marked differences were found in the distributions of the numbers of 
pups per litter (Figure 7, page 87).
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3.3.3.4 Discussion
At the beginning of the study, the hsh mutation was known to result in a tremor of 
the hindquarters and tail in young homozygous mice that reduced with age 
(Beechey, 1993). However, the detailed study of the behavioural phenotype 
presented here demonstrated that there was a marked variation in the expression of 
the tremor, with some mice exhibiting a marked shake for several weeks and others 
having only a slight tremor for a short period of time. It is also became apparent 
early in this work that there was incomplete penetrance of the mutation, with 10% of 
homozygous animals appearing phenotypically normal throughout development. It 
is known that the phenotype resulting from a mutation in a specific gene can vary 
markedly on different genetic backgrounds due to modifying genes at other non­
disease loci (see (Erickson, 1996) for review). Since the hsh mutation was not 
maintained on an inbred background but instead represented a combination of C3H, 
101 and original background genetic material, mice were not genetically identical. 
Since they were maintained under the same environmental conditions, the variation 
seen in the hsh phenotype, in terms of both penetrance and expressivity, was likely 
to result from these genetic differences. In other words, the presence or absence of 
specific alleles at loci separate to hsh was influential on the appearance and the 
severity of the phenotype. Support for this came from the apparent heritability of 
the intensity of the shake; selection for only the markedly shaky mice as breeding 
stock appeared to lead to a more homogeneous population and a more predictable 
phenotype. At the time of writing, non-shaky homozygous mice have not been 
identified for about 1 year and the vast majority of mice develop a shake of at least 
grade 2 at P20. Presumably most mice now carry a complement of modifier alleles 
that is compatible with penetrance and greater expression of the hsh phenotype.
When the study was initiated, the homozygous stock carried the dl and Mgj%1-con 
mutations. Mice homozygous for dl grew poorly, probably due to dental 
abnormalities related to dl. These mice were not used for breeding or phenotypic
studies and the mutation may well have been eliminated. Silver-coated mice were 
also rejected for breeding and the Mgf^~con mutation also appears to have
disappeared from the stock.
The growth rate and/or viability of mice carrying a particular mutation can be 
affected either directly as a consequence of the altered gene product, or indirectly, 
for example, due to behavioural abnormalities that interfere with feeding. No 
marked differences were found in the body weights of hsh or wild type animals at 
any age. This suggested that the hsh gene product was unlikely to have a significant 
role in the growth of mice and that their ability to feed was not affected by their
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tremor. The viability of mice into adulthood also appeared to be unaffected by the 
mutation.
Mutations involving myelin genes or genes in their vicinity can affect fertility of one 
or both sexes, for example, in quaking mice where the deletion of a neighbouring 
gene is responsible for sterility in homozygous males (Ebersole et al., 1992). 
Deleterious mutations may also lead to embryonic or perinatal death, resulting in 
small litter sizes. Although it was known that homozygous hsh mice of both sexes 
were fertile (Beechey, 1993), the consequences of the mutation, if any, on litter size 
had not been closely studied. The results presented here suggested that the mutation 
had no deleterious effect on the number of pups bom.
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Figure 6: Age-related weight gains for wild type and hsh animals. Between 50 
and 100 animals of each phenotype were weighed at each time point (Mean ± 
SEM). No marked differences are seen.
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Figure 7: Results of the breeding study. The number of litters of each size is 
shown as a percentage of the total number of litters (156 mutant and 189 wild 
type litters). No marked differences are seen.
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3.4 Characterisation of the myelin defect
3.4.1 Introduction and aims
At the inception of the project, there was limited information concerning the effects 
of the hsh mutation on myelination. It was known that young homozygous animals
exhibited hypomyelination of the CNS, with the spinal cord being more prominently 
affected than the brain. The PNS appeared unaffected (Prof I.R. Griffiths, personal 
communication). Thus, the initial aim of this work was to further define the 
affected areas and to describe the nature and severity of the myelin defect in these 
regions. An indepth study of the development and resolution of the myelin 
abnormality over time was performed on a selected area of the CNS. Assessment of 
the presence of a panel of myelin proteins was also undertaken, both to further 
characterise the phenotype and to identify any putative candidate genes. The results 
presented here encompass the myelin defect specifically; analysis o f glial cell 
biology is given in the following section (Glial cell morphology and quantification, 
page 119).
3.4.2 Materials and Methods
3.4.2.1 Mouse breeding
Mutant and wild type mice were maintained and bred as described in Breeding, page 
67. Unless stated otherwise, only hsh mice that exhibited a marked tremor at P20 
were used for analysis. Younger mice were obtained from parents that had been 
shown to consistently produce markedly affected offspring.
3.4.2.2 Preparation of tissue
Tissue was prepared for resin and paraffin wax embedding and cryosections as 
described in Tissue processing and cutting, page 46. Wild type and mutant mice at 
P10, 20, 30, 50, and P I00 were used. Blocks were obtained from cervical, thoracic 
and lumbar cord, cerebellum, midbrain, forebrain, optic nerve and sciatic nerve. In 
addition, tissues were removed from thymus, heart, lungs, liver, kidney, testis, 
intestine and muscle.
3.4.2.3 Histopathology
To define the distribution, nature and severity of the hypomyelination, a survey of 
the nervous system was undertaken on 1pm resin sections stained with methylene 
blue/azur II and on paraffin sections stained with H&E. To search for any other
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abnormalities resulting from the mutation, the non-neural tissues were examined on 
paraffin sections after H&E staining.
3.4.2.4 Immunocytochemistry
This was performed for a number of purposes. PLP/DM20 and MBP PAP 
immunostaining was employed to further characterise the phenotype, illustrating the 
extent of the myelin deficit in various regions of the CNS. Staining for a panel of 
myelin proteins was assessed in hsh spinal cord white matter to establish the relative 
effects of the mutation on the levels of these proteins. Immunostaining was also 
used to confirm the presence of specific myelin proteins in hsh myelin to aid in 
excluding their encoding genes as likely candidates for the mutation.
PAP immunostaining for PLP/DM20 and MBP was performed on resin and paraffin 
sections from spinal cord, forebrain and optic nerve at P10, 20, 30 and P50. This 
technique can give a clearer assessment of the extent of myelination than methylene 
blue/azur II stained sections since detail of the myelin sheaths is not obscured by 
surrounding cell bodies. Also, large areas such as the forebrain are more easily 
processed for PAPs than for resin sections. The technique is described in 
Peroxidase-anti-peroxidase (PAP) immunostaining, page 50. CNP, MAG, MOBP 
and MOG immunostaining was carried out on frozen sections of cervical cord from 
P10 and P20 animals. The protocols and details of the antibodies, fluorescent 
conjugates and their sources are given in Immunofluorescence, page 51.
GFAP PAP and immunofluorescent immunostaining was performed on spinal cord 
resin sections to assess the astrocyte population in mutants. The techniques are 
given in Immunofluorescence, page 51.
3.4.2.5 Myelin volume
The cervical cord ventral white matter was selected for measurement of myelin 
volume on the basis of the initial histopathological observations. Myelin volume 
was determined at P10, 20, 30, 50 and P100 as described in Myelin volume, page 
48. It was also measured at P20 in the optic nerve.
3.4.2.6 Morphometric analysis
Axon and myelin morphometry to assess axonal size and myelin sheath thickness 
was performed on cervical cord ventral columns of P30 and P I00 wild type and 
mutant mice (see Morphometry, page 49). These ages were selected to describe the 
maximal defect in young mice and the extent of resolution with age, based on the 
results from the myelin volume study. G ratios were calculated for individual fibres
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to allow comparison of sheath thickness for equivalent axon sizes in mutant and 
wild type animals. The mean g  ratio for all fibres was also evaluated for both 
phenotypes at the two ages. Frequency distributions of axon diameter for 
myelinated and unmyelinated axons were calculated for P30 mutant animals 
(Morphometry, page 49) to assess any effect of the mutation on axon populations of 
different sizes. The number of myelinated axons was also determined for these mice 
and expressed as a percentage of the total number of axons analysed (Classification 
of fibre type, page 49).
3.4.3 Results
3.4.3.1 Distribution of the lesion
The most obvious abnormality at all ages was a myelin deficit, which was due to a 
combination of naked and thinly sheathed axons. This was confined to the CNS, 
with the sciatic nerves and dorsal and ventral nerve roots appearing normal by light 
microscopy (data not shown). The most marked changes were found in the spinal 
cord whilst the brain appeared considerably less affected. In the spinal cord, there 
was generalised hypomyelination with no predilection for any tract or cord segment 
(Figure 8, page 97). Ventral and dorsal columns appeared equally affected and 
changes extended from the cervical to lumbar segments. No abnormalities were 
detected on paraffin sections of fore, mid or hindbrain stained with H&E and little 
difference was seen in hsh and wild type forebrain sections immunostained for 
PLP/DM20 (Figure 9, page 98). The majority of optic nerves at all ages appeared 
adequately myelinated on examination of resin sections and by PLP/DM20 
immunocytochemistry (Figure 10, page 99). There was, however, evidence of 
hypomyelination on EM (Figure 11, page 100). Non-neural tissues were examined 
grossly and on paraffin sections stained with H&E; no abnormalities were evident.
3.4.3.2 General morphological features of the cervical cord
Since the spinal cord was the most severely affected area and the changes were 
uniformly distributed, the cervical cord (approximately C2) was selected for a 
detailed developmental study of the pathology. Hypomyelination was grossly 
visible during dissection of mice up to P30, with the spinal cord white matter 
forming a thinner rim than in equivalent control animals. The number of myelinated 
fibres in the ventral white matter was already lower in hsh by P10 but these 
differences were most obvious at P20-P30; the larger, more peripheral axons were 
thinly myelinated and were interspersed with groups of naked smaller axons (Figure 
12, page 101 and Figure 13, page 102). With advancing age, an increasing 
proportion of small axons were myelinated and by P I00, most axons were
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myelinated although the sheaths tended to remain abnormally thin (Figure 14, page 
103). Dorsal columns exhibited a similar degree of hypomyelination in younger 
mice that showed partial resolution with age.
The structure and periodicity of myelin in hsh was comparable to normal mice (data 
not shown) and no obvious axonal degeneration or ultrastructural abnormalities 
were seen. Glial cell development will be described in the subsequent section (Glial 
cell morphology and quantification, page 119), but initial observations suggested an 
increase in white matter total glial cell density. Morphological abnormalities of the 
oligodendrocytes were not detected and a marked astrocytosis was not observed on 
visual inspection of sections. Cells with an LM appearance typical o f microglia 
seemed more numerous in the white matter. Myelin breakdown and debris was not 
observed at any age, and pyknotic nuclei were not more frequent than in 
corresponding wild type tissue.
3.4.3.3 Phenotypic variation
In the morphological study of hsh, only those mice which had demonstrated an 
obvious tremor when young, or came from affected parents in the case of P10 mice, 
were selected. However, to assess the variation in phenotypic expression, a single 
litter, all homozygous for the mutant allele but showing markedly different 
severities of tremor, was perfused at P20. The degree of hypomyelination in the 
spinal cord varied considerably (Figure 15, page 104) and reflected the intensity of 
tremor.
3.4.3.4 Immunostaining of the cervical cord
All myelin proteins assessed were present in hsh tissue although the amounts were 
reduced in comparison to wild type. On PAP sections of cervical cord stained for 
PLP and MBP, there was a reduction in the amount of myelin due to thin and absent 
sheaths (Figure 8, page 97). The majority of myelin sheaths were associated with 
the larger, peripherally located axons (Figure 16, page 106) and the myelin deficit 
partially resolved in older mice. Immunofluorescent staining for MAG, MOG, 
MOBP and CNP was reduced in all cases. MAG immunostaining (Figure 17, page 
107) and MOBP (Figure 18, page 108) at P20 revealed an obvious reduction in the 
number of positive sheaths in the white matter of hsh. On the MAG section, the 
majority of positive sheaths were within the peripheral white matter of the ventral 
cervical spinal cord. MOG staining was bright in hsh white matter although this 
was clearly reduced in area compared to wild type and staining in the grey matter
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was reduced (Figure 19, page 109). Immunostaining for CNP was reduced (Figure 
20, page 110).
GFAP PAP and immunofluorescent staining did not demonstrate a marked 
difference between hsh and wild type (Figure 21, page 111).
3.4.3.5 Myelin volume
Measurements of hsh total cord and white matter areas were reduced in comparison 
to wild type animals at all ages (Figure 22, page 112). Significant differences were 
found at P10, P20 and P30 (p = 0.0286 at all these ages). A decrease in myelin 
volume was already detectable at P10, with the greatest disparity between mutant 
and wild type animals occurring at P20-P30 (p = 0.0286 at P10 and P20, p = 0.05 at 
P30)(Figure 23, page 113). At P20 and P30, myelin volume was approximately 40- 
45% of normal. A marked improvement occurred between 30 and 50 days of age so 
that by P50, myelin volume had reached approximately 75% of normal. There was 
no further improvement beyond this and mice remained hypomyelinated in 
comparison to wild type.
3.4.3.6 Axon and myelin morphometry
Axon/myelin sheath relationships were examined and quantified in the ventral white 
matter of the cervical spinal cords of P30 and PI 00 mutant and wild type animals.
General observations
On visual examination, many axons in mutant mice were unmyelinated at P30 
whereas virtually all fibres in wild type animals had myelin sheaths at this age. A 
few ensheathed but unmyelinated fibres were apparent in mutants. There was a 
tendency for small diameter axons to be unmyelinated, with larger fibres being 
surrounded by disproportionately thin sheaths. There was an impression that small 
axons made up a larger proportion of the total axon population in hsh compared to 
control animals. There was no evidence of excessively abundant astrocytic 
processes in contact with naked axons.
At P I00, most axons in mutant animals were myelinated. No degenerating axons 
were identified at either age and qualitatively the density of neurofilaments appeared 
comparable to control fibres. Relationships between myelinated axons and their 
surrounding sheaths were unremarkable and no instances of interposition of 
astrocytic processes between myelin lamellae or axon and sheath were identified.
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Axonal diameter distributions
The axonal diameter frequency distributions for total axons were similar in mutant 
and wild type mice at P30 (Figure 24, page 114). The proportions of myelinated, 
ensheathed and unmyelinated fibres in mutants varied considerably between animals 
despite a similar phenotype; in the 4 mice studied, the percentage of myelinated 
fibres ranged from 27% to 66% whilst the majority of remaining axons were 
unmyelinated. No greater than 2% of total axons were ensheathed in any of the 
mutant animals. The calculation of axonal frequency distributions for myelinated 
and unmyelinated axons in hsh confirmed the impression that the majority of
unmyelinated fibres were of small diameter (Figure 25, page 115).
Myelin sheath thickness
The majority of sheaths that were present in mutant animals at P30 were 
disproportionately thin (Figure 26, page 116) and hence the g  ratios were increased 
(Figure 27, page 117). By P I00 the sheaths were thicker, and although many 
remained thin compared with wild type, a proportion of the smaller axons were now 
surrounded by sheaths of normal dimensions (Figure 26, page 116). Thus, the g
ratios were lower than at P30 but still tended to be greater than wild type figures, 
particularly for large axons (Figure 27, page 117). The mean g  ratios at P30 and 
P I00 illustrate the accumulation of myelin between these two time points and the 
deficit still present at the older age (Figure 28, page 118).
3.4.3.7 Myelin volume in the optic nerve
At the level of light microscopy, hsh optic nerves were of comparable diameter to 
wild type, and myelin sheaths appeared to be of similar dimensions to those in 
normal nerves. However, when examined by EM, a mild degree of hypomyelination 
was identified by the presence of thin sheaths and some naked axons (Figure 11, 
page 100). These changes were not as marked as in the spinal cord and when the 
myelin volume was assessed in two animals of each phenotype at P20, the value in 
mutant nerves was 74% of wild type versus 40-45% in the spinal cord.
3.4.4 Discussion
The hindshaker mouse is a hypomyelinating mutant exhibiting a delay in 
myelination of the CNS but no obvious pathology in the PNS. Interestingly, the 
spinal cord is more severely affected than the forebrain and optic nerve. A partial 
resolution of the myelin deficit occurs with increasing age of mice. The severity of 
hypomyelination in the cords of young animals is reflected in the intensity of tremor. 
No segmental or tract selectivity is observed within the cord; dorsal and ventral
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columns are both hypomyelinated and changes extend from the cervical to lumbar 
regions. Myelin sheaths appear structurally normal despite their attenuation, as do 
axons, and there is no evidence of degenerative change in either. PLP, MBP, CNP, 
MAG, MOG and MOBP are all present in hsh myelin although they are reduced in 
amount. Overall, the impression is of retardation of an otherwise essentially normal 
myelination process.
In contrast to hsh, the best characterised murine myelin mutants Mbps^  and the Pip 
mutants such as PlpJP and its various alleles, generally show persistence of the 
behavioural phenotype and myelin defect. Both Mbps^  and PlpJP have much less 
myelin than hsh and the most severe reductions are seen in the brain rather than in 
the spinal cord, (for reviews, see (Duncan, 1990; Nave, 1994; Lunn et al., 1995; 
Griffiths, 1996)). Additionally, any myelin formed in Mbpshi and the Pip mutants is 
structurally abnormal. Affected mice also die prematurely. Quaking mice have 
normal longevity but the brain is severely affected (Friedrich, Jr., 1974) and the PNS 
is also involved (Suzuki and Zagoren, 1977; Suzuki and Nagara, 1982). Two 
uncharacterised canine mutations show some similarities to hsh in terms of 
inheritance and the preferential susceptibility of the spinal cord to hypomyelination. 
In Chow Chow and Weimaraner dogs, autosomal recessive mutations cause 
hypomyelination principally of the peripheral spinal cord white matter and some 
resolution of the defect with time (Duncan, 1987; Komegay et al., 1987; Lunn et al.,
1995).
Assessment of myelin volume in the cervical cord at several ages suggests that 
greatest myelin production in hsh occurs between P30 and P50, in contrast to wild 
type mice in which the biggest increase in myelin volume is seen between P10 and 
P20. This results in the most marked myelin deficit occurring at P20-P30 and 
partially resolving between P30 and P50 as mutants “catch up”. The early tendency 
for small axons to be unmyelinated probably reflects the normal pattern of 
myelination, in which oligodendrocytes associate with larger axons prior to smaller 
ones (Lord and Duncan, 1987; Remahl and Hildebrand, 1990; Butt et al., 1997). 
The delay in this process in hsh leads to small fibres remaining unmyelinated for a 
extended period of time. By P50, the majority of axons are myelinated although 
many sheaths remain disproportionately thin. This is particularly obvious for large 
fibres whilst a greater proportion of small axons acquire sheaths of normal 
thickness. This may be related to the fact that more myelin is required for the single 
intemode of a large axon than for multiple intemodes of smaller axons (Smith et al., 
1982; Remahl and Hildebrand, 1990). Oligodendrocytes in mutant mice may be
94
able to meet the lesser demands of a number of small fibres but unable to elaborate 
sufficient myelin for single large axons.
The total axonal diameter distribution reveals no differences between mutant and 
wild type animals at P30. This is surprising in light of studies showing that myelin 
influences the calibre of axons and their radial growth during development (De 
Waegh et al., 1992; Colello et al., 1994; Hsieh et al., 1994; Sanchez et al., 1996). 
In shiverer, quaking and myelin synthesis deficiency (PlpjP~msd) mice, even the 
prolonged ensheathment stage that occurs in these mutants is sufficient to induce 
full calibre growth and neurofilament accumulation (Sanchez et al., 1996). There is 
no increase in the proportion of ensheathed axons in hsh to account for the 
apparently normal axonal size distribution in the face of a large population of 
unmyelinated fibres. Also, there is a conflicting visual impression that small axons 
actually do make up a greater proportion of the total axonal population compared to 
wild type. It may be that any presumptive difference could not be detected by the 
method of measurement used in this study; perhaps a higher magnification, the 
analysis of a greater number of fibres or the use of electron micrograph montages to 
include more large fibres which often spanned the photographic borders and were 
therefore excluded, would highlight a difference.
Optic nerves in hsh are relatively less severely hypomyelinated than spinal cord 
ventral columns. The reason for this is open to conjecture but could possibly relate 
to differences in axonal size or times of myelination between the two regions. The 
optic nerve is composed mainly of small, late myelinating axons, while the spinal 
cord comprises fibres of various diameters which myelinate at different times. 
However, comparison with spinal cord dorsal columns makes these explanations 
unlikely; optic nerves and dorsal column corticospinal tracts both contain a similar 
population of small axons that myelinate relatively late in development, yet the 
corticospinal tracts appear to be as severely hypomyelinated as the ventral columns 
on visual examination at appropriate ages. An alternative explanation is that the hsh 
mutation involves a gene which is more significant in the function of 
oligodendrocytes in the spinal cord than in other CNS regions, regardless of size of 
glial unit or time of active myelination. The characterisation of the hsh product may 
therefore provide further information on intrinsic and/or environmental factors 
determining cell heterogeneity, particularly in relation to location within the CNS.
Immunostaining of hsh CNS tissue was performed as a quick and straightforward 
way to assess the presence, location and amount of several known myelin proteins. 
This served both to further characterise the myelin deficit and to test known myelin 
genes as candidates prior to identification of a chromosomal locus for the hsh
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mutation. The complete absence or dramatic reduction of a protein might suggest a 
causative role for the gene encoding that protein. It has been shown that this is the 
case in some myelin mutants; for example, Plp/P has undetectable PLP/DM-20 (Sorg 
et al., 1987), as does md rat (Yanagisawa et a l , 1986) whilst shiverer and its allele 
do not stain for MBP (Sorg et al., 1987). Often, however, the pleiotropic effects of 
a mutation mean that the expression of other proteins is also altered as a 
consequence of the abnormal myelination process (Nave, 1995). In addition, a 
mutation may not result in lack or absence of a protein but rather, production of an 
abnormal protein. Therefore reduced protein levels cannot be taken as definitive 
proof of a mutation in the encoding gene and near normal protein levels do not 
necessarily indicate a normal gene, although these may be useful gauges. A further 
reason for performing MOG immunostaining in particular was the suggestion of 
genetic linkage of hsh to genetic markers on chromosome 17, made early in the 
study by workers at Harwell (Beechey and Cattanach, 1996). Mog lies in the region 
of apparent linkage (Daubas et a l, 1994) and, being the only known myelin gene in 
the vicinity, was a logical candidate to assess. The positive immunostaining in the 
cervical cord did not strongly implicate this gene, although in situ studies were 
carried out concomitantly (see In situ hybridisation study of myelin-oligodendrocyte 
glycoprotein, page 146) to investigate gene expression. Later in the mapping study, 
chromosome 17 was shown not to harbour the hsh gene and complete concordance 
was detected between hsh and a region of chromosome 3. This lay close to the map 
position of one of the two reported Cnp genes (Bernier et al., 1988), Cnp2, casting 
this a candidate. The presence of CNP in hsh myelin was confirmed using 
immunostaining, although the two protein isoforms could not be differentiated using 
the antibody employed. Hence, western blotting was carried out to investigate this 
further and is discussed in Western blotting for CNP, page 153.
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Figure 8: PLP/DM20 peroxidase-antiperoxidase immunostaining of paraffin 
sections from the cervical cord of (A) wild type and (B) hsh at P20. There is a 
reduction in immunoreactivity due to hypomyelination which appears to 
involve all white m atter tracts. (Approx. magnification x50).
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Figure 9: PLP/DM20 peroxidase-antiperoxidase immunostaining of paraffin 
sections of the corpus callosum and cingulate gyrus of (A) wild type and (B) hsh 
mice at P20. There is little detectable difference in staining intensity between 
the two. (Approx. magnification x60).
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Figure 10: PLP/DM20 peroxidase-antiperoxidase immunostaining of a paraffin 
section of the optic nerve of a P20 hsh animal. Most axons are surrounded by 
adequate sheaths compared with the spinal cord (Approx. magnification x990).
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Figure 11: Optic nerves from (A) wild type and (B) hsh mice at P20. This 
example represents the most marked hypomyelination seen in the optic nerve 
at this age. Bar = 2p.m.
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Figure 12: Areas of ventral spinal cord from P20 (A) wild type and (B) hsh 
mice showing typical hypomyelination with a mixture of thinly myelinated and 
amyelinated axons. (Approx. magnification xl500).
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Figure 13: Area of ventral spinal cord from P20 hsh mouse showing 
hypomyelination with a mixture of thinly myelinated and amyelinated axons. 
The myelin present is well compacted. Bar = 4pm.
102
Figure 14: Area of ventral cervical spinal cord from P100 (A) wild type and (B) 
hsh showing that although most axons are now myelinated, the sheaths of both 
large and small axons are disproportionately thin. (Approx. magnification 
xl500).
(B)
Figure 15: Areas from the ventral cervical cord of P20 (A) wild type and (B-D) 
hsh mice to show variation in phenotype. B-D are litterm ates and show a 
progressive increase in the myelin defect which reflected the intensity of the 
trem or. The mouse in B was phenotypically virtually norm al, having only a 
slightly stilted gait, and shows slightly thinner sheaths than wild type with only 
an occasional naked axon. (Approx. magnification xllOO).
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(C)
Figure 15 (cont.) Areas from the ventral cervical cord of P20 hsh mice to show 
variation in phenotype. The mouse in C showed a trem or when ambulating 
and has more naked axons. The most severe phenotype, with a trem or at rest, 
is seen in D where many axons lack a myelin sheath. (Approx. magnification 
xllOO).
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Figure 16: PLP/DM20 peroxidase antiperoxidase immunostaining of the 
cervical spinal cord ventral white m atter of a P20 m utant animal. The 
majority of the myelin sheaths are associated with larger fibres. (Approx. 
magnifications (A) xl 10. (B) x990).
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( B )
Figure 17: Immunofluorescent staining for MAG on cryosections from the 
cervical spinal cord ventral white matter of P20 (A) wild type and (B) hsh 
animals. There is an obvious reduction in the number of positive staining 
sheaths. (Approx. magnification x400).
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Figure 18: Immunofluorescent staining for MOBP on cryosections from the 
cervical spinal cord dorsal columns of P20 (A) wild type and (B) hsh animals. 
There is a marked reduction in the intensity of staining in the mutant. 
(Approx. magnification x400).
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(B)
Figure 19: Immunofluorescent staining for MOG on cryosections from the 
cervical spinal cord dorsal columns of P20 (A) wild type and (B) hsh animals. 
Staining intensity is bright in the m utant. The area of reduced staining 
intensity in wild type is probably an artefact. (Approx. magnification x400).
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(B)
Figure 20: Immunofluorescent staining for CNP on cryosections from the 
cervical spinal cord ventral white m atter of P20 (A) wild type and (B) hsh 
animals. Staining is reduced in the white and grey m atter of the mutant. 
(Approx. magnification x400).
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Figure 21: Immunofluorescent staining for GFAP on cryosections from the 
cervical spinal cord ventral white m atter of P20 (A) wild type and (B) Itsh 
animals. There is a reduced amount of white m atter in the m utant with an 
increased intensity of staining. (Approx. magnification x500).
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Figure 22: Graphs showing (A) Total areas of transverse sections of cervical 
spinal cord of wild type and mutant animals and (B) Areas of white matter only 
from the same sections. The deficit in white matter, a consequence of 
hypomyelination, is evident in hsh animals. Significant differences are marked 
with *.
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Figure 23: Myelin volumes in ventral columns of cervical spinal cord of wild 
type and mutant mice. Three to four mice were recorded for both groups at 
each age and shown as individual points. The myelin deficit is maximal at P20- 
P30 and partially resolves in the older animals. Significant differences are 
indicated by *.
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Axon diameter frequency distribution for 
cervical spinal cord ventral white matter in P30 
mice
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Figure 24: Axon diameter frequency distributions for cervical spinal cord 
ventral white m atter in P30 wild type (n = 2) and hsh (n = 3) mice. 
Measurements from mice in each group were pooled. Both myelinated and 
unmyelinated axons are included. The distribution is similar.
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Axon diameter frequency distributions of 
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Figure 25: Axon diameter frequency distributions of myelinated and 
unmyelinated axons in the cervical spinal cord ventral columns of P30 hsh mice 
(n = 3). A larger proportion of small diameter axons are unmyelinated 
compared with bigger fibres.
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Figure 26: Myelin sheath thickness in wild type and hsh mice at (A) P30 and (B) 
P I00. Most axons in mutant animals possess a disproportionately thin sheath 
compared with wild type animals. Sheaths are thicker by P100. Fibres are 
plotted as individual points and the linear regression line for each group is 
shown.
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Figure 27: G ratios for wild type and hsh mice at (A) P30 and (B) P100. At 
P30, the higher g  ratios for the majority of axons in mutant mice indicates that 
most sheaths are disproportionately thin. By P100, g  ratios are reduced in 
mutants. Many small fibres now have g  ratios comparable to fibres of the same 
diameter in wild type mice.
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Figure 28: Mean g  ratios for wild type and mutant mice at P30 and P100. The 
higher ratio in hsh indicates the sheaths are disproportionately thin. An 
improvement occurs with age and by P100, the g  ratio is reduced, although still 
greater than in the equivalent wild type.
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3.5 Glial cell morphology and quantification
3.5.1 Introduction and aims
Hypomyelination may be due to the presence of inadequate numbers of 
oligodendrocytes, appropriate numbers but insufficient myelinating function of 
these cells or a combination of both. Quantification and scrutiny of 
oligodendrocytes in affected regions may infer which of these is the basis of the 
myelin defect. Gross deficits in cell numbers can be measured and ultrastructural 
abnormalities may suggest a functional impairment. Mutations may also have 
effects on other glial cells, either directly or as a response to abnormal myelination. 
Thus, analysis of astrocytes and microglia may shed further light on the basis and 
consequences of the mutation. The aim in this part of the study was to investigate 
the effect of the hsh mutation on glial cell biology in terms of their distribution, 
absolute and relative numbers and their ultrastructural appearance.
3.5.2 Materials and Methods
3.5.2.1 Preparation of tissue
Tissue was resin embedded for glial cell quantification and ultrastructural analysis 
(Resin processing and sectioning, page 46). Cryosections were prepared as 
described in Cryopreservation and sectioning, page 47 for ISH while sections for 
F4/80 microglial specific staining were prepared as described in Periodate-lysine- 
paraformaldehyde (PLP) fixative, page 45.
3.5.2.2 Glial cell quantification
Total and differential glial cell counts were performed on ventral white matter in 
cervical cord sections from mutant and wild type mice at P10, 20, 30, 50 and P I00 
as described (Quantification of glia, page 48). Three mice of each phenotype were 
used at P10 and P I00 whilst 4 to 6 mice were used at the intervening ages. 
Classification of cell types was based on nuclear and cytoplasmic morphology with 
cells being categorised as oligodendrocytes, astrocytes or ‘other’, which included 
microglia and cells of indeterminate class. The Mann Whitney t test was used for 
statistical analysis. The methodology for dead cell quantification is given in Dead 
cell density, page 48.
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3.5.2.3 Immimostaining for microglia
The microglial population was further investigated qualitatively in the cervical cord 
at P20 and P50 using immunostaining for F4/80. The protocol is given in F4/80 
immunocytochemistry, page 53.
3.5.2.4 Ultrastructure of glial cells
Ultrastructural analysis of glial cells was performed on EM photographs of the 
cervical cord ventral columns from P10, 20, 30, 50 and P100 mice at 7500 to 15000 
times magnification.
3.5.2.5 In situ hybridisation
In situ hybridisation was employed in this study as an independent technique for 
qualitative assessment of the numbers and distribution of oligodendrocytes that did 
not rely on morphological critera. Experiments were performed using a probe for 
Plp-1 on sections of cervical, thoracic and lumbar cord, forebrain and cerebellum at 
P5, 10, 15, 20, 30 and P50. This recognises both Pip and Dm20. A probe for Ugt8 
was used on cervical cord sections at P5, P10 and P20. The ISH technique is 
described in In situ hybridisation, page 60.
3.5.3 Results
3.5.3.1 Histological studies
The observed distribution of hsh oligodendrocytes in the spinal cord white matter 
appeared identical to wild type. There was a significant increase in total glial cell 
density at P20 (p = 0.0043), P30 (p = 0.0079) and P50 (p = 0.0286) in comparison 
with wild type, but by P I00 values were very similar (p = 0.2286) (Figure 29, page 
126). With compensation for the reduced amount of white matter, there was 
actually a slight decrease in total glial numbers up to P50 (Figure 29, page 126). 
Significant differences were found at P20 and P30 (p = 0.0043 for both).
The reduction in total glial numbers appeared to be due to a decrease in the number 
of oligodendrocytes which showed significant differences between hsh and wild 
type at P20 and P30 (p = 0.0043 for both). There was little alteration in astrocyte 
numbers (Figure 30, page 127) or ‘other’ cell types (Figure 31, page 128). The 
maximum cell deficit occurred at P20 when oligodendrocyte numbers were about 
60% of wild type values. Between P30 and P50, oligodendrocyte numbers 
increased so that by P50, they were virtually identical to wild type .
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No obvious morphological abnormalities were found in hsh glial cells on resin 
sections but there was the impression of a greater proportion of “light” 
oligodendrocytes at P10 and P20, implying a delay in maturation. Examination of 
EM photographs revealed ultrastructurally unremarkable oligodendrocytes with no 
obvious maturational delay (Figure 32, page 129). No astrocytic abnormalities were 
apparent.
On visual examination of spinal cord ventral white matter on thick resin sections, 
microglial cells appeared subjectively more numerous in mutant animals of all ages 
than in wild type. Immunostaining with F4/80 at P20 (Figure 33, page 130) and P50 
(Figure 34, page 131) confirmed the increased microglial cell density. 
Morphological quantification indicated no increase in the total number o f microglia 
and unclassified cells at P20 but at P50, elevated cell numbers were detected (Figure 
31, page 128) with about twice as many cells in hsh sections. On EM photographs, 
the majority of cells classified as microglia were unremarkable, although the 
occasional cell contained multiple cytoplasmic vacuoles with wispy membranous 
inclusions (Figure 35, page 132).
There was no increase in the number of pyknotic nuclei in hsh white matter, with
only 2-3 cells identified in each section up to P20-P30. After this time, very few 
pyknotic nuclei were seen in either hsh or wild type cords.
3.5.3.2 In situ studies
A probe for Plp/Dm20 message isoforms suggested the distribution of hybridising 
cells was similar to wild type in all the CNS regions and ages examined (P5-P50). 
However, the number of positive cells was dramatically reduced in the spinal cord 
compared to normal, even when exposure times were increased (Figure 36, page 
133). This difference was most prominent in mice up to P30 but was still apparent 
at P50. The intensity of signal per cell in the mutant was comparable to that in wild 
type. A marked difference was also found in the number of Plp/Dm20 positive cells 
in the cerebellum (Figure 37, page 135) but in contrast, little difference was 
observed between hsh and wild type mice in the hybridisation pattern of the 
forebrain (Figure 38, page 136). ISH for Ugt8 demonstrated a similar paucity of 
oligodendrocytes in hsh cervical spinal cord at all ages examined (P5-P20) (Figure 
39, page 137). A difference in intensity of signal in individual cells was difficult to 
assess as hybridisation was more diffuse than for Plp/Dm20, even in wild type.
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3.5.4 Discussion
The distribution of oligodendrocytes in hsh spinal cord is identical to wild type, 
suggesting that cells are able to migrate normally. Using morphological criteria, a 
deficit in total glial numbers is found in younger mice, and is apparently due to a 
lack of oligodendrocytes. An increase in oligodendrocyte numbers between P30 
and P50 leads to complete resolution of this difference. Interestingly, this matches 
the period of maximum myelin production in the mutant as measured by point 
counting (see Myelin volume, page 92). A more profound paucity of 
oligodendrocytes is found using ISH for Pip and Ugt8. No astrocytosis is detected 
but microglial cell numbers appear increased from P50. Cell death does not 
apparently exceed control results, although this was assessed only by counting 
pyknotic nuclei.
Quantification of cells was carried out primarily in 1pm resin sections using 
morphological criteria to enable the sampling of a large number of cells from 
several animals at each time point, a task which is not easily undertaken using 
ultrastructural identification. However, this technique is complicated by the 
difficulty in unambiguously assigning cells to a particular lineage at younger ages 
and there is a potential for misidentifying cells (Skoff, 1990). Thus, ISH was 
employed to provide an alternative means of assessing the apparent reduction in 
oligodendrocyte numbers in younger mice.
ISH was carried out with two oligodendrocyte-specific probes, Plp-1 and Ugt8; 
although this resolves the problems of morphological identification, its limitations 
lie in the ability to clearly distinguish positively hybridising cells and hence, to 
quantify cell numbers precisely. Thus, it cannot be easily used as the sole method 
for enumeration. Although the Plp-1 probe hybridises with both Pip and Dm20 
mRNA, positive cells are likely to be mature Pip expressing oligodendrocytes based 
on the age of mice tested, the distribution of cells and the intensity of signal. Ugt8 
is expressed earlier than Pip (Kagawa et al., 1996) and serves as a marker of less 
mature oligodendrocytes.
There is a dramatic reduction in the number of Plp/Dm20 expressing cells in the 
cervical spinal cord at P20 that appears subjectively greater than the difference 
detected using morphological criteria; with that technique, oligodendrocyte numbers 
are approximately two thirds of control values at P20. At P50, the paucity of cells is 
still apparent with ISH for Pip whereas morphological assessment suggests a 
resolution of the deficit has occurred. The disparity between the two results may 
imply a delay in maturation, which is supported by the impression of more “light” 
oligodendrocytes on resin sections from young mice. Interestingly, the Pip signal
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intensity per cell is not reduced and in fact, in many cells it appears comparable to 
the most strongly expressing wild type oligodendrocytes. However, high signal 
intensity does not always correlate with the final protein levels and the ability to 
form myelin, as has been demonstrated for other mutations, for example some of the 
Pip mutants (Gardinier and Macklin, 1988; Boison and Stoffel, 1989; Nadon et al., 
1990; Fremeau, Jr. and Popko, 1990) and Mbpphi together with its allele, Mbpshi- 
(Popko et al., 1987).
The deficit in Plp/DM20 expressing cells is also obvious in the cerebellum, but is 
hardly detectable in the forebrain. This correlates with the more mild degree of 
hypomyelination in the forebrain (see Distribution of the lesion, page 90) and 
suggests that hypomyelination is indeed related to a paucity o f mature 
oligodendrocytes. It also demonstrates that the hsh factor is not only important in 
myelination in the spinal cord but also in the hindbrain, whilst it is of less 
significance in the forebrain.
Ugt8 is considered to be a key enzyme in the biosynthesis of galactocerebroside and 
has been shown to be a good marker for localising oligodendrocytes (Kagawa et a l , 
1996). It is expressed a short time prior to myelination and is therefore an earlier 
marker than Pip (Kagawa et al., 1996). The dearth of Ugt8 expressing 
oligodendrocytes seen in hsh indicates that the cellular defect involves not just the 
most mature myelin forming stages but also cells preparing to myelinate nearby 
axons.
Other CNS myelin mutants in which oligodendrocytes have been quantified exhibit 
disparate changes. A paucity of oligodendrocytes is seen many of the Pip mutants 
where it is associated with cell death (Skoff, 1976; Dentinger et a l , 1982; Duncan et 
al., 1983). In these animals, hypomyelination is presumably due partly to 
inadequate cell numbers. However, one Pip mutant, rumpshaker, does not suffer 
from increased cell death and in fact has increased numbers of oligodendrocytes 
(Schneider et al., 1992), but is still hypomyelinated albeit less severely. The other 
well-studied mutants shiverer and quaking have also been reported to have more 
oligodendrocytes than normal (Friedrich, Jr., 1975; Nagara and Suzuki, 1981). 
Hypomyelination in these cases results from inadequate myelin production by 
individual cells rather than too few cells. A report of a tremor/hypomyelinating 
syndrome in Samoyed dogs quantified glial cell numbers in the ventral funiculus of 
the spinal cord and found a marked decrease in oligodendrocytes (Cummings et a l , 
1986). There appeared to be a preponderance of light and medium oligodendrocytes 
with few dark cells being identified, leading the authors to conclude that there was a 
deficit in stem cell division with a delay in maturation. A definite hereditary basis
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was lost. Weimaraner dogs with an inherited hypomyelinating condition also 
demonstrate reduced numbers of oligodendrocytes in the affected white matter 
(Komegay et al., 1987), which is largely the peripheral portion of the lateral and
ventral columns. Possibly cell migration is impaired in these animals.
The basis of the reduced hsh oligodendrocyte population in young animals is not 
obvious but any hypothesis must explain both the histological findings and the more 
profound paucity of Pip and Ugt8 expressing cells. Also interesting is the apparent 
increase in oligodendrocyte numbers between P30 and P50. Abnormal cell death 
does not appear to be involved, although a slight increase might pass undetected. 
This could be further assessed using a terminal deoxynucleotidyltransferase- 
mediated incorporation of biotinylated nucleotides (TdT-mediated dUTP biotin nick 
end labelling; TUNEL) technique to label apoptotic cells that may be missed using 
morphological criteria. In the absence of perturbed cell death, perhaps some aspect 
of the proliferative capacity of precursors is disrupted by the mutation, with reduced 
proliferation in early myelination but a compensatory extension of the proliferative 
period to generate adequate numbers later. Cell mitosis studies using tritiated 
thymidine labelling as an index of DNA synthesis could be carried out to shed light 
on this. There may also be a delay in differentiation, resulting in the 
disproportionate reduction in mature Pip gene expressing cells. It was this 
hypothesis that stimulated the in vitro culture study of oligodendrocyte development 
presented in the following section. In addition, it would be interesting to know how 
far back in the oligodendrocyte lineage the cell deficit extends and whether the 
precursor population is also affected; ISH for PDGFRa, a marker of 
oligodendrocyte precursors (Pringle et al., 1992), could be employed investigate 
this.
No astrocytosis is found in hsh and in general, a marked astrocytic response is not a 
feature of other autosomal recessive mutants (Duncan, 1995). In contrast, Pip 
mutants exhibit an astrocytosis that is more marked in the most severely 
hypomyelinated animals. Defects in astrocyte cell cycle and metabolism have also 
been reported in Pip mutants and may be a direct effect of the mutation (Knapp et 
al., 1993; Knapp and Skoff, 1993) rather than a consequence of hypomyelination.
There appears to be an increased density of microglia in spinal cord white matter at 
all ages. In younger animals this can be ascribed to the increased total glial cell 
density, but in older animals it seems disproportionately elevated on visual 
examination of immunostained sections, a finding supported by quantification using 
morphological criteria. Cytoplasmic vacuoles are present in a small proportion of 
hsh microglia but were not found in equivalent wild type cells, implying that these
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occur as a consequence of the hsh mutation. Microglia are numerous in Plp/P (Vela 
et al., 1996) and the md rat (Jackson and Duncan, 1988), and seem related to the 
time of maximum cell death. The single report on hypomyelination in Samoyed 
dogs also described an increase in microglia but cell death was not an obvious 
feature of this disease on morphological assessment (Cummings et al., 1986). A 
similar increase in microglia has not been reported in quaking or shiverer mice. 
Since cell death is not prominent in hsh, the stimulus for the apparent expansion of 
the microglial population in older mice is obscure. It may be, however, that any 
increase in cell death escaped detection using only quantification of pyknotic nuclei 
and a higher rate of death may be identified using the TUNEL technique. The basis 
of the cytoplasmic vacuoles in the absence of apparent cell death or myelin 
breakdown is also puzzling, but perhaps it is a consequence of more rapid turnover 
of myelin products.
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Figure 29: A) Glial cell density in the cervical cord ventral column white matter 
in wild type and hsh animals. Values are increased and P20, P30 and P50. B) 
Total glial cell numbers for the same animals. A slight reduction in total glial 
numbers is evident up to P30. Significant differences are marked with *.
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Figure 30: A) Oligodendrocyte numbers in the cervical cord white m atter in 
wild type and hsh animals. Values are reduced at P10, P20 and P30. 
Significant differences are marked with *. B) Astrocyte numbers in the same 
sections. No differences are seen.
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Numbers o f microglia and unclassified cells in spinal 
cord white matter
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Figure 31: Numbers of microglia and unclassified cells in the cervical cord 
white matter in wild type and hsh animals. No consistent differences are seen 
before P50. At P50 and P100, an elevated cell count was obtained in mutants; 
at these ages very few cells have ambiguous morphology so the difference is 
almost entirely due to an increase in microglia. The numbers of cells involved 
are nevertheless small in comparison to total cell numbers.
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Figure 32: U ltrastructure of a typical hsh oligodendrocyte from a P20 animal. 
No abnorm al features can be seen. A) x7500 and B) x!5000
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Figure 33: Dorsal columns of P20 (A) wild type and (B) hsh cervical cord 
stained for F4/80, a microglial antigen. An increase in cell density is seen in 
m utant tissue but quantification showed no increase in absolute numbers. 
(Approx. magnification x400).
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Figure 34: Dorsal columns of  P50 (A) wild type and (B) lisli cervical  cord 
stained for F4/80. There is an increase in microglia l  cell density in the mutant.  
(Approx.  magnification x400).
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Figure 35: A P20 hsh microglial cell containing multiple lucent cytoplasmic 
inclusions. (Approx. magnification xlOOOO).
132
:* * s . . . f ' >7 », T: *•f  • ' • ' ■ ■ .'S;*- . ‘ V-:
. • **" W •■*«<*£• ••'. ■ >• * .  '.: ’ >.
. . • •'  . • . * *  .
X . . . •
• m. m ■*  * ^  4 .  . *  r *  - y f i .  J v  V
$&&■ i •
* * • » -  •« . , • * -i .; • * i  . i Y*.
* v -r t . V  * V *  • ■«»* ♦ •, * , * *. " ‘ I
*.  v 7 * . > .  •  * ~  4 , 7  ■- v v  • i .  * . • _ .
»1 • * *■* • _
• '  ^
-t
** Alt
•f • Vw*i' .*
(A)
% ■ £
• * i «-2V> *.• *;Vn- • A'.
».■ : • **» -v 
' *  V ,  ‘ ~■ * . s . f/’*■ ■ ’ V
■ ** » '■ * ■ * « v»v;!vV 
if • ^
A * * # .
’ ‘ ' ‘ 44 * ’ ' «.
• \  * *
A > ’\.
' * y-‘‘ ^ * ♦ / ’*• '*. *. t * ' *
rV
r f ‘v*- •'
,■ / * • j . * • • • . . - ;
4 1 * .
t  • « •* » *‘ « . * . 4 v 
'  . 
. • -  V ,  '  ;.. • V' V ' '.« A fc , my> ♦ •. * ' * \  * '♦ . ' a . * • * 4 ‘ • '• '. v . f
V
♦V '-
* • » ,/  \  V44* , - «?, * » # V *. • - ■ • 4 . «.* ■ > -,y
t a ),X  ^ - . * -fi  vy>- . •: ." ' •" • ..> - ' • ; • ‘ Ai* * k *. ? *  - ? ^ ^  - y  '• *r
K'f i .  v ‘ - - V . "  * v
■" r. f  t  *•
(B)
Figure 36: Autoradiograms of P20 (A,C) wild type and (B,D) hs/i cervical 
spinal cord hybridised for Plp/Dm20 and counterstained with haematoxylin. 
Fewer positive oligodendrocytes are seen in hsh although the distribution 
throughout the cord is similar. (Approx. magnification A, B x40, C, D x90).
133
v f . .  *  .• v ,  » >
A ' A t *  i  « 1 < \ '  T U -St?
(D)
Figure 36 (cont).: Autoradiograms o f  P20 (C) wild type and (D) hsh  cervical 
spinal cord hybridised for P lp /D m 2 0  and counterstained with haematoxylin.  
The comparable  intensity of  signal per cell in the mutant can be seen. (Approx.  
magnification x90).
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Figure 37: Autoradiograms o f  P20 (A) wild type and (B) hsh  cerebella 
hybridised for P lp /D m 2 0  and counterstained with haematoxylin.  The hsh  
cerebellum contains fewer hybridising cells than the age matched wild type 
although a similar distribution is seen. (Approx.  magnification x50).
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Figure 38: Autoradiograms of the forebrain of P20 (A) wild type and (B) hsh 
mice hybridised for Plp/Dm20 and counterstained with haematoxylin. In the 
corpus callosum and cingulate gyrus, there is less difference in cell numbers 
than the spinal cord and cerebellum. (Approx. magnification x50).
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Figure 39: Darkfield autoradiograms of P20 cervical spinal cord from (A) wild 
type and (B) hsh mice hybridised for Ugt8 and counterstained with 
haematoxylin. Fewer positive cells are seen in the mutant animal compared 
with wild type. (Approx. magnification x50).
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3.6 In vitro development of hsh oligodendrocytes
3.6.1 Introduction
Without question, the most convenient means of studying oligodendrocyte 
differentiation is in tissue culture. Cells in culture are more accessible, can be 
observed directly during development and most importantly, their environment can 
be controlled in a way that is impossible in vivo. Dissociated cells undergo a 
complex pattern of antigenic and morphological development that appears similar to 
the in vivo situation, culminating in the formation of myelin membrane. However, 
because cell culture lacks the framework of intact tissue, many intercellular 
interactions that occur during development may not occur in culture; this limits the 
extent to which results can be extrapolated to development of oligodendrocytes in 
situ.
3.6.2 Aim
These experiments were stimulated by the finding of a deficit of mature 
oligodendrocytes in areas of hypomyelination in hsh mice. The aim was to observe 
the effects of the mutation on oligodendrocyte survival and differentiation in vitro 
with the hope of correlating this to the in vivo findings. The study was performed 
on cells from dissociated spinal cord because this region was known to be the most 
severely affected by the mutation. A small range of markers was tested at a limited 
number of time points to provide an overview of the developmental profile of hsh 
oligodendrocytes in relation to wild type cells. Any further experiments were to be 
decided on the basis of results from these preliminary studies.
3.6.3 Materials and Methods
3.6.3.1 Cell culture technique
Cultures were established from spinal cords of P5 hsh and wild type mice; this age 
was selected to provide a suitable balance between the ease of establishing cultures 
whilst being sufficiently mature for the presumptive developmental delay in hsh to 
be apparent. Pups were obtained only from hsh mice that were known to reliably 
produce offspring with a marked phenotype. Control and mutant cultures were set 
up from similar sized litters within a close time interval and with the same batches 
of solutions and antibodies The technique has been described in Cell culture, page 
64 and was closely adhered to for consistency of results. Cultures that had obvious 
variation in cell density between mutant and control coverslips after plating were 
not used.
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3.6.3.2 Immunostaining
0 4  staining for sulfatide and related glycolipids was taken as the marker of 
commitment to the oligodendrocyte lineage and considering this as 100%, the 
percentage of cells positive for other antibodies was obtained from double 
immunofluorescent immunostaining. 01 staining was used to identify more mature 
cells, and MBP and PLP detected the most mature stages of the lineage. The PLP 
antibody detected an antigen common to both PLP and DM20. R-mAb, an antibody 
for sulfatide and GalC, was used in the first set of experiments but as there was 
virtually no difference between that and 01, it was abandoned. Immunostaining 
was performed as described in Immunofluorescent staining, page 65 after 24, 48 and 
72 hours in culture with 3 coverslips being used for each antibody combination at 
each time point. Three hundred cells were counted for each coverslip. The 
experiment was repeated three times and the results were pooled.
3.6.4 Results
The yield of oligodendrocytes from hsh spinal cord was comparable to that from 
wild type tissue and survival in culture was good. Mutant oligodendrocytes did not 
show obvious morphological differences from controls. Staining for 0 4  was bright 
and a similar number of cells were stained in relation to the total number of nuclei 
as was estimated in wild type (Figure 40 page 143). They produced processes in a 
similar fashion to wild type and eventually developed myelin membranes of 
comparable dimensions at the expected time (Figure 41, page 144). Quantification 
of percentages of 04+ cells that were also stained for either O l, MBP or PLP 
showed no difference between hsh and wild type cultures (Table 4, page 140). The 
only remarkable difference between mutant and control cells was a subjective 
reduction in intensity of staining for MBP and PLP in mutant cells at all time points. 
This was identified as less bright fluorescence and more localised staining; 
fluorescence appeared to be more likely to be perinuclear in hsh whereas 
membranes also stained brightly in differentiated wild type cells.
Only small increases in the percentages of double-stained cells occurred over the 72 
hour time period in cultures of both phenotypes. It was noted that there appeared to 
be a wave of 04+/01- cells appearing between 48 and 72 hours, both in wild type 
and hsh. These were multipolar, had not yet started to form membrane sheets and 
appeared to boost the population of cells stained for 0 4  at 24 hours.
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Phenotype Wild
type
hsh Wild
type
hsh Wild
type
hsh
Hours in culture 24 hours 48 hours 72 hours
0 4 /0 1 15 13 16 14 17 16
04/M BP 8.6 6 9 8.5 11 10.3
04/PLP 7 6 9 8.5 10 9.4
Table 4: A table showing the percentages of 0 4  positive cells that stain for O l, 
MBP and PLP at 24 hours, 48 hours and 72 hours. Results are the mean of 
three experiments (a total of about 2700 cells per test). Minimal difference is 
seen between the values obtained for mutant and wild type cells.
3.6.5 Discussion
In culture, the differentiation of 0-2A cells, the precursors to oligodendrocytes and 
type 2 astrocytes, is controlled by both intrinsic and extrinsic factors. In this study, a 
low concentration of foetal calf serum allowed differentiation of 0-2A  cells into 
oligodendrocytes rather than type 2 astrocytes. By placing cells from mutant and 
wild type animals in a similar environment that was permissive for rapid 
differentiation, it was hoped that intrinsic differences in their survival and/or 
differentiation and maturation would become apparent. Great care was taken to 
ensure that wild type and mutant cultures were obtained from similar sized litters 
and were of comparable densities to minimise extraneous influences on 
oligodendrocyte development. Obviously mice from smaller litters may be 
developmentally more advanced in comparison to those from very large litters, 
which could be reflected in the population of oligodendrocytes and precursors 
obtained from them. Cell density has been shown to influence proliferation and 
differentiation of oligodendrocytes in culture, with low density increasing 
proliferation (Zhang and Miller, 1996) and high density favouring progression of O- 
2A progenitors along the oligodendrocyte lineage (Levi et al., 1991; Agresti et a l , 
1991). No mitogens other than insulin and any present in the FCS were added, to 
facilitate the immediate differentiation of precursors (Temple and Raff, 1985; 
Barres et al., 1992b). High concentrations of insulin have been shown to have a 
major beneficial effect on cell survival and differentiation (Barres et al., 1992a; 
Barres et al., 1993), for which it was used here. However, it has also been shown to 
stimulate proliferation of 0-2A progenitors (McMorris and Dubois-Dalcq, 1988) so 
it is possible that some precursors did undergo divisions before differentiating.
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Cultures established from hsh cords yield a large population of cells and in fact, it is 
subjectively easier to obtain good cell density than from normal cords. This may be 
related to the more advanced stage of axonal ensheathment/myelination of many of 
the normal oligodendrocytes, which thus sustain greater mechanical trauma and 
subsequent cell death upon dissociation. No morphological differences are observed 
at any stage, with hsh oligodendrocytes surviving and developing similar features to 
cells in control cultures. However, in view of the preceding phenotypic studies, it 
was anticipated that a developmental delay would be described, so it is a little 
surprising that no quantifiable variance is found in the expression of stage specific 
markers. Even PLP and MBP, late markers in oligodendrocyte maturation that are 
expressed at high levels in myelinating cells, show no quantifiable differences. This 
suggests that in vitro at least, hsh oligodendrocyte precursors are capable of
regulated differentiation to mature myelinating cells over a temporal period 
comparable to wild type. How this correlates to the in vivo finding of a 
disproportionate reduction in the number of mature oligodendrocytes is not clear; 
perhaps extrinsic signals triggering differentiation are absent or not responded to in 
vivo but are provided or not required in vitro. Whether these differentiated cells are 
functionally normal and capable of producing adequate myelin, is not known. The 
subjective finding in the culture experiments of reduced intensity of fluorescent 
staining for MBP and PLP and its persistent perinuclear localisation would suggest 
that they are not. It is also not clear if this apparently reduced ability to form 
normally stained sheaths is due to an intrinsic defect in oligodendrocytes or if it is 
because extrinsic signals are not forthcoming. It has to be borne in mind that 
cultures of this nature are mixed glial cultures, containing microglia, 
oliogodendrocytes and heterogeneous astrocytes, so the effects of other glial cells on 
oligodendrocyte development cannot be eliminated. It has been shown for PlpiP, 
culturing oligodendrocytes in the presence of medium conditioned by astrocytes 
from wild type mice can significantly improve survival, suggestive of a role for a 
specific astrocytic abnormality in the oligodendrocyte cell death seen in this mutant 
(Bartlett et al., 1988). Therefore, although the present study has tried to remove the 
majority of potential environmental differences between hsh and wild type to allow 
investigation of intrinsic oligodendrocyte properities, the presence of other glial cell 
types could still be influential.
The absence of mitogens other than insulin led to the expectation that differentiation 
would be rapid and that by 72 hours, many cells would have reached MBP and PLP 
positive stages. In fact, very little increase in percentages of 04+ cells stained for 
these later markers is found. Instead, there appears to be a wave of 04+/01- cells 
appearing in cultures derived from both phenotypes between 48 and 72 hours. Thus, 
although there are subjectively more 01+, MBP+ and PLP+ cells, judging by their
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density on coverslips, the increase is partly disguised by newly appearing 04+ cells. 
Such findings have been found by other workers performing cell culture in our 
laboratory (Dr C. Thomson, personal communication). Whether this wave is due to 
differentiation of pre-04+ cells in the cultures, or to proliferation of 04+ precursors 
already present is still under investigation by other workers in our laboratory. 
Labelling with bromodeoxyridine would identify cells replicating DNA and thus 
clarify to what extent proliferation versus differentiation is occurring under our 
culture conditions.
Antibody to CNP was originally tested on cultures but staining was too weak with 
my technique to be unequivocal in identification of positive cells. Instead, 
immunostaining of cryosections and western blotting were carried out to investigate 
this protein. Other late markers, such as MOG and MOBP, were not thought to be 
likely to yield further information in the first instance and were omitted from the 
study.
Taken together, it has to be concluded that cell culture has not greatly illuminated 
the nature of the mechanism underlying the hsh mutation. No explanation for the 
lack of mature oligodendrocytes identified in situ has been found and it remains 
unclear whether oligodendrocytes in hsh are inherently defective or whether they 
lack the correct extrinsic signals in vivo. What can be said is that there is little 
difference in the ability of oligodendrocytes to differentiate on schedule in vitro. 
However, their intrinsic ability to produce normal amounts of myelin is still under 
debate with the finding of reduced intensity of staining for major structural myelin 
proteins.
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Figure 40: Immunofluorescent staining with 0 4  antibody on 24 hour cultures 
of (A) wild type and (B) hsh spinal cord cultures obtained from P5 animals. No 
morphological differences can be seen between oligodendrocytes in the two 
cultures. (Approx. magnification x400).
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Figure 41: Immunofluorescent staining with 0 4  (this page) and PLP (next 
page) antibodies on 72 hour cultures of (A,C) wild type and (B,D) hsh spinal 
cord cultures from P5 mice. Using 0 4  staining, m utant cells have developed 
similar morphological features to wild type, producing processes and 
membranes in a comparable fashion on schedule. (Approx. magnification 
x400).
Figure 41 (cont.): Immunofluorescent staining with PLP antibody on 72 hour 
cultures of (C) wild type and (D) hsh spinal cord cultures from P5 mice. Less 
intense PLP staining is apparent in oligodendrocytes from hsh mice. (Approx. 
magnification x400).
3.7 Analysis of candidate genes
3.7.1 Background
The characterisation of a phenotype due to a mutation in a particular gene can be 
valuable in defining the function of the gene product, even if the gene is 
unidentified. However, without knowledge of the molecular basis o f the mutation, 
the ultimate goal of correlating the phenotype with the precise genetic alteration 
cannot be achieved. Thus, an integral part of the hsh study was the endeavour to 
identify the mutated gene. This was approached by recombinational linkage 
analysis using an intersubspecific backcross and by immunohistochemical studies of 
a panel of myelin proteins, the results of which are described in Immunostaining of 
the cervical cord, page 91. The absence of a particular protein in the hsh CNS might 
have implicated its encoding gene, although it may also be possible to have normal 
immunostaining in the presence of altered protein. In addition, two specific myelin 
genes were highlighted as candidates during the genetic mapping of the hsh locus; 
the Mog gene on chromosome 17 and Cnp2 on chromosome 3. The results of 
immunostaining for MOG and CNP have been presented previously in 
Immunostaining of the cervical cord, page 91. Additional studies performed to 
further examine the expression of these genes are described here. The genetic 
mapping data that led to the emergence of these genes as candidates are presented in 
the following chapter.
146
3.7.2 In situ hybridisation study of myelin-oligodendrocyte 
glycoprotein
3.7.2.1 Background and aims
Initial mapping studies performed at Harwell suggested linkage of hsh to distal 
chromosome 17 (Beechey and Cattanach, 1996). Since Mog is mapped to this 
region (Daubas et al., 1994), it was manifestly a candidate gene at that time. 
Immunostaining of cervical cord at P10 and P20 was positive although reduced in 
comparison to wild type tissue (see Immunostaining of the cervical cord, page 91). 
Concomitant with immunostaining, ISH with a Mog probe was undertaken to 
examine the distribution and amount of mRNA. The aim was to investigate the 
expression of the Mog gene in hsh animals at appropriate ages.
3.7.2.2 Experimental procedure for subcloning of the mouse Mog sequence
A Mog cDNA was provided by Andre Dautigny (Institut des Neurosciences, Paris 
Cedex) as purified pCL642 plasmid and JM109 cells containing vector in 50% 
glycerol. The insert was a 780bp RT-PCR fragment amplified from mouse brain 
RNA and included all eight exons (Daubas et al., 1994). This had been inserted at 
an EcoK V site in a 5^  to 3  ^ direction. Directional subcloning into the pGEM-4Z 
vector was necessary for generation of an antisense riboprobe using the T7 
promoter. Digests of the original plasmid were carried out using BamU I and Sal I 
to check the insert. The only restriction site for each enzyme was in the multiple 
cloning site so separate digests linearised the plasmid whilst a fragment of 
approximately 780bp was liberated with a joint digest. A fragment for subcloning 
was obtained with a BamR I and Sal I digest followed by gel extraction using a 
QIAEX kit (see DNA fragment isolation, page 55) (Figure 43, page 150).
The fragment was ligated into pGEM-4Z following BamH l/Sal I digest and CIP 
treatment of the plasmid (see Subcloning for riboprobe production, page 55). To 
generate sufficient plasmid DNA for analysis of fragment incorporation, 
transformation of JM101 competent cells and plasmid minipreps were performed as 
described (Subcloning for riboprobe production, page 55). Correct orientation of 
the fragment in a 5^  to 3 / direction was assessed for a number of clones using a Pvu 
II digest, exploiting the asymmetric restriction site in the insert (Figure 42, page 
149). The fragment sizes yielded for these were consistent with correct orientation 
(Figure 44, page 151) so one clone was selected for a maxiprep (see Maxipreps, 
page 58) and the plasmid was termed pG4MOG.
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Separate EcoK I and Hind III digests were carried out to linearise pG4MOG for 
sense and antisense riboprobe production respectively. Sense probe was generated 
from the SP6 promotor and antisense from the T7 promoter (Preparation of 35S 
labelled riboprobes, page 60).
3.7.2.3 In situ hybridisation study
3.7.2.3.1 Methods
The technique was carried out on cryosections of cervical spinal cord from mice of 
10, 20 and 50 days as described in In situ hybridisation, page 60.
3.7.2.3.2 Results
The distribution of positive cells and qualitative assessment of their numbers was 
indistinguishable from that of Pip expressing cells at the same age (Figure 45, page 
152).
3.7.2.4 Discussion
This study shows that oligodendrocytes in hsh were transcribing the Mog gene and 
taken in conjunction with the immunostaining, were capable of producing a 
considerable amount of protein. The number of Mog expressing cells was 
comparable to those positive for Pip, an unsurprising finding in light o f expression 
of both proteins relatively late in myelination (Coffey and McDermott, 1997). 
Although these findings do not necessarily exonerate the Mog gene as a candidate, it 
does appear to reduce the likelihood. Later work in the genetic study actually 
excluded chromosome 17 as harbouring the hsh gene, substantiating these 
observations.
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PvuII 3419
Eco RI 7 
• Bam HI 28
SP6
Pvu II 154
pG4MOG
3510 bp
amp
MOG
T7
•Sal I 826 
Hind III 844
u II 1055
Pvu II restriction profile
MOG insert 5'-3'1 MOG insert 3 -5
2364/901/245 2364/791/355
Figure 42: pG4MOG plasmid map showing restriction sites utilised in the study. 
Diagnostic Pvu II restriction profile is shown below. The diagnostic fragment 
sizes used in identification are shown in bold.
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Figure 43: pCL642 digests; Lane 1 XHind III m arker, Lane 2 undigested 
pCL642 with insert, Lane 3 BamH l/Sal I digest showing liberated fragment, 
Lane 4 lOObp calibration ladder, Lane 5 isolated fragment.
4  5 7 8 9  10
Figure 44: pG4MOG orientation digests. Lane 1 undigested pGEM 4Z, Lane 2 
pGEM4Z BamH  I /Sal I digest, Lane 3 undigested pG4MOG, Lane 4 pG4MOG 
linearised with Hind  III, Lane 5 pG4MOG linearised with EcoR  I, Lane 6 100 
bp calibration ladder, Lane 7 pG4MOG BamH  I /Sal I digest to show insert, 
Lane 8 pG4MOG Pvu II digest to liberated a fragm ent of about 250 bp, Lane 9 
PGEM 4Z Pvu II digest and Lane 10 XHind III m arker.
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Figure 45: Autoradiogram from a 20 day old hsh spinal cord hybridised for 
Mog and counterstained with haematoxylin. The distribution and num ber of 
positive cells is similar to that seen with Pip. (Approx. magnification x50).
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3.7.3 Western blotting for CNP
3.7.3.1 Introduction and aims
Linkage of the hsh gene to the middle third of chromosome 3 was identified towards 
the end of the study period. One of two reported Cnp genes, Cnp2, has been 
mapped to chromosome 3 (Bernier et al., 1988), at a position about 3cM proximal to 
the region of the hsh locus on the Chromosome Committee map 
(http://www.informatics.jax.org). However, different mapping techniques mean that 
precise distances and positioning of markers and genes cannot always be relied on in 
combined maps (see Genetic maps, page 74 for discussion of genetic maps) so Cnp2 
was still considered as a candidate. The protein product for Cnp2 remains to be 
elucidated (see 2 ’, 3’-cyclic nucleotide 3’-phosphodiesterase (CNP), page 25), 
although it has been suggested that it may generate a particular CNP protein isoform 
or exhibit activity in specific tissues (Bernier et al., 1988). It has also been 
suggested that it may be a pseuodgene or encode for a CNP-related polypeptide 
(Bernier et al., 1988). The most logical initial strategy thus appeared to be the 
investigation of CNP protein isoforms in the hsh CNS. Two peptides, CNP1 and 
CNP2, with respective apparent molecular weights of 46kD and 48kD, are detected 
in the mouse (Sprinkle et al., 1978). Western blotting was undertaken with the 
assistance of Mr Douglas Kirkham to study total protein and relative isoform levels 
in hsh.
3.7.3.2 Materials and Methods
Spinal cords were obtained from P20 hsh and wild type animals and processed for 
protein extraction (Isolation of protein from tissue, page 66). These were analysed 
by western blot and immunostained for CNP using polyclonal CNP antibody (P. 
Brophy) (SDS-polyacrylamide gel electrophoresis, page 66).
3.7.3.3 Results
There is a marked reduction in the level of CNP protein in hsh spinal cord. 
However, both isoproteins are present, with the 46kDa form predominating as in the 
control sample.
3.7.3.4 Discussion
Genetic mapping of the hsh mutation identified a region on chromosome 3 that was 
likely to contain the mutated gene (Fine mapping of chromosome 3, page 187). The 
interval was examined for candidate genes on integrated mouse genetic maps 
(http://www.informatics.jax.org) and was found to be about 3cM distal to the map 
position of one of the two reported Cnp genes, Cnp2. The precise role of CNP in
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myelination is not yet entirely elucidated (2’, 3’-cyclic nucleotide 3 ’- 
phosphodiesterase (CNP), page 25) but it appears to be the first myelin-related 
protein detected during development (Trapp, 1990), and has postulated roles in 
signal transduction (Thompson, 1992) and in the formation of cell processes that 
contact and envelop axons (Gravel et al., 1996). The suggestion has therefore been 
made for a role in early myelination. Interestingly, oligodendrocytes in transgenic 
mice with extra copies of Cnp appear to mature earlier in development, resulting in 
premature maximum gene expression for Mbp and Pip (Gravel et al., 1996). This 
contrasts to the retardation of myelination and the reduction in numbers of mature 
oligodendrocytes that is identified in hsh. Taken with the putative functions for 
CNP, this made Cnp2 a potentially interesting candidate gene. CNP is also found at 
lower levels in the PNS and a number of non-neural tissues but since no 
abnormalities were detected in the hsh PNS or in other body systems, it is not clear 
how this would relate to a mutation in Cnp2.
However, a complication in the analysis of Cnp2 as a candidate arose from the 
putative identification of two Cnp loci in the mouse, on chromosomes 3 and 11. No 
function has yet been ascribed to the gene on chromosome 3 and in fact it has been 
reported that both mRNA isoforms (Cnpl and Cnp2) are transcribed from the single 
gene on chromosome 11 (Monoh et al., 1989; Kurihara et al., 1990). Cnpl mRNA 
gives rise to the smaller CNP1 protein (46 kDa) while Cnp2 mRNA generates the 
larger CNP2 protein (48 kDa). In man only the homologue to the mouse 
chromosome 11 gene has been described (Sprinkle et a l, 1992), although two 
protein isoforms and mRNAs have been identified (Douglas and Thompson, 1993). 
Nevertheless, it seems ostensible that one isoform may be preferentially generated 
from each of the two genes in the mouse, perhaps at different stages of development 
and/or in different tissues. Interestingly, it has been shown that one mRNA isoform, 
Cnp2, is specifically expressed in oligodendrocyte precursors in vitro (Scherer et al., 
1994). The absence of abnormalities in other hsh tissues might also be explained if 
these utilise an isoform from the Cnp gene on chromosome 11. If isoform or tissue- 
specific expression from the two genes is the case and Cnp2 is the affected gene, it
could be hypothesised that an absence or marked reduction in one protein isoform 
might be found in hsh CNS tissue. Immunostaining for CNP had previously shown
a reduction in the intensity of staining (Immunostaining of the cervical cord, page 
91) but did not distinguish between isoforms. It was therefore considered a useful 
undertaking to establish the presence and proportions of the protein isoforms using 
western blotting.
The data presented here demonstrates that both isoforms are present in hsh spinal 
cord, although markedly reduced in amount. In normal mice, the ratios of the
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46kDa and 48kDa isoforms are about 10:1 (Thompson, 1992) and as an 
approximation, no marked deviation from this appears to occur in hsh. It must 
therefore be concluded that, if Cnp2 does encode for a CNP isoform, there is no 
convincing evidence that a mutation of this gene is responsible for the hsh 
phenotype. The reason for the rather marked reduction in protein levels remains 
obscure. Cnp mRNA and protein expression have been studied in some myelin 
mutants and do not seem to correlate with the amount of myelin present; virtually 
normal CNP protein and mRNA levels have been reported, for example, in shiverer 
mice (Mikoshiba et al., 1980) whilst others, including quaking and shaking pup, 
show reduced expression (Kurihara et a l , 1989; Nadon and Duncan, 1996). None 
of these mutations involves Cnp, and the significance of the CNP levels has not 
been explained.
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Figure 46: W estern blot for CNP in wild type and hsh spinal cord. Lanes 1,2,3 
aliquots of wild type protein, Lanes 4,5,6 equivalent aliquots of hsh protein. A 
m arked reduction is seen in the m utant and although the 48kDa band is faint, 
both isoforms can be detected.
1I
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The pathway from spontaneous mutant phenotype to gene function has been 
successfully employed in the deciphering of several myelin genes. Particularly 
profitable has been the analysis of those genes coding for structural proteins of CNS 
and PNS myelin, such as MBP, PLP and P0 (Nave, 1995). Few regulatory genes 
have yielded spontaneous phenotypic mutants, with the exception of quaking, 
although several mutants remain uncharacterised (see (Lunn et al., 1995; Griffiths, 
1996) for reviews). It is likely that, in the absence of mutant phenotypes, the 
existence or function of many of these genes would not have come to light for some 
time and new mutations resulting in impaired myelination are obviously extremely 
valuable. The novel spontaneous hindshaker mutation represents a unique 
opportunity to identify and study a previously unrecognised function of a known 
protein or an entirely novel protein involved in the synthesis of CNS myelin. A 
description of the phenotype that results from abnormal hsh gene product has been 
provided in an attempt to shed some light on the putative function(s) o f the protein 
in normal myelination and a number of candidate genes have been excluded.
Within the hsh CNS, the spinal cord is the most severely affected area, whilst the 
brain shows a caudal to rostral gradient of hypomyelination. In contrast, many of 
the CNS mutants exhibit the reverse pattern of hypomyelination, for example, 
shiverer, quaking and the Pip mutants (for example, see (Friedrich, Jr., 1974; 
Duncan, 1990; Nave, 1994; Lunn et al., 1995; Griffiths, 1996)), although a similar
distribution is seen in some uncharacterised canine mutations (Duncan, 1987; 
Komegay et al., 1987; Lunn et al., 1995). In addition, the myelin sheaths of all 
diameters of axons are affected within a region, so it appears that the hsh gene 
product relates to oligodendrocyte heterogeneity in terms of location rather than the 
diameter of target axons or time of myelination. A partial resolution of the myelin 
defect occurs between 30 and 50 days of age, the time of peak myelin formation in 
the spinal cord of mutant mice.
A moderate reduction in total cell numbers is found in conjunction with 
hypomyelination and appears to be due to a paucity of oligodendrocytes. In situ 
studies using Plp-1 as a marker for mature oligodendrocytes show a more dramatic 
reduction in cell numbers throughout the CNS that reflects the extent of the 
hypomyelination. This suggests there is an overall reduction in the total 
oligodendrocyte population with a more profound decrease in the numbers of fully 
differentiated cells in young mice. It appears very likely that hypomyelination is at 
least partly a consequence of insufficient myelinating oligodendrocytes but it 
remains to be answered at what precise stage(s) oligodendrocyte development is
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impaired. It is therefore difficult to conjecture about the putative function(s) of the 
hsh gene at this stage.
As oligodendrocytes are post-mitotic cells, the total population size in a region 
depends on the number of precursors that migrate into it, their proliferative capacity 
and the proportion that undergo apoptosis (Barres et al., 1992a). The final stages of 
differentiation will determine the number of mature cells. A hypothesis of 
dysfunction of one or more of these developmental process(es) in hsh must be able 
to account for the findings of a moderately reduced total oligodendrocyte population 
and a greatly decreased number of fully differentiated cells, and explain the regional 
effects of the mutation. The normal distribution of oligodendrocytes in all areas of 
the hsh CNS examined suggests that it is unlikely that impaired migration of
precursor cells is the basis of the reduced oligodendrocyte population. Other aspects 
of oligodendrocyte development must therefore be considered in relation to the hsh
mutation.
Oligodendrocytes appear to originate in discrete regions of the developing CNS 
(Warf et al., 1991; Noll and Miller, 1993; Pringle and Richardson, 1993; Ono et al., 
1995; Dickinson et al., 1996). The correct environmental cues and subsequent 
mechanisms for mediating the choice of cell fate are likely to be important in the 
establishment of an appropriate founding population for this lineage. The induction 
of an inadequate precursor population could result in a dearth of mature cells if 
proliferation and survival were not compensatory. It has been shown that the 
induction of oligodendrocyte precursors in the spinal cord and hindbrain is 
influenced by the dorsoventral axis of the developing neural tube, in particular, 
signals from the notochord and the floorplate (Orentas and Miller, 1996; Pringle et 
al., 1996). In more rostral regions of the developing CNS, oligodendrocyte 
precursors appear to be generated both from the ventral diencephalon (Pringle and 
Richardson, 1993) and the subventricular zones surrounding the lateral ventricles 
(Levison et al., 1993a; Levison and Goldman, 1993b). It is not known whether this 
is specified by signals from an organising centre equivalent to the 
notochord/floorplate of the more caudal hindbrain and spinal cord and if so, the 
nature and location of this putative centre remains unknown. Since different 
structures appear critical for oligodendrocyte induction in distinct regions of the 
CNS, it is feasible that a mutation may impair induction in one region exclusively or 
more profoundly than in another. However, it might be expected that precursor 
proliferation and survival would compensate to a large extent for a paucity in 
founding cells, particularly as it seems likely that the regulation of proliferation and 
survival is dominated by local environmental signals and competition for growth 
factors. With fewer precursors, one would surmise that greater stimulation of
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proliferation might occur and that less cell death would result from reduced 
competition for limiting growth factors. An initial approach to the study of 
precursor induction could be made using ISH with a probe to PDGFRa, a marker 
that appears to be specific for oligodendroycte precursors at the time of their 
development (Pringle and Richardson, 1993); this would provide an assessment of 
oligodendrocyte precursor numbers in various CNS regions and their proliferation 
rate could then be subjected to investigation.
Alternatively, increased cell death, perhaps due to an absence of, or an inability to 
respond to, survival factors, or a reduction in precursor proliferation would explain 
the decrease in hsh oligodendrocyte numbers. However, cell death is not a feature 
of the mutation on resin or EM sections, although clearance of apoptotic cells is 
very rapid (Raff, 1992; Barres et al., 1992a) and it is possible that some increase 
could pass undetected. Cell proliferation has not yet been studied in hsh but should 
certainly be regarded as one of the next avenues for investigation.
Differentiation and/or formation of myelin sheaths may also be impaired in hsh 
oligodendrocytes. A defect in the late stages of maturation is suggested by the 
finding of a relative decrease in the number of Pip expressing cells that is apparently 
greater than the reduction in total oligodendrocyte numbers. However, if  a delay in 
maturation is the sole basis for the deficit in mature oligodendrocytes, the total 
number of oligodendrocytes should remain unaltered, which does not appear to be 
the case. It therefore seems likely that there is both impaired generation of cells, for 
whatever reason, and a defect in their differentiation to fully mature 
oligodendrocytes. Interestingly, there is no evidence for slower differentiation of 
hsh oligodendrocytes in culture, suggesting in vitro development can proceed 
normally.
The ability of individual mature hsh oligodendrocytes to produce myelin has not yet 
been investigated. Since very few axons acquire sheaths of normal thickness, it is 
possible that individual oligodendrocytes generate less myelin that their wild type 
counterparts. However, it is also conceivable that these cells are in fact 
compensating for the cellular paucity by producing longer intemodes and/or more of 
them; therefore, although individual sheaths are abnormally thin on cross-section, 
the amount of myelin produced by each oligodendrocyte would be normal or even 
increased. Increased production of myelin by individual oligodendrocytes has 
apparently been demonstrated in female carriers of the jimpy gene, suggesting 
flexibility in the amount of myelin that individual oligodendrocytes can produce 
(Skoff and Ghandour, 1995).
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The environmental signals regulating oligodendrocyte lineage induction and 
development and the cellular mechanisms mediating the responses are complex and 
poorly understood, and with the current knowledge of the hsh phenotype, lengthy 
conjecture on the specific function of the mutated gene is difficult. As discussed, 
the gene could be involved in any or all of the stages of oligodendrocyte 
development, and it could be expressed either by oligodendrocytes or by signalling 
cells such as neurons or astrocytes in the environment. It must also be remembered 
that with a mutant phenotype, one is studying the whole response of a system to the 
absence or dysfunction of a specific protein, and not purely the removal of the 
culprit protein. To extricate from a complex phenotype the function of one single 
component can be a monumental task.
In summary, it appears that retarded myelination in the hsh mouse is at least partly 
due to a paucity of myelinating cells. The partial resolution of the myelin defect is 
related to increasing numbers of oligodendrocytes. Defective function of the hsh 
gene product retards oligodendrocyte development more profoundly in the spinal 
cord and hindbrain than forebrain, which suggests regulation of different 
oligodendrocyte populations that is dependent on their location. The reason for the 
cellular deficit is not yet known but could involve oligodendrocyte precursor 
induction, proliferation and/or survival. Differentiation of post-mitotic cells and 
formation of myelin sheaths may also be impaired. Much work remains to be done 
on characterising this phenotype, the most pressing of which must include cell 
mitosis studies to examine cell proliferation and in situ hybridisation for PDGFRa 
to quantify precursor numbers. Although the study is far from complete, it has laid 
the foundations for further analysis of the hsh phenotype. Characterisation of the 
gene and its protein product should elucidate another aspect of the complex network 
of pathways and interactions involved in CNS myelination.
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5. Linkage mapping of the hsh 
mutation
5.1 General introduction and aims
The fundamental goal of molecular biology is to understand, at the molecular level, 
how genotype is translated into phenotype. One pathway in the analysis of gene 
function begins with a mutant phenotype and follows this back to a clone of the 
altered gene. The process of moving from a phenotypic difference to the causative 
gene is referred to as positional cloning and can be divided into two distinct stages. 
Firstly, linkage analysis is performed to find flanking DNA markers that lie very 
close to the gene of interest. The second stage involves cloning across the region 
that must contain the gene responsible for the phenotype, and then separating the 
desired sequence from other genes and non-genic sequences within this interval. It 
was the first stage that formed the basis of the hsh study.
Breeding studies carried out at Harwell had established the mode of inheritance as 
autosomal recessive and disproved the possibility of mutation at the previously 
characterised quaking locus (Beechey, 1993). Immunostaining had confirmed the 
qualitative presence and distribution of the major myelin proteins. Since no other 
known myelin genes or dysmyelinating mutants appeared to be possible candidates 
for the hsh mutation at that time, it was necessary to set up a new mapping cross in 
which DNA markers from across the genome could be tested for linkage. This was 
initially carried out at Harwell using classical linkage analysis with visible markers 
to establish a chromosomal location. Within the first year of the study, linkage was 
found between hsh and two markers, brachury (T) and tufted (jtf), on chromosome 
17 (Beechey and Cattanach, 1996), the results of which indicated that the hsh locus 
lay distal to quaking, also on chromosome 17. Final results suggested that hsh was 
positioned about 29cM distal to tf, which is located at 12.5cM from the centromere. 
Incomplete penetrance of the hsh phenotype was identified on these backgrounds 
(Beechey and Cattanach, 1996). The Mog locus lies distal to quaking on 
chromosome 17 (Pham-Dinh et a l , 1993) and, being a CNS myelin-specfic gene, it 
was a strong candidate gene. The investigations of Mog gene expression using 
immunostaining and in situ hybridisation have been discussed previously in 
Analysis of candidate genes, page 146. Since there was no evidence for this as the 
altered gene, with positive immunostaining and strong hybridisation signal, and no 
other candidate genes were obvious, fine mapping of the chromosome 17 locus 
using molecular techniques and an intersubspecific backcross was initiated as part of 
the hsh study.
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5.2 Breeding of mouse mapping panels
5.2.1 Introduction and aims
For fine mapping of the putative hsh locus on chromosome 17, it was necessary to 
establish a recombinational backcross to follow the inheritance of polymorphic 
microsatellite markers in the F2 offspring. The aim was to collect 500-1000 F2 
mice from an appropriate backcross to map to a sufficiently small interval for the 
next stage of positional cloning.
5.2.2 Materials and Methods
5.2.2.1 Mouse breeding
Outcrosses to generate FI mice were set up with Mus spretus (,spretus), CAST/Ei 
(CAST), C57BL/6J (C57) and BALB/cJ (BALB) mice and where successful, FI 
mice were backcrossed to hsh to produce F2 offspring as described in Breeding, 
page 68. Only hsh mice that had a marked tremor as young animals were used for 
breeding. The offspring from the backcross matings were graded on the basis of a 
shaky phenotype at 20 days of age and tissues retained after euthanasia as necessary.
5.2.2.2 Principles of phenotypic analysis
The principles underlying the expected distributions of F2 hsh versus wild type 
phenotypes are described in General principles of linkage analysis, page 71. In 
summary, since hsh is an autosomal recessive condition, two mutant alleles are 
required to express a shaky phenotype. Half of F2 mice inherit two hsh alleles and 
should therefore exhibit a shake. The other half are heterozygous at the hsh locus 
and should be phenotypically wild type.
5.2.2.3 Histopathology
The first 50 mice {hsh and wild type phenotypes) from the CAST backcross were 
phenotypically scored and their cervical cords processed for resin embedding (see 
Resin processing and sectioning, page 46). Thick sections were cut and stained with 
methlyene blue/azur II (see Methylene blue/azur II for resin sections, page 47) for 
light microscopic examination of white matter.
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5.2.3 Results
5.2.3.1 Intersubspecific backcross
Two spretus males were obtained but failed to breed with hsh females and this 
attempt was abandoned. From the CAST backcross, 1122 F2 mice were weaned 
over a period of 20 months; litter sizes were subjectively comparable to wild type 
and hsh stock maintained under similar conditions and there was no apparent 
abnormal neonatal death. Only 93 (8.2%) phenotypically hsh animals were 
identified. The sex of the FI /zs/z/CAST parent did not influence the production of 
hsh mice, with FI males responsible for 42 of the 93 animals (45%). The sexes of 
the F2 mice were equally distributed with 46 females and 47 males. There was 
some variation in the intensity of the tremor and subjectively, mice did not appear as 
shaky as the outcross and backcross hsh parents had been at the equivalent age.
Examination of cervical cord sections obtained from the first 50 CAST backcross 
mice confirmed the accuracy of phenotypic identification. No mice had been 
misidentified phenotypically and only the cords from the phenotypic hsh mice 
(4/50) exhibited hypomyelination histologically.
5.2.3.2 Interstrain backcrosses
Over a ten month period, 176 F2 mice were weaned from an interstrain backcross 
using C57 mice. Of these, 68 mice (38%) of both sexes were scored as 
phenotypically hsh. The tremor was subjectively comparable in intensity to the hsh 
outcross and backcross parents and showed little variation between mice of the same 
age.
During the same time, 139 F2 mice were bom from an interstrain backcross 
employing BALB as the second parental strain. Only 27 (19.4%) of these had a 
definitive shake. There was some variation in expressivity and the impression was 
that mice did not tremor with as much intensity as those on the C57 background.
Litter sizes in both crosses appeared normal and there was no apparent increased 
incidence of neonatal death.
5.2.4 Discussion
One of the first decisions to be made in the establishment of the backcross was the 
choice of the second parental species or strain. A balance had to be struck between 
the considerations of genetic distance and the ability to generate offspring in which 
segregation of the mutant allele could be observed. Initially an interspecific 
backcross using Mus spretus was considered as this is the most distant species from
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M. musculus that still allows the production of fertile FI hybrids (Avner et al., 
1988). DNA polymorphisms are therefore more numerous than between more 
closely related mice. However, the FI males are infertile so that only female 
meiosis can be examined and there is an inversion on chromosome 17 that may 
suppress recombination (Hammer et al., 1989). This strategy was therefore quickly 
abandoned when the mice failed to breed.
Intersubspecific crosses using Mus musculus castaneus (CAST) for mapping 
purposes have largely supplanted spretus for mapping. Although more closely 
related to laboratory strains, the degree of polymorphism is still high, mice breed 
readily and are easy to handle, and both FI sexes are fertile.
A surprising finding was the small proportion of shaking F2 mice identified on the 
CAST backcross. Half of all animals were predicted to be homozygous at the hsh 
locus and should therefore have demonstrated a tremor. Instead, only 8.6% were 
classified as hsh. A number of possible reasons were mooted for this finding, 
namely embryonic or early neonatal death of homozygous hsh on the CAST 
background, misclassification of mice or incomplete penetrance of the phenotype on 
this cross. Litter sizes were subjectively comparable to wild type and hsh stock 
which would tend to rule against embryonic death as the explanation. Neonatal 
death was not a feature. Misclassification of the phenotype was eliminated by 
histological examination of a large number of previously scored mice. The only 
remaining explanation was the incomplete penetrance of hsh on the CAST 
background. Presumably only about 17% of homozygous animals carried a 
complement of enhancing/suppressing alleles from the C3H/101 and CAST 
backgrounds that was permissive for the shaky phenotype. Support for this came 
from similar findings on the backgrounds used for classical linkage analysis 
(Beechey and Cattanach, 1996) and the fact that hsh was only 90% penetrant on the 
C3H/101 background at the onset of the study (see General phenotypic description, 
page 83). It has long been recognised that mouse mutants can show considerable 
variation in the penetrance and expressivity of a phenotype despite a common 
genotype, due to the presence of genes at other non-disease loci (Erickson, 1996). 
The mechanism(s) by which modifiers achieve their effects are still unclear in many 
cases but several pathways have been suggested. Suppression or enhancement of 
other involved genes is likely, perhaps by altering transcription rates, mRNA 
stability or modifying the degree of DNA methylation (Wilkins, 1990). 
Alternatively, a redundant gene may come into play to compensate for the mutated 
locus (Rozmahel, 1996).
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The penetrance/expressivity of a particular mutation may vary between several 
different backgrounds, as in curly tail (Neumann et al., 1994), presumably due to 
species/strain-specific modifying alleles that are not present in other strains. It was 
therefore decided to investigate the penetrance of hsh on a small number of inbred 
laboratory strains. Incomplete penetrance was apparent in both of the interstrain 
crosses although it was less profound than on the CAST backcross. On the C57 
background, 76% of animals predicted to have a shaky phenotype were identified as 
hsh. About 40% of homozygous animals exhibited a phenotype on the BALB 
background. Presumably the number of loci at which the strain-specific allele 
suppressed the hsh phenotype was reduced in comparison to CAST as a result of the 
lack of genetic diversity that exists between inbred laboratory strains (Ferris et al., 
1982).
The incomplete penetrance of the hsh phenotype on the genetic backgrounds used in 
the mapping crosses had profound implications in terms of the numbers of mice that 
were to be bred. Usually in mapping studies, both the phenotypic wild type and the 
mutant animals are examined for recombination. In this project, only the shaky F2 
mice could be used in linkage analysis; the genotype of the non-shaky mice could 
not be ascertained and it was therefore impossible to examine these mice for 
recombination between the hsh and marker loci. Since only about 1/12 mice from 
the CAST backcross exhibited a shake, a large number of F2 mice were required to 
generate 500-1000 useful samples, the minimum number considered necessary for 
mapping sufficiently close to a mutated gene for positional cloning. The higher 
penetrance on the interstrain backcrosses was open to exploitation to provide shaky 
F2 mice faster, but at the cost of genetic polymorphism and again, only the 
phenotypic hsh animals could be utilised.
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5.3 Fine mapping of chromosome 17
5.3.1 Aim
The aim was to identify a set of markers flanking the disease locus as closely as 
possible. The first step in this process was the evaluation of a number of 
microsatellite primer pairs to select an appropriate set for use with the CAST 
backcross. The heterogeneous genetic background of hsh, which contained C3H, 
101 and possibly other uncharacterised alleles from the original strains (see 
Background to the hsh mutation, page 80), had to be considered when testing 
individual primer pairs. The next step was the testing of the selected microsatellite 
markers with individual DNA samples from the backcross to establish the interval 
containing the hsh locus. Finally, samples from the C57 and BALB backcrosses 
were typed for a single marker for detection of linkage on these backgrounds.
5.3.2 Materials and Methods
5.3.2.1 gDNA preparation
gDNA was extracted from the tails of shaky mice from the F2 generations of the 
CAST, C57 and BALB backcrosses as described (see Preparation of genomic DNA, 
page 75). Fifty phenotypically unaffected mice from the CAST backcross were also 
subjected to the same treatment.
5.3.2.2 Selection of microsatellite primer pairs
Primer pairs were selected as described (Microsatellite primer pairs, page 76) to 
cover the proximal two thirds of the chromosome in order to span the region of 
interest.
5.3.2.3 PCR
Primer pairs were tested using the PCR protocol given in Polymerase chain reaction, 
page 77 and the products detected as described in Analysis of PCR products, page 
78. If  primers failed to produce clearly defined product, manipulation of PCR 
conditions was attempted; magnesium (Mg2+) concentration, annealing temperature 
and cycle number were adjusted as considered appropriate. Formamide and Q- 
solution (Qiagen) were sometimes added to the PCR reaction to improve priming. 
If primers still failed to generate suitable PCR products after these simple measures, 
they were abandoned.
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5.3.2.4 Mapping protocol and statistical analysis
The principle of linkage analysis is described fully in Genome-wide linkage 
analysis, page 72. For a description of statistical analyses, see Statistical analysis, 
page 73. Due to incomplete penetrance of the hsh phenotype, only the shaky F2 
population could be utilised for mapping as the non-shaky mice were of unknown 
genotype; it was not possible to classify them as homozygous or heterozygous at the 
hsh locus and recombination events could therefore not be evaluated.
5.3.2.5 Illustration of linkage
For the sake of succinct illustration of the findings of linkage, PCRs were performed 
on pools of DNAs made up of equal amounts of DNA from each of the backcross 
mice (see Preparation of pooled DNA samples, page 76). Pools of CAST, C57 and 
BALB backcross DNA were made and run for D17MitlO only. With an unlinked 
marker, a quarter of the alleles will be derived from CAST and the remainder will 
be C3H/101, giving 1:3 proportionate band intensities on a gel. If  the marker is 
linked, more alleles are C3H/101 so this band increases in intensity whilst the CAST 
band becomes fainter. With very tight linkage, only a C3H/101 band is identified.
5.3.3 Results
5.3.3.1 Microsatellite primer pair selection
The primers shown inTable 5, page 170 were found to be suitable. Their positions 
on the chromosome gave good coverage for an initial scan to position the hsh locus 
more precisely prior to finer mapping (Figure 47, page 180). The product sizes for 
C3H and 101 differed from CAST and could be resolved on 3% Nusieve agarose 
gels. In an equal mix of C3H/CAST, both the C3H and the CAST bands were 
amplified with approximately equal intensity.
5.3.3.2 Intersubspecific backcross
In total, 78 F2 shaky mice from the CAST backcross were typed. The first 29 mice 
were typed for all 9 markers whereas the remaining 49 were only typed for 
D17Mit248, D17MitlO and D17Mit6. The haplotypes derived from these animals 
are represented in Figure 48, page 181. Recombination rates were calculated using 
all mice typed for each marker whilst LOD scores were derived from only the 29 
mice typed for all markers. Results are given in Table 6, page 171.
The lowest recombination rate detected was 20.7 ± 7.52 at D17Mit36 but only 29 
mice were typed for this marker and this result was not statistically significant = 
9.96, p<0.005). A recombination rate of 23 ± 4.77% was found for D17MitlO
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MIT marker C3H-derived 
allele (bp)
CAST-derived 
allele (bp)
Distance from 
centromere (cM)
D17M itl8 241 256 3
D17Mit248 104 134 5
D17mit44 154 128 15.5
D17Mit47 226 210 20
D17Mit36 114 146 22.5
D17MitlO 148 131 24
D17Mit9 115 132 30
D17Mit6 102 88 32
D17Mit2 230 250 46
Table 5: D17Mit marker panel used to type CAST backcross. Markers are 
ordered from centromere to telomere. Distances are based on the 
Whitehead/MIT map.
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Mit Marker Recombination rate LOD score
D17Mitl8 27.6 ± 8.27% 3.7
D17Mit248 26.4 ±4.96% 3.7
D17Mit44 20.7 ± 7.52% 4.5
D17Mit47 24 ± 7.9% 3.7
D17Mit36 20.7 ± 7.52% 4.5
D17MitlO 23 ± 4.77% 4.5
D17Mit9 27.6 ± 8.3% 3.7
D17Mit6 27 ±5% 3.7
D17Mit2 34.5 ± 8.87% 2.9
Table 6: Recombination rates and LOD scores for the D17Mit panel. 
Recombination rates were calculated for all mice typed for that individual 
marker whilst LOD scores have been calculated for only those 29 mice typed 
for all markers. Markers are ordered from centromere to telomere.
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(18/78 animals are heterozygous) which was consistent with demonstration of 
linkage at p<0.001 (%^=22.6l). Recombination rates increased to 26 ± 4.96% at 
D17Mit248 proximally (20/78 mice) and 27 ± 5% at D17Mit6 distally (21/78 mice). 
No region of complete concordance i.e. homozygosity, was present and eleven mice 
were heterozygous across the entire region, specifically Maps 6, 42, 43, 77, 90, 96, 
97, 98, 105, 108 and 124. LOD scores were significant for all markers except 
D17Mit2, with the highest score of 4.5 for D17Mit44, D17Mit36 and D17MitlO. 
Linkage is illustrated in Figure 49, page 185 where the pooled sample has been run 
against D17MitlO; the very weak CAST band and the strong C3H/101 band indicate 
the presence of little CAST DNA in the pool due to most mice carrying two 
C3H/101 alleles.
To rule against transmission distortion, that is, the non-random inheritance of a 
C3H/101 allele as opposed to a CAST allele, 50 of the phenotypically normal mice 
were tested for D17Mit248, D17MitlO and D17Mit6. The recombination fractions 
were 53 ± 7%, 50 ± 7% and 48 ± 7 %  respectively, consistent with random 
recombination.
5.3.3.3 Interstrain backcrosses
Shaky mice derived from the C57 backcross were tested against D17MitlO. A 
recombination fraction of 38 ± 6.2% was calculated (23/61 recombinant mice) 
which was not indicative of statistically significant linkage (%2=3.69, p<0.05). PCR 
of a pooled DNA sample containing contributions from all shaking mice on this 
background shows that compared to the 1:1 ratio in the control sample, there is no 
convincing evidence of a departure from the expected 3:1 ratio in the test pool 
(Figure 50, page 186). The same marker was used to test the small population of 
shaky mice from the BALB backcross and this time, a recombination rate of 22.5 ± 
7.5% (7/31) was detected. Although this is not a statistically significant result 
(X^=9.22, p<0.005), it is highly suggestive of linkage. A pooled sample 
demonstrates the linkage; the C3H/101 band is considerably stronger than the 
BALB and appears to exceed the expected 3:1 ratio (Figure 50, page 186).
5.3.4 Discussion
Before the typing of the backcross population could be performed, individual primer 
pairs had to be tested to ensure suitability for this study. The selection of 
appropriate microsatellite markers was complicated by the presence of the 101 
background which has not been characterised for marker polymorphism. The 
significance of this lay in the fact that hsh mice could carry either a 101 or a C3H 
allele at any locus throughout the genome, so mapping required being able to define
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polymorphism between 101 and CAST in addition to C3H and CAST. C3H and 
101 alleles did not have to demonstrate polymorphism since they both originated 
from the same background. Primers were therefore ordered on the basis of marker 
polymorphism between C3H and CAST and then tested to ensure that the 101 and 
CAST bands were distinguishable. A useful guide was found to be the existence of 
very little polymorphism between the characterised laboratory strains for a marker 
but a large polymorphism between these and CAST; the 101 allele tended to be 
close to the size of the other laboratory strains rather than the CAST. Large 
polymorphisms between CAST and C3H also increased the chance of 
polymorphism between CAST and 101. In addition, it was important to establish 
that the primer pairs did not preferentially amplify one allele in the heterozygote 
animal. This probably occurs as a result of strain-specific sequence differences in 
the region of primer complementarity. It is usually, although not always, the 
laboratory strain that is amplified (Taylor et al., 1994), which would lead to 
misclassification of heterozygotes as homozygotes with the false impression of 
linkage to that marker. An equal mixture of C3H/CAST DNA was used to test for 
this phenomenon and although it was not encountered with any of these markers, it 
did occur later in the mapping study and has been reported previously (Taylor et al., 
1994).
It was rather surprising when early in the study, it became apparent that a number of 
mice from the CAST backcross were heterozygous across the whole region, 
implying that they carried entire segments of CAST chromosome 17 where they 
should have harboured a mutant hsh allele. Several possible explanations for this 
were considered; misclassification of mice, contamination or confusion of samples, 
double crossover events, expression of a shaky phenotype in heterozygotes, a more 
distal location of the hsh locus and the erroneous mapping of a modifying locus 
were all debated. It also had to be considered that the putative linkage could in fact 
have been a genetic phenomenon associated with this particular genetic cross that 
led to preferential inheritance of two C3H/101 alleles rather than a CAST allele. In 
this scenario, apparent linkage would not be associated specifically with the hsh 
mutation but rather, with the strains of mice used in the backcross.
Misclassification of mice was felt to be most unlikely in view of the great care taken 
in retaining only those mice with a definitive shaky phenotype. In addition, Maps 6, 
42 and 43 had been perfused and confirmed histologically as hsh. Confusion or 
contamination of samples also appeared an inadequate explanation since phenotypic 
hsh tissue constituted the only samples being collected and processed at that time; 
hence contamination/confusion could only occur between mice that were all 
homozygous at the hsh locus. However, in the unlikely event that contamination of
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tail fur and skin with urine or faeces from other mice was influencing PCR results, 
DNA was also extracted from the spleens of these mice collected using aseptic 
techniques. Identical PCR results were obtained from the spleens for all markers.
Double crossover events do occur but their frequency depends on the genetic 
distance separating the two markers (Silver, 1995b) and the distances here are far 
too small for the numbers of crossover events that would be required to explain all 
heterozygous mice. Also, it would be expected that regions of homozygosity would 
be detected between flanking heterozygous regions, which was not the case.
Heterozygotes have been reported to exhibit a phenotype with a mutation that is 
recessive on other backgrounds, for example, the curly tail mouse mutant was long 
considered recessive until a small proportion of heterozygotes on different 
backgrounds expressed the phenotype (Neumann et al., 1994). This suggested that 
ct may exhibit dominance in the presence of particular combinations of modifier 
alleles. In light of the much reduced penetrance of the hsh mutation on the CAST 
background, it seemed improbable that such a large proportion (14%, 11/78) of 
shaking mice would be heterozygous, but the possibility could not be excluded on 
the sole basis of these results.
A more distal location of the hsh locus on chromosome 17 was most unlikely in 
view of the location of D17Mit2, only 14cM from the telomere. Also, the 
recombination fraction for the whole group was increasing distally, indicating that 
linkage was reducing towards the telomere. For linkage to then increase again 
would require an unfeasible number of double crossover events.
It was possible that the tendency towards homozygosity was in fact not due to 
linkage with the hsh mutation but was due to transmission distortion. This occurs 
when two alleles are not equally inherited from the parent, perhaps because one 
combination is lethal in the embryo. Litter sizes were good, tending to rule against 
this, but confirmation was sought by testing 50 of the non-affected mice for 3 of the 
markers across the region. If transmission distortion was occurring due to the 
incompatible combination of CAST alleles with C3H/101 in this region, this would 
be seen for all mice, not just those expressing a phenotype. This was not observed 
and in fact, proportions were evenly distributed between heterozygotes and 
homozygotes. The removal of a small number of homozygotes (8%) did not 
significantly move the wild type population towards heterozygosity.
The remaining explanation was that classical linkage analysis had identified a region 
that was incompletely linked to the hsh phenotype, that is, a modifying locus. This 
would be consistent with a proportion of mice being heterozygous across the region
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but a larger proportion showing linkage. Rather than the hsh locus lying 29cM 
distal to tf, as was indicated by linkage analysis (Beechey and Cattanach, 1996), this 
figure was likely to have been distorted by a proportion of heterozygous animals. 
The locus of interest would therefore lie substantially closer to t f  than the 
recombination fraction indicated. However, it was surprising that a similar 
recombination rate was found for a number of markers spanning about 30cM of the 
chromosome; for a single modifying locus, it would be expected that markers 
located proximally and distally to the locus would exhibit higher recombination 
rates than was found here. The reason for the apparent extension of the region of 
linkage is not clear but it may be that more than one modifying locus was present on 
proximal chromosome 17. It is interesting that the same region was probably 
modifying penetrance on both the t f  and CAST backgrounds, and the fact that 
linkage achieved statistical significance in both molecular and classical mapping 
experiments suggested that this was a major modifying locus. Whether or not it was 
the same gene within this region that was involved in both cases is not known but 
seems likely. Also intriguing is the finding that a curly tail modifier maps to the 
very same region, being roughly localised near D17Mitl 1 (Letts et al., 1995). This 
marker lies between D17Mit44 and D17MitlO and it is therefore appealing to 
conjecture that the same locus may be modifying the pentrance of both ct and hsh 
phenotypes. Curly tail embryos show a reduced rate of cell proliferation in the 
notochord and hindgut epithelium but not the neuroepithelium (Neumann et al., 
1994), causing ventral curvature and delayed closure o f the neural tube. It has been 
hypothesised that ct may code for a protein associated with the cell cycle and that 
the modifier could be a transcriptional regulator, although no strong candidates were 
identified (Letts et al., 1995). Since the notochord is involved in induction of 
oligodendrocyte precursors (Orentas and Miller, 1996; Pringle et al., 1996), and hsh 
exhibits a lack of oligodendrocytes, it is imaginable, although rather tenuous, that 
the same modifier may be involved in the pathobiological pathways of both 
mutations. It must be borne in mind, however, that a region of this size contains 
many hundreds of genes and it may be no more than coincidence that two 
neurological mutants have a modifying locus within it.
Final confirmation that this was not the hsh locus came later in the study when mice 
from the C57 interstrain backcross were tested for D17MitlO. There was only very 
weak evidence of linkage, with 38% of mice inheriting a CAST allele from the FI 
parent. The 80% penetrance on this background was much higher than the CAST; 
presumably modifying genes were less significant in this cross because of the lack 
of genetic diversity between the laboratory strains (Ferris et al., 1982), which may 
account for the weaker linkage to the chromosome 17 locus. The stronger linkage to 
chromosome 17 found with the BALB backcross may at least partly explain the
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lower penetrance on this background compared to the C57 backcross. In both cases, 
larger populations of mice may lead to statistical demonstration of linkage.
The aim of the project was the mapping of the hsh locus. Although linkage at a 
probability of 95% had been found to a region of chromosome 17 with a CAST 
backcross, it had been unequivocally shown that this did not contain the hsh locus. 
Undoubtedly it will prove interesting to examine this region in greater detail in the 
future, but it was necessary to pursue the elusive hsh gene for this study. Classical 
linkage analysis had not proceeded far prior to the discovery of linkage to 
chromosome 17, so no other chromosomal regions had been excluded. 
Consequently, the whole genome, except the X chromosome and chromosome 17, 
was available for analysis. Although a return to classical linkage analysis with 
phenotypic markers was contemplated, the decision to perform a genome scan using 
molecular techniques was made; now that the intersubspecific backcross was 
underway, albeit slowly with the low penetrance, and the PCR technique was 
established, it was likely to be a faster and more accurate process. However, as with 
all these things, an element of luck is indispensable.
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5.4 Genome scan for chromosomal identification
5.4.1 Background and aims
Having excluded chromosome 17 as harbouring the hsh locus, it was necessary to 
initiate a genome scan for location of an alternative subchromosomal region 
showing linkage to one or more markers. A stratified protocol is the most efficient 
approach so that only a small number of samples are typed for initial linkage 
detection and when linkage is found, the remainder of the animals are typed for 
these markers. Once this first stage is completed, it is possible to concentrate on the 
construction of a high resolution map in the vicinity of the locus using a selected set 
of markers and a handful of recombinant animals.
5.4.2 Materials and Methods
5.4.2.1 Preparation of DNA
Samples were prepared previously as described in Preparation of genomic DNA, 
page 75. Only backcross mice with a shaky phenotype were typed.
5.4.2.2 Selection of microsatellite primer pairs
Primer pairs were selected as discussed (Microsatellite primer pairs, page 76). 
Since markers cover 15cM proximally and distally, they were chosen to be no more 
than 30cM apart, and proximal and distal markers were no greater than 15cM from 
the centromere and telomere respectively. Markers from chromosomes 8, 9, 10, 11, 
1, 2 and 3 were tested and a number of these typed for the CAST backcross.
5.4.2.3 PCR
Primer pairs were first tested on C3H, 101, CAST and a C3H/CAST pool using the 
standard protocol given in Polymerase chain reaction, page 77 and the products 
detected as described (Analysis of PCR products, page 78). Those that did not yield 
easily interpreted results were abandoned to allow progress with primer pairs that 
did. Useful markers were subsequently tested with 52 shaky CAST backcross mice.
5.4.2.4 Principles of linkage analysis
This is discussed fully in General principles of linkage analysis, page 71. The aim 
was to cover as much of the genome as rapidly as possible with primer pairs that 
were straightforward to use. Genetic distances, where given, were obtained from
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the Whitehead/MIT map (http://www-genome.wi.mit.edu) which is based on a 
C57BL/6J-ob and CAST/Ei intercross.
5.4.2.5 Statistics
The calculation of recombination rates, genetic distances and significance values is 
described in Statistical analysis, page 73.
5.4.3 Results
The recombination rates for those markers which were successful are summarised in 
Table 7 below.
Mit marker C3H-derived 
allele (bp)
CAST-derived 
allele (bp)
Distance from 
centromere
Recombination 
rate (± SE)
D llM it36 240 302 44cM 42 ± 7.3%
D llM itl80 147 167 70cM 42 ± 7.3%
D8Mit211 166 186 50cM 37.5 ± 6.7%
D8Mitl3 91 114 70cM 50 ± 6.9%
D8Mit64 156 106 15cM 50 ± 6.9%
DlMit33 94 114 82cM 46 ± 6.9%
DlMit224 142 120 lllc M 41 ±6.8%
D2Mitl 120 140 2cM 39 ±6.7%
D2Mit25 138 116 85cM 46 ± 6.9%
D3Mit203 138 158 lOcM 25 ± 5.4%
D3Mitl27 168 106 49cM 20 ± 4.6%
Table 7: Microsatellite marker panel tested in genome scan. Product sizes, 
distance from the centromere and recombination rates are given.
Significant results were obtained for D3Mit203, positioned lOcM from the top of 
chromosome 3, which was found to recombine with a frequency of 25 ± 5.4% 
(16/64 mice) (%2=\6, p<0.001), and D3Mitl27, 49cM from the centromere, which 
gave a recombination fraction of 20 ± 4.6% (15/73 mice) (%2=25, p<0.001). Two 
mice were heterozygous for both markers. At this point, the genome scan was 
halted while a detailed analysis of chromosome 3 was performed.
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5.4.4 Discussion
To analyse as much of the genome as expediently as possible, unsuitable markers 
i.e. those that did not give good PCR results or yielded 101 bands similar to CAST, 
were left to allow testing of potentially more profitable primer pairs. The regions 
covered by these markers were to be returned to at a later date if linkage had not 
been detected elsewhere in the genome. Seven out of 20 markers tested here did not 
prove useful, which is similar to findings in other projects (Taylor et al., 1994) (C. 
Rasberry, I. Jackson, personal communications).
No linkage was detected on the distal two thirds of chromosome 11, on chromosome 
8, the distal half of chromosome 1 or proximal and distal chromosome 2. 
Significant linkage was evident for two markers on chromosome 3, one proximal 
marker, D3Mit203 and one about 40cM distal to this, D3Mitl27. The finding of a 
recombination fraction of 25 ± 5.41% for a marker only lOcM from the centromere 
suggested that the locus lay distally, or that weak linkage was present, such as might 
occur for a modifying locus. However, the finding of a recombination rate of 20 ± 
4.68% for a more distal marker tended to suggest the former and that the locus lay in 
the intervening region. The addition of the two recombination fractions should be 
about equal to the genetic distance separating the markers and although a different 
cross has been used by the Whitehead/MIT, their distance of about 39cM was very 
close to the value of 45cM obtained here.
Two mice were heterozygous for both markers and may therefore not have 
possessed a region of homozygosity in the interval of interest. However, it was 
possible that they were double recombinants. Suppression of recombination occurs 
within the chromosomal vicinity of an initial crossover event and is responsible for a 
severe reduction in the expected frequency of double crossover events in 10-20cM 
lengths of the genome. These two markers are separated by about 40cM so the 
effects of recombination suppression are not strong and in fact, the double 
recombinant rate can be evaluated from multiplying the two single recombinant 
fractions, i.e. treating the events independently. Thus a double recombinant rate of 
5% (5/100) can be expected for these markers based on a probability of 
recombination of 0.2 for one marker and 0.25 for the other. Thus, 2/64 doubly 
recombinant mice would not be surprising. Further linkage testing in the region of 
interest was therefore initiated with a very strong suspicion that linkage had been 
found with the disease locus rather than another modifier.
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Figure 47: A genetic map of chromosome 17 showing the location of pertinent 
loci in terms of recombinational distance from the centromere. Microsatellite 
markers used in this study, brachyury (T), tufted (tf), quaking (qk) and myelin- 
oligodendrocyte glycoprotein (Mog) are shown. The putative hsh locus was 
mapped to about 29 cM distal to t f  Distances should be regarded as very 
approximate.
180
□□□ □ □ □ □ □ □ □□
□ □ □ □ □ ■□
□ □ □
□
□
n
□
□ □
□
□ □ □ □ □
□ □ □ □
9
I O 1
Fi
gu
re
 
48
: 
H
ap
lo
ty
pe
s 
of 
F2 
mi
ce
 
ge
ne
ra
te
d 
fro
m 
the
 
hs
h/
C
AS
T 
ba
ck
cr
os
s. 
Al
l 
mi
ce
 
we
re 
ho
m
oz
yg
ou
s 
at 
the
 
hsh
 
loc
us
 
on 
the
 
ba
si
s 
of 
a 
sh
ak
in
g 
ph
en
ot
yp
e 
an
d 
are
 
id
en
tif
ied
 
nu
m
er
ic
al
ly
. 
Ho
m
oz
yg
os
ity
 
for
 
a 
m
ar
ke
r 
is 
in
di
ca
te
d 
by 
an 
op
en
 
bo
x 
w
hi
lst
 h
et
er
oz
yg
os
ity
 
is 
sh
ow
n 
as 
a 
fdl
ed
 
bo
x. 
M
ar
ke
rs
 a
re 
or
de
re
d 
fro
m 
ce
nt
ro
m
er
e 
to 
te
lo
m
er
e.
□□
G
■
□
□ ■ ■
□ □
■ ■ ■
□
tn
3oo>
□ □  □  □ □ n oEoX
□  □  □ 2 □  L
□ □ □ □ □ □ □ □ □ □ □
182F
ig
ur
e 
48 
(c
on
t):
 T
ab
le
s 
sh
ow
in
g 
the
 
ha
pl
ot
yp
es
 
of 
F2 
mi
ce
 
ge
ne
ra
te
d 
fro
m 
the
 
hs
h/
CA
ST
 
ba
ck
cr
os
s. 
Al
l 
mi
ce
 
we
re
 
ho
m
oz
yg
ou
s 
at
 
the
 
hsh
 
loc
us
 o
n 
the
 
ba
sis
 
of 
a 
sh
ak
in
g 
ph
en
ot
yp
e 
an
d 
are
 
id
en
tif
ied
 
nu
m
er
ic
al
ly
. 
H
om
oz
yg
os
ity
 
for
 
a 
MI
T 
m
ar
ke
r 
is 
in
di
ca
te
d 
by 
an
 
op
en
 
bo
x 
w
hi
lst
 h
et
er
oz
yg
os
ity
 
is 
sh
ow
n 
as 
a 
bla
ck
 
bo
x. 
MI
T 
m
ar
ke
rs
 a
re 
or
de
re
d 
fro
m 
ce
nt
ro
m
er
e 
to 
te
lo
m
er
e.
Is-o c
COo □
ino ■ ■ ■
COo
2 ■ □
o
8
8
8 ■ ■ ■
Is -O) ■ ■ ■
8 ■
lO ■ ■ oCD
cn
o
E
o
X
8 □
OJ
CD □
5 □
S
<y>
■ ■ ■
©
o
CO
CO
CO ■
GO
o
©
b
X
CO □ ■
00
1
Is-
5 D1
7M
it
24
8
D
17
M
it
44
D
17
M
it
47
D
17
M
I1
36 0
1
D-
Q
2
2
5
<D
i
5
2
2
5
Fi
gu
re
 
48 
(c
on
t):
 T
ab
le
s 
sh
ow
in
g 
the
 
ha
pl
ot
yp
es
 
of 
F2 
mi
ce
 
ge
ne
ra
te
d 
fro
m 
the
 
hs
h/
C
AS
T 
ba
ck
cr
os
s. 
Al
l 
mi
ce
 
we
re
 
ho
m
oz
yg
ou
s 
at
 
the
 
hsh
 
loc
us
 
on 
the
 
ba
sis
 
of 
a 
sh
ak
in
g 
ph
en
ot
yp
e 
an
d 
are
 
id
en
tif
ied
 
nu
m
er
ic
al
ly
. 
H
om
oz
yg
os
ity
 
for
 
a 
MI
T 
m
ar
ke
r 
is 
in
di
ca
te
d 
by 
an
 
op
en
 
bo
x 
wh
ils
t 
he
te
ro
zy
go
sit
y 
is 
sh
ow
n 
as 
a 
bla
ck
 
bo
x. 
MI
T 
m
ar
ke
rs
 
are
 
or
de
re
d 
fro
m 
ce
nt
ro
m
er
e 
to 
te
lo
m
er
e.
■ ■■ □□■ ■ ■□ □□ □
□■ ■■ ■
■
■ ■ ■
o
CD
o
a3*
X
2
1
2
1h-
2i
0
1 r^
22
2s-
2
2
22
5 5 Q Q Q 5 5
1 5 4
Fi
gu
re
 
48 
(c
on
t):
 T
ab
le
s 
sh
ow
in
g 
the
 
ha
pl
ot
yp
es
 
of 
F2 
mi
ce
 
ge
ne
ra
te
d 
fro
m 
the
 
hs
h/
CA
ST
 
ba
ck
cr
os
s. 
Al
l 
mi
ce
 
we
re 
ho
m
oz
yg
ou
s 
at
 
the
 
hsh
 
loc
us
 o
n 
the
 
ba
sis
 
of 
a 
sh
ak
in
g 
ph
en
ot
yp
e 
an
d 
are
 
id
en
tif
ied
 
nu
m
er
ic
al
ly
. 
H
om
oz
yg
os
ity
 
for
 
a 
MI
T 
m
ar
ke
r 
is 
in
di
ca
te
d 
by 
an
 
op
en
 
bo
x 
wh
ils
t 
he
te
ro
zy
go
sit
y 
is 
sh
ow
n 
as 
a 
bla
ck
 
bo
x. 
MI
T 
m
ar
ke
rs
 a
re 
or
de
re
d 
fro
m 
ce
nt
ro
m
er
e 
to 
te
lo
m
er
e.
Figure 49: Gel showing a PCR with a CAST backcross pooled sample using 
D17MitlO. Lane 1 100 bp ladder, Lane 2 C3H, Lane 3 101, Lane 4, CAST, 
Lane 5, 50:50 ratio of C3H/CAST, Lane 6 CAST backcross pool. Equal band 
intensity is seen in the C3H/CAST pool whereas the test pool shows a very 
weak CAST band and a much stronger C3H/101 band, indicative of linkage to 
this marker. The 101 and C3H bands are very similar in size for this m arker.
Figure 50: Gels showing the bands generated from PCRs using D17MitlO and 
pooled DNA samples from the C57 and BALB backcrosses. (A) Lane 1 C3H, 
Lane 2 101, Lane 3 C57, Lane 4 50:50 ratio of C3H/C57, Lane 5 C57 backcross 
pool, Lane 6 lOObp ladder. (B), Lane 1 lOObp ladder, Lane 2 C3H, Lane 3 101, 
Lane 4 BALB, Lane 5 50:50 ratio of C3H/BALB, Lane 6 BALB backcross pool. 
The C57 pool appears to show about the expected band intensities for an 
unlinked m arker (3:1 C3H/C57) although a recombination fraction of 38% had 
been found using individual samples. On the BALB pooled sample, there may 
be slight departure from these proportions, with a slightly stronger C3H/101 
band and fainter BALB, which would be in accordance with the lower 
recombination rate of 22.5%.
5.5 Fine mapping of chromosome 3
5.5.1 Introduction
Now that linkage had been detected for two markers on chromosome 3, it was 
necessary to confirm that a region of homozygosity did exist and that no mice were 
heterozygous across the whole region. Heterozygosity might indicate the 
identification of a modifying locus or perhaps expression of a phenotype in 
heterozygotes. If it appeared that the disease locus had been flanked, the study was 
to be extended to encompass the C57 and BALB backcrosses. The ultimate goal 
was the identification of a handful of markers and recombinant mice that defined a 
very small interval containing the hsh gene so that this could be subjected to 
positional cloning.
5.5.2 Materials and Methods
5.5.2.1 Preparation of gDNA
New samples from shaky F2 mice were treated as described in Preparation of 
genomic DNA, page 75. Pools of DNA from CAST, C57 BALB backcrosses were 
utilised to illustrate linkage within the entire population. A ratio of 3:1 for C3H/101 
and tester strain indicates no linkage; a stronger C3H/101 band suggests linkage.
5.5.2.2 PCR
The routine protocol is given in Polymerase chain reaction, page 77 and appropriate 
adjustments were made as necessary. Gel analysis is described in Analysis of PCR 
products, page 78.
5.5.2.3 Selection of microsatellite primer pairs
Primer pairs were selected initially from the region between D3Mit203 and 
D3Mitl27 on the basis of the position of microsatellite markers on the 
Whitehead/MIT map and polymorphism between C3H and CAST. As the interval 
defined by flanking markers became smaller, the study was extended to include 
samples from the C57 and BALB backcrosses. At this point, data on the position of 
markers from the EUCIB and the MGD maps (see Genetic maps, page 74) were 
utilised to permit finer mapping. Genetic distances are different between the 
Whitehead/MIT map and the integrated maps so the derivation of map positions is 
given where necessary. Eventually all markers within the interval of interest that 
demonstrated polymorphism between C3H and any one of these strains were typed. 
A list of these markers can be seen in Figure 52, page 196.
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5.5.2.4 Genetic maps
The genetic maps employed in this part of the study are discussed in Genetic maps, 
page 74.
5.5.2.5 Approach to mapping
All available CAST backcross samples were typed for a small number of markers. 
Mice that were homozygous for markers spanning the region of interest were 
abandoned and further markers typed against only recombinant animals. The aim 
was to identify proximal and distal markers as close as possible to the disease locus 
and to establish a region of complete concordance in the interval. Samples from the 
C57 and BALB crosses were also tested for linkage to this region. The integrated 
MGD and Chromosome Committee mouse genetic maps were examined for their 
gene content in the interval of interest and the syntenic human subchromosomal 
regions determined. The human genetic maps were also inspected for gene and 
disease loci in the syntenic regions.
5.5.3 Results
5.5.3.1 CAST backcross
5.5.3.1.1 Mapping using the entire panel o f mice
D3Mit72 at 30cM, D3M itll at 37cM and D3Mit316 at 41cM on the 
Whitehead/MIT map were tested against all 97 CAST backcross samples available 
at that time. Details of these and the two previous markers on chromosome 3 are 
presented in Table 8 below.
Mit
marker
C3H-
derived
allele
(bp)
CAST-
derived
allele
(bp)
Distance
from
centromere
(cM)
Number of 
recombinants
Recombination 
rate (±SE)
D3Mit203 138 158 lOcM 16/64 25 ± 5.4%
D3Mit72 142 120 30cM 3/97 3 ± 1.73%
D3M itll 112 145 37cM 3/97 3 ± 1.73%
D3Mit316 114 146 41cM 7/97 7 ± 2.59%
D3Mitl27 168 106 49cM 15/73 20 ± 4.6%
Table 8: D3Mit panel used for initial localisation of the interval containing the 
hsh locus. Distances are those given in the Whitehead/MIT map.
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Haplotypes for the 64 backcross animals that were typed for all 5 markers are given 
in Figure 51, page 195. The two mice which were heterozygous for both of the 
original two markers, D3Mit203 and D3Mitl27, were homozygous for all three 
intervening markers, indicating that they were double recombinants. A region of 
homozygosity containing the hsh locus lay between D3Mit72 and D3Mitl 1.
5.5.3.1.2 Fine mapping using informative mice
The 6 mice recombinant for D3Mit72 or D3M itll were typed for intervening 
polymorphic markers and haplotypes developed for them. Expected product sizes 
are given in Table 9, page 197 and the relative positions of the markers according to 
the EUCIB map are shown in Figure 52, page 196. The 3 markers that are not 
precisely ordered within their bin are indicated in red (D3Mit311, D3MM41, 
D3Mit29) and the other markers from that bin that have been ordered are boxed in 
red (D3Mitl56, D3Mit28, D3Mit232, D3Mit99, D3Mit76).
Additional mice bom after identification of linkage on chromosome 3 were typed 
only for the flanking markers. After testing of all 120 CAST backcross samples that 
were collected during the study period, an interval was defined proximally by one 
recombination event for D3Mit74 at 39.16cM (0.83 + 0.83cM proximal to hsh) and 
distally by three recombination events for D3Mit41 at 43.5cM (2.5 ± 1.42cM distal 
to hsh). The haplotypes of the 4 informative recombinant mice are shown in Figure 
53, page 198. Those markers that have not been typed exhibited no detectable 
polymorphism between C3H/101 and CAST (D3Mit73, D3Mitl39, D3Mitl56, 
D3Mit99).
Examples of gels obtained for one proximal marker, D3Mit40 (Figure 54, page 199) 
and one distal primer pair, D3Mitl02 (Figure 55, page 200), are given to illustrate 
the results. A pool of all 120 samples was also created to demonstrate linkage to the 
markers in the complete population, as is seen by the complete absence of a CAST 
band on the gel pictures. Homozygosity of all mice is shown for D3Mit232 (Figure 
56, page 201) and D3Mit49 (Figure 57, page 202). This latter PCR is very 
interesting because the C3H and CAST bands are indistinguishable (this primer pair 
was originally selected for use on the C57 backcross) whilst the 101 allele is larger. 
All mice, including the pool of 120 samples, appear to carry the 101 allele.
5.5.3.2 C57 backcross
A set of 7 markers that showed polymorphism between C3H and C57 was tested 
against all 67 of these backcross mice and an identical region of complete 
concordance was identified. The use of the C57 backcross enabled the number of
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markers tested to be extended (D3Mit73 was polymorphic for C57 but not CAST) 
and the interval containing the locus was further defined distally. The haplotypes of 
recombinant mice are shown with the CAST backcross haplotypes Figure 53, page 
198. New distal flanking markers, D3Mit311 and D3Mitl41 at about 42cM, were 
defined, for which 3 mice are heterozygous. This is equivalent to a genetic distance 
of 4.50 ± 2.53cM.
The following markers were not typed for the C57 backcross mice; D3Mit282, 
D3Mitl39, D3Mit28, D3Mit232, D3Mit99, D3Mit41 (no polymorphism), D3Mit76 
(4bp difference was not detected on polyacrylamide gel analysis) or because no 
further information was to be gained (D3Mitl75, D3Mit74, D3Mit49). The region 
of homozygosity is illustrated by D3Mit73 (Figure 58, page 203). Again, a pooled 
sample containing DNA from all 67 mice is included for the purpose of illustrating 
linkage in the entire population. Only a single C3H/101 band can be seen in this 
pool, indicating a shortage of heterozygous mice.
5.5.3.3 BALB backcross
The 31 BALB backcross mice were all homozygous for D3Mit73, D3Mit49 and 
D3Mitl56. Homozygosity in the entire population is illustrated with D3Mit73 in 
Figure 59, page 204.
5.5.4 Discussion
The region containing the hsh locus was localised to chromosome 3 between 
D3Mit74 proximally and D3Mit31 l/D3Mitl41 distally. One intersubspecific and 
two interstrain backcrosses showed linkage to the same region, with all 215 mice 
being homozygous in this interval. Although penetrance is low on the CAST 
backcross and therefore identification of another major modifier with obligate 
homozygosity could not be completely excluded, the higher penetrance on the C57 
background made this statistically impossible. With a penetrance of 76%, 
expression of the hsh phenotype on this backcross could not require homozygosity 
at two separate loci (penetrance would be reduced to 50% in that case, i.e. 25% of 
total mice born) and in fact, linkage to chromosome 17 had already been suggested, 
which would further reduce penetrance. In fact, it may be that chromosome 17 
contains the sole modifying locus on the C57 background, although a much larger 
population will be required to confirm this hypothesis. It is interesting to note that 
results from one marker, D3Mit40, were consistent with the mutation arising on the 
101 background rather than the C3H. However, there may still be some A/H or SN
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strain specific microsatellite alleles present in the hsh genome and the possibility of 
these being the same size as the 101 alleles cannot be excluded.
Although markers have been placed in linkage groups known as “bins” by 
Whitehead/MIT, because only 98 meiotic events were used, resolution of greater 
than lcM  cannot be achieved. With over 6000 microsatellite markers across a 
genome of 1600cM, bins can obviously contain many markers. About 3200 of these 
markers have now been more finely positioned relative to one another on the much 
larger EUCIB backcross using 983 Mus spretus x C57BL/6 backcross mice, 
allowing mapping to a resolution of 0.1 cM (European Backcross Collaborative 
Group, 1994). A proportion of the markers here in one bin, D3Mit311, D3Mit341 
and D3Mit29, have not yet been positioned relative to other markers in that bin on 
either cross. This could be performed on the hsh backcrosses by assessing 
haplotypes if recombination events have occurred between these markers. Only one 
other marker in this bin with a known map position, D3Mit76, is polymorphic 
between C3H and C57 and this is only a 4bp difference (124bp versus 128bp). 
Polyacrylamide gel analysis has failed to separate the bands although PCR utilising 
radiolabelling techniques might be a successful approach. However, the 101 allele 
appeared to be the same size as the C57 on agarose gels, which may prevent typing. 
In addition, since distances between adjacent markers within a bin will be less than a 
centimorgan, fewer than 1/100 mice will demonstrate a recombination event 
between them and it may not yet be possible to place D3Mit31 l/D3Mit341 relative 
to other markers in the bin on this population of 67 mice.
Although there are no absolute cut-offs for determining what level of linkage is 
necessary before one can pursue a positional cloning exercise, it is generally 
accepted that 500-1000 backcross mice are required to map a locus to a sufficiently 
small interval (Silver, 1995a). Within the 2.17 ± 1.07cM interval that has been 
defined so far, there remain a number of potentially useful markers, and the rate- 
limiting step is now the generation of mice needed to define further recombination 
events. The very low penetrance on the CAST backcross resulted in only 120 mice 
over a period of over 2 years, and at this time, only 2/100 new mice is likely to 
demonstrate a recombination event in the defined interval. The C57 backcross in 
particular generates shaky mice considerably faster due to the higher penetrance. 
However, it may be worthwhile continuing with both backcrosses since they 
demonstrate polymorphisms with C3H for some different markers, increasing the 
number of useful markers. It is also possible that recombination differences 
between the two crosses will be helpful; certainly, more recombination events 
occurred distally on the C57 backcross compared to the CAST, whilst the reverse 
was true for the proximal region. Perhaps there are different “recombination
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hotspots” in the crosses, i.e. areas where crossover events are more likely to occur. 
On the other hand, the BALB backcross exhibits lower penetrance and subjectively 
does not appear to be such a prolific cross. It is also polymorphic for only three of 
the markers currently mapped to the interval and not for the current flanking 
markers. As fine mapping progresses, it is possible that a vital recombination may 
occur for one of these markers, but the very small population size makes this 
unlikely, and it may not be worth continuing with this backcross.
Concomitant with continued breeding of backcross mice for fine mapping, other 
approaches to gene identification were attempted. High resolution mapping can 
greatly assist the candidate gene approach since genes that recombine outwith a 
defined interval can be excluded. This combination of positional cloning and 
candidate gene identification is increasingly successful as more genes are placed on 
the mouse genetic map, and will probably overtake positional cloning using contigs 
as the approach to identification of a novel mutant locus (Collins, 1995). However, 
with only about 5500 genes placed on the map out of an estimated 100,000, there is 
a very large probability that the guilty gene has not yet been mapped.
The integrated mouse genetic maps from the MGD and the Chromosome Committee 
were both examined for their gene content in the interval of interest. However, it 
must be borne in mind that often data have been mapped using different breeding 
strategies and species/strains or even different techniques, such as in situ 
hybridisation or somatic cell hybrids. Distances between loci may vary between 
studies and even the order of loci may be misrepresented on an integrated map. 
Therefore, the position of gene loci and the mapping of a gene to outwith the region 
of interest should be regarded with some caution.
Candidate genes would be those with a putative role in the CNS, especially with 
regard to oligodendrocytes and myelination. There were no obvious candidates 
from the 32 genes placed between D3Mit74 and the bin containing D3Mit311/341. 
A version of the map is shown in Figure 60, page 205 where genes are outlined in 
red, and the human homologues and their chromosomal loci are given where known. 
The full name for each locus is given in Table 10, page 223. Data for each gene was 
accessed through the MGD and examined for evidence of a putative role in the CNS 
but none appeared to have a specific CNS function. This failure to identify a 
candidate may be because the gene has not yet been identified or mapped, or that the 
culprit has a previously unrecognised role in the CNS.
Due to the inherent problems with allocating precise positions to loci, genes that 
were mapped close but outwith the region could not be definitively excluded. Other 
myelin-associated genes on chromosome 3 were therefore given consideration.
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Cnp2 has been positioned at 38.4cM, 2.6cM proximal to D3Mit74 using analysis of 
recombinant inbred strains (Bernier et al., 1988) and Ugt8 has been cytogenetically 
mapped to bands E3-F1 in the middle of chromosome 3 using somatic cell hybrids 
and in situ hybridisation (Coetzee et a l, 1996). Neither has been mapped relative to 
microsatellite markers and their exact map positions must remain open to question. 
The role, if  any, of the gene product from Cnp2 in myelination is not known, while 
Ugt8 has a key function in the biosynthesis of galactocerebroside, a frequently used 
marker for oligodendrocytes (Kagawa et al., 1996). Both genes were subjected to 
further investigation but the phenotypic studies suggested that neither of these was a 
likely candidate. Western blotting for CNP levels indicated the presence of both 
CNP1 and CNP2 protein isoforms (see Western blotting for CNP, page 153), and in 
situ hybridisation using a Ugt8 riboprobe demonstrated positive cells in the spinal 
cord white matter (see In situ hybridisation, page 120). However, mRNA and 
protein levels are not confirmation of a normal gene and to exclude them with 
certainty, the genes could be mapped on the recombinant mice using DNA 
polymorphisms such as intragenic polymorphic repeats or RFLPs to confirm their 
position outwith the interval of interest.
Since no further candidates were identified near to or within the defined interval, the 
human genetic map was examined for synteny. It is known that nearly all human 
genes have homologues in the mouse and vice versa, and that the order of genes is 
also conserved, to some extent, in segments up to 8cM in length along the 
chromosome (Nadeau, 1984). The practical implication of this is that the map 
position of a gene in one species may be applied to the other, although one should 
be cautious in overinterpreting synteny information; there are many examples of 
smaller genomic segments that have been inserted in or removed from larger 
syntenic regions. One gene in the interval of interest has its homologue on human 
chromosome 4 whilst the remaining 16 have homologues on with human 
chromosome 1 (Figure 60, page 205). Gene order does not appear to have been 
conserved, although it is possible that linkage mapping data are flawed in one of the 
species. Physical mapping advances may clarify the differences between man and 
mouse in this region in the future. No candidate genes or mutations associated with 
dysmyelinating disorders were gleaned from examination of the syntenic regions on 
the human map.
In order to progress further with the positional cloning of the hsh gene, it appears 
that the generation of more backcross mice is a priority. Once an interval of 0.1- 
0.5cM (200-1000kb) is achieved, the next stage of gene identification can be 
initiated. Although no likely candidates have been mapped to the region so far, the 
rate at which new loci are being placed on the mouse map is accelerating and it is
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possible that, as fine mapping continues, a number of candidate genes may be 
discovered; this would potentially obviate the need for positional cloning using 
overlapping contigs and subsequent gene identification, which are labour intensive 
and slow processes.
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Figure 51: Haplotypes for the 64 CAST backcross animals typed for all 5 
markers used in initial positioning of the hsh locus. Open boxes represent 
C3H/101 alleles, filled boxes CAST. The number of mice recombinant for each 
m arker is given at the bottom of each column. The hsh locus has been 
positioned in a region of homozygosity between D3Mit72 and D 3M itll.
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Figure 52: Location of markers mapped on the EUC1B backcross in the interval 
of interest. D3Mit311, D3Mitl41 and D3Mit29 are in the same bin as the 
markers boxed in red on the Whitehead/MIT map but have not been positioned 
on the EUCIB map. D3IVlitl39 and D3Mit99 were not polymorphic for the 
crosses in this study and were therefore not used. Distances are those given on 
the EUCIB map.
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Mit M arker
C3H- 
derived 
allele (bp)
CAST- 
derived 
allele (bp)
C57- 
derived 
allele (bp)
BALB- 
derived 
allele (bp)
Distance
from
centromere
(cM)
D3Mit212 130 108 124 128 36.5
D3Mit40 110 120 140 110 36.72
D3Mitl75 133 107 139 139 38.94
D3Mit74 148 170 152 148 39.16
D3Mit49 110 108 128 148 39.6
D3Mit282 123 109 123 119 39.6
D3Mitl39 87 87 85 85 40.5
D3Mit73 106 106 148 144 40.5
D3Mitl56 252 -1 252 260 41.5
D3Mit99 216 216 216 216 42.48
D3Mit232 154 170 154 152 42.26
D3mit76 124 112 128 124 43.14
D3Mit311 130 122 122 136 unknown
D3Mitl41 159 147 149 157 unknown
D3Mit29 148 188 150 200 unknown
D3Mitl01 126 118 108 -1 43.5
D3Mit41 210 236 210 210 43.5
D3Mit75 98 112 110 98 44.9
D3Mitl02 142 162 152 142 47.34
Table 9: D3Mit panel available for fine mapping the hsh locus on the CAST, 
C57 and BALB backcrosses. D3Mit99 and D3Mitl39 were not used due to 
insufficient polymorphism in all 3 backcrosses. All other m arkers were typed 
on informative mice from at least one backcross. The symbol -1 indicates that 
no product was generated for this strain.
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Figure 53: Haplotypes of recombinant F2 mice generated from the CAST and 
C57 backcrosses. CAST mice are indicated by the prefix MAP and C57 by BL. 
Homozygosity for a m arker is indicated by an open box whilst heterozygosity is 
shown as a black box. Blank rows indicate there was no polymorphism for that 
m arker or that testing was not be useful because mice were all homozygous for 
the preceding marker. M arkers are ordered from centromere to telomere. The 
hsh locus is seen to lie between the proximal m arker D3Mit74 and the distal 
markers D3Mit311 and D3Mitl41.
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Figure 54: A gel showing PCR products for CAST mice and D3Mit40. Lane 1 
lOObp ladder, Lane 2 C3H, Lane 3 101, Lane 4 CAST, Lane 5 FI hs/t/CAST, 
Lane 6 pooled sample of 120 CAST backcross DNAs, Lane 7 M apl7, Lane 8 
M ap ll2 , Lane 9 M apl23 and Lane 10 M apl45. The C3H and 101 alleles are 
very sim ilar in size and the CAST allele is amplified in the presence of a 
musculus allele. The pooled sample has been included to dem onstrate the 
strong linkage to this m arker in the whole population; no CAST band is visible 
at all. One mouse, M apl23, is recombinant.
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Figure 55: A gel showing PCR products for CAST mice and D3MR102. Lane 1 
lOObp ladder, Lane 2 C3H, Lane 3 101, Lane 4 CAST, Lane 5 FI hsh/CAST, 
Lane 6 M apl7, Lane 7 M ap ll2 , Lane 8 M apl23 and Lane 9 M apl45. The 
C3H allele produces two bands but they are not similar to CAST. Maps 17, 112 
and 145 are heterozygous while M ap 123 is now homozygous.
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Figure 56: A gel showing PCR products for CAST mice and D3Mit232. Lane 1 
C3H, Lane 2 101, Lane 3 CAST, Lane 4 FI hsh/C AST , Lane 5 pooled sample of 
120 CAST backcross mice, Lane 6 M ap 17, Lane 7 Map 112, Lane 8 123, Lane 
9 M ap 145, Lane 10 lOObp ladder. All four Map mice are now homozygous. 
No CAST band is seen in the pool, suggestive of a largely homozygous 
population.
Figure 57: A gel showing PCR products for CAST mice and D3Mit49. Lane 1 
lOObp ladder, Lane 2 C3H, Lane 3 101, Lane 4 CAST, Lane 5 F I hsh/CAST, 
Lane 6, pooled sample of 120 CAST backcross mice, Lane 7 M apl7 , Lane 8 
M ap 112, Lane 9 M ap 123, Lane 10 145. The CAST and C3H alleles are very 
sim ilar in size while the 101 is a heavier fragment. Only a 101 allele is 
identified in the pooled or 4 individual samples. Since this m arker lies in the 
region of concordance where all mice are homozygous, it suggests the mutation 
may have arisen on the 101 background. The intense lower band is excess 
prim er.
1 2 3 8 9 10 11 12
Figure 58: A gel showing PCR products for the C57 backcross and D3Mit73. 
Lane 1 lOObp ladder, Lane 2 C3H, Lane 3 101, Lane 4 C57, Lane 5 FI hshJCSl, 
Lane 6 BL8, Lane7 BL12, Lane 8 BL13, Lane 9 BL25, Lane 10 BL29, Lane 11 
BL53, Lane 12 pooled sample of 67 C57 backcross mice. Only a C3H/101 allele 
is seen in the pool and the BL mice heterozygous for the next distal m arker. An 
extra faint band is seen in the C57 sample but does not affect interpretation.
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Figure 59: A gel showing PCR products for the BALB backcross and D3Mit73. 
Lane 1 lOObp ladder, Lane 2 C3H, Lane 3 101, Lane 4 BALB, Lane 5 FI 
hsh!BALB, Lane 6 pooled sample of 31 BALB backcross mice. A slight 
difference can be seen between the sizes of the C3H and 101 alleles. The pooled 
BALB sample has only a single band, at the level of the 101 allele. No BALB 
band can be seen at all in this sample.
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Figure 60: A composite genetic map of chromosome 3 between the two flanking 
m arkers D3Mit74 and D3Mit311/D3Mitl41. Genes are boxed in red whilst 
other symbols represent microsatellite and other DNA segments or viral 
sequences. The known human homologues and their chromosomal loci are 
given in black type adjacent to the appropriate mouse gene. The centromere is 
towards the top of the page and genetic distances are those given on the MGD 
map. The full names of all loci are provided in Table 10, page 238.
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Figure 60 (cont.) A composite genetic map of chromosome 3 between the two 
flanking markers D3Mit74 and D3Mit311/D3Mitl41.
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6. Concluding remarks and future 
work
Historically, myelin mutants have added greatly to the wealth of knowledge 
concerning the complex processes of myelination in the CNS and PNS. The 
greatest benefits have come from those mutants in which a phenotypic abnormality 
has been related to a precise alteration in a gene product, for example, shiverer and 
the Pip mutants in the CNS and trembler in the PNS (see (Griffiths, 1996) for 
review). Thus, the ultimate goal of the hsh project must be both the definition of the 
phenotypic effects of the mutation and the identification and characterisation of the 
gene product. To that end, a multidisciplinary approach was employed in this study, 
with the dual aims of describing the effects of the novel hindshaker mutation on 
myelination, and mapping of the culprit gene to a sub-chromosomal locus. As the 
work presented here shows, both aims have been achieved; knowledge of the 
phenotype has been extended and a surprisingly complex genetic picture has been 
illuminated. The purpose of this final discussion is to bring together the genotypic 
and phenotypic studies, place them in context with current genetic and 
neurobiological research and to suggest future work for gene isolation.
In summary, the hypomyelinating phenotype appears to be due to a paucity of 
mature oligodendrocytes that is more profound in specific regions of the CNS (see 
Discussion of the hsh phenotype, page 157). This culminates in a retardation of 
myelination that is most severe in the spinal cord and cerebellum and less obvious in 
the forebrain and optic nerve. There is a subsequent partial resolution of the myelin 
deficit with age that is concomitant with an increase in the number of mature 
oligodendrocytes. Myelin appears structurally normal and it seems likely that the 
mutation does not involve a gene encoding for a major structural component of 
myelin, but more probably affects the biology of the oligodendrocytes. Autosomal 
recessive inheritance had already been shown although it is now known that there is 
variation in expressivity and penetrance of the mutation on different backgrounds. 
The hsh gene has been mapped to a 2cM interval in the middle of chromosome 3 
and three flanking markers and five markers showing complete concordance have 
been identified using backcrosses with CAST/Ei or C57BL/6J as the second parental 
strains. A suppressor modifying locus has also been found on chromosome 17.
Inspection of the interval of interest on chromosome 3 for candidate genes has failed 
to yield any contenders to date. The Cnp2 gene, mapped to 2cM proximal to the 
region of interest, was considered but no strong evidence for its involvement was
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forthcoming (see Western blotting for CNP, page 153 for discussion). It is not yet 
clear whether the Cnp2 gene generates any of the observed Cnp mRNA transcripts 
(Bernier et al., 1988), or whether it encodes for a CNP-related polypeptide or is in 
fact a pseudogene. However, since the possibility of it generating a CNP protein 
isoform has not been completely excluded, further investigation would be 
warranted; certainly the putative functions of CNP protein could be consistent with 
a possible aetiology in the hsh phenotype. Although its precise function remains 
unknown, it is expressed early in myelination (Trapp, 1990), may have a role in 
signal transduction (Thompson, 1992) and appears to influence the development of 
filopodia in cultured cells (De Angelis and Braun, 1994). Thus, the suggestion has 
been made for a role in early development and differentiation of oligodendrocytes. 
In addition, extra copies of Cnp result in premature peak expression of myelin 
proteins (Gravel et al., 1996). Thus, it appears that perturbation of these putative 
functions could correlate with the phenotypic abnormalities identified in hsh. The 
mapping data are not strong enough to exclude conclusively the gene from the 
interval and the identification of both protein isoforms in hsh does not necessarily 
indicate normal gene function. Mapping of the Cnp2 gene on the CAST/Ei and/or 
C57BL/6 backcrosses should indicate whether the gene lies within the interval or is 
in fact, accurately mapped to a proximal locus. The difficulty comes in 
differentiating between the Cnp and Cnp2 genes. A Cnp2 specific restriction 
fragment length polymorphism has been identified using Taql digestion (Bernier et 
al., 1988) but C57BL/6 and C3H/HEH yield fragments of the same size and CAST 
and 101 have not been tested. The next stage in elimination of Cnp2 as a candidate 
could be investigation of possible Taql RFLPs between CAST, 101 and C3H to 
allow mapping of the gene on this backcross. Until it has been mapped outwith the 
interval, it must remain a potential candidate.
If the “positional candidate” approach, based on correlation of gene function with 
the hsh phenotype, fails to identify the affected gene, other strategies for gene 
cloning will be required. Positional cloning, where the gene is isolated purely on the 
basis of its position in the genome (Collins, 1992; Ballabio, 1993), is certainly one 
option. Currently, although only 2cM is contained within the region, this is a huge 
distance in terms of the number of genes that it may contain. Estimates place gene 
frequency at about 1 gene every 30kB (Silver, 1995c), although this can vary 
tremendously depending on gene density and size. Since 2cM is equivalent to about 
4Mb in the mouse, over 130 genes may lie in this interval, of which about 30 have 
been mapped to date. A distance of this size far exceeds that amenable to positional 
cloning, but the bottleneck in further high resolution mapping is not the lack of 
markers but the ability to obtain further mice with recombination breakpoints close 
to the hsh gene. Ideally this should be well under 0.5cM, requiring a total of at least
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500 backcross mice. At that stage, it should be possible to move to “chromosome 
walking” by developing large insert contigs, using either yeast or bacterial artificial 
chromosomes or bacteriophage PI as cloning vectors. At the present rate of 
breeding, about 300 useful mice will be bred over the coming year, taking the total 
to more than 500. Approximately 6 (2/100) of these are likely to be recombinant in 
the interval of interest and may have breakpoints sufficiently close to the gene to 
permit higher resolution mapping. Obviously the larger the number of meiotic 
events being examined, the smaller the interval for contig construction. Also, 
markers later generated from overlapping YACs can be typed to define the interval 
even more tightly to reduce the number of genes that have to be examined.
The strategy outlined above does not require a large labour commitment and merely 
necessitates the breeding of sufficient mice and typing for flanking markers using 
PCR until chromosome walking can be attempted. It is, however, time consuming 
with the breeding of large numbers of mice now the rate limiting step. Therefore, 
consideration could be given to alternatives to increasing the cross size, for 
example, boosting of recombination frequency in gametes using cisplatin (see 
below) or gene identification based on non-breeding mapping strategies. The choice 
will partly depend on the profile of the study in the future; a higher financial and 
labour input would be necessary for either of these alternatives but may yield results 
sooner.
It has been shown that the anticancer drug cisplatin, which causes DNA strand 
breakage and is highly recombinogenic in some model organisms, has the ability to 
increase recombination in the offspring of treated male mice (Hanneman et al., 
1997). This was at a level of up to twice that of controls and could therefore reduce 
the number of meioses that must be screened to localise a gene by half. The 
protocol is simple and could markedly decrease the time, cost and effort that will 
still be required to map hsh to a suitably small interval. What is not clear, however, 
is the effect of cisplatin on females or different strains of mice. Also, only a small 
number of chromosomal regions were tested for recombination and it may be that 
the interval on chromosome 3 will be affected differently by cisplatin treatment.
The hsh locus maps to a region of mouse chromomsome 3 that exhibits synteny with 
regions of human chromosomes 1 and 4. It has not been possible to assign hsh to 
either of these homologous groups, and it was also difficult to define precisely the 
limits of the homologous regions on the respective human chromosomes; gene order 
does not appear to be completely conserved and some homologous genes have only 
been mapped to cytogenetic bands in man. However, the existence of homology 
could theoretically be exploited as a non-breeding mapping strategy for gene
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identification. The emphasis on the human genome project in recent years has led to 
the development and mapping of a large number of partial cDNAs termed expressed 
sequence tags (ESTs). These are short incomplete sequences of cDNAs, usually 
derived from RNA prepared from tissues that are restricted temporally and spatially. 
ESTs therefore correspond to the genes that are being expressed in specific tissues at 
certain stages of development and provide a handle to many, as yet, uncharacterised 
genes. It is conceivable that the analysis of ESTs mapped to the homologous 
chromosomal regions on chromosomes 1 and 4 could eventually lead to 
identification of the mutated gene. Data on the expression of ESTs are accessible 
through the WWW (http://www.ncbi.nlm.nih.gov/dbEST/index.html) and could be 
used to select those ESTs that are CNS or glial cell specific. Assuming homology 
between human and mouse ESTs, the expression of appropriate ESTs could then be 
studied in normal and hsh CNS tissue from suitable ages. Differences in expression 
between these may suggest the involvement of that particular gene in the phenotype. 
The obstacles to such a strategy cannot be underestimated, however. The 
homologous regions are still enormous and cover large expanses o f two 
chromosomes. The number of ESTs mapped to these regions runs into hundreds, 
and at the moment, many ESTs from the same gene may be mapped separately with 
no indication of their shared origin. The same gene may therefore be tested several 
times. Additionally, there is no reason a priori to suggest that expression will be 
altered either at RNA or protein level or that the gene will not be expressed in 
tissues other than the CNS. With these considerations, further fine mapping in an 
attempt to exclude one of the homologous human chromosomes and refine the 
interval would be expedient before sweeping analysis of human ESTs.
One unexpected discovery made during the study was the revelation of a rather 
more complex pattern of inheritance than had been anticipated. First it appeared 
that modifying genes were responsible for incomplete penetrance and variable 
expressivity on the C3H/101 background. Subsequently, incomplete penetrance was 
identified on the CAST/Ei, C57BL/6J and BALB/cJ backgrounds, again due to the 
presence of specific alleles at non-disease loci. This was a major setback for the 
mapping study because the rate of generation of mice for linkage analysis was 
severely curtailed. Since only those mice with a definitive shake could be classified 
genotypically, non-shaky mice could not be utilised and the number o f useful 
samples was only a fraction of the total bom. The positive aspect o f the low 
penetrance was the opportunity to identify additional loci involved in the 
pathophysiological pathway that would have otherwise remained obscure.
A prediction of the number of modifying loci influencing penetrance on a particular 
genetic background cannot be made with precision; genes may be enhancers or
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suppressors of a phenotype, and some may act in a recessive manner, some 
dominantly and many may be influenced by interaction with proteins encoded by 
other genes. However, with a penetrance of 16% on the CAST background, several 
loci are likely to be involved, of which one, on chromosome 17, has been identified. 
Since the CAST alleles are under-represented in this region in the phenotypic hsh 
population, this is a suppressor locus. The same locus also appears likely to 
influence penetrance of the hsh phenotype on several other backgrounds, including 
C57BL/6J and BALB/cJ. As discussed (Fine mapping of chromosome 17, page 
168), curly tail, a murine model for neural tube defects, also has a modifying locus 
within the region identified on chromosome 17. It would be interesting to know 
whether the same gene is involved, but no obvious candidates have been found to 
date. Positional cloning of modifiers is extremely difficult due to the unknown 
genetic status of mice; it cannot be determined which are homozygous or 
heterozygous at the locus on the basis of the phenotype, and therefore the 
classification of recombinant animals cannot be authenticated. Thus, the 
identification of modifying genes is currently dependent on typing a large 
population of segregating mice to define a set of markers with the lowest 
recombination rate and then assessing candidate genes already mapped to that 
region. Definitive identification then requires careful characterisation of sequence 
and expression variation and, eventually, transgenesis experiments where the mutant 
genotype receives the non-permissive modifying allele and is then studied for a 
phenotype. The interval is still poorly defined in hsh, partly because of small 
population size but also because not all available markers in that region have been 
typed. A greater number of samples must be tested for a battery of markers on 
proximal chromosome 17 to define the region more precisely. This will allow a 
more directed search for candidate genes. Such procedures are being attempted for 
other murine mutants, for example, the mouse model for cystic fibrosis which has a 
modifier on chromosome 7 for which there are several contending genes (Rozmahel, 
1996) and multiple intestinal neoplasia (Min) mice with a candidate modifying gene 
(the secretory phospholipase A2 gene) on chromosome 4 (MacPhee et a l , 1995). 
Interestingly, the Plp/P~rs mutation, maintained at Glasgow on the C3H/101 
background, has been shown to exhibit a far more severe phenotype on the C57BL/6 
background with death of hemizygous males (I.R. Griffiths, personal 
communication). It might be fruitful to examine proximal chromosome 17 for 
evidence of linkage to the same region. A predominance of C3H/101 alleles in this 
region might suggest the presence of a modifying locus on chromosome 17 with a 
ubiquitous function in CNS development.
The identification of further modifying loci could be achieved by completing the 
genome scan using the statistical criteria employed in this study. Using p<0.001,
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only 1 in 20 findings of positive linkage is likely to have occurred by chance. 
However, one must remember that regions that fall short of statistical significance 
may nonetheless be correct. Unfortunately there is no way of distinguishing 
between small peaks that represent weak true positives and peaks of the same height 
arising from random fluctuation. Thus, it is entirely possible that regions that 
exhibit only weak linkage to the hsh phenotype may be overlooked.
Although cloning of modifiers is still a major hurdle, it is now possible to clone 
virtually any mouse gene for which the genetic status of contributing animals is 
known, purely on the basis of its position in the genome. Consequently, it is likely 
to be merely a matter of time until the hsh gene is identified. The protein product 
may then be deduced and its expression in normal animals compared to that in hsh 
mutants. By correlating the precise genetic alteration in hsh with the phenotype, it 
may be possible to further clarify the role of the protein in normal myelination. In 
addition, transgenic/knock-out mice may be created to study myelination in the 
complete absence or in the presence of extra copies of the gene. Based on the data 
from the phenotypic studies to date, the premise is that characterisation of the hsh 
gene product will shed light on the development of oligodendrocytes and regulation 
of their heterogeneity in different regions of the CNS. However, the pleiotropic 
effects of many mutations obfuscate the correlation of protein function with 
phenotype and only a minority of currently defined mutations have an apparently 
simple pathogenesis due to lack of a functional protein. On the other hand, it has 
tended to be autosomal recessive mutations that have been more likely to yield clear 
indications of the role of the gene rather than X-linked or dominant mutations 
(Griffiths, 1996). Thus it is hoped that the hindshaker mouse may provide 
elucidation of at least one link, if not more, in the complex network of events called 
myelination. Through the addition of such small components, a thorough 
understanding of the interactive processes involved in normal myelination can be 
developed, allowing a rational approach to be extended to investigation and 
treatment of disease states affecting myelin.
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7. Appendix
7.1 Fixatives
7.1.1 Buffered neutral formaldehyde, 4% (BNF)
For 1L of fixative:
40% formaldehyde 100ml
Tap water 900ml
sodium dihydrogen phosphate 4g
di-potassium hydrogen phosphate 8g
7.1.2 “Strong fix” (paraformaldehyde/glutaraldehyde 4%/5%)
For 500ml “strong fix”:
8% formaldehyde1 250ml
25% glutaraldehyde 100ml
0.08M cacodylate buffer^ mix formaldehyde and 
glutaraldehyde and make 
up to 500ml
calcium chloride 250mg
Filter and store at 4°C for up to 2 weeks.
1 8% formaldehyde - 20g paraformaldehyde in 250ml distilled water; heat to 65°C 
and add 1M NaOH until the solution clears. Cool to 4°C.
2 0.08M sodium cacodylate buffer - 17.1224g sodium cacodylate made up to 1L 
with distilled water and pH adjusted to 7.2.
7.1.3 Periodate-lysine-paraformaldehyde
For 1L of fixative:
lysine monohydrochloride 13.7g in 375ml distilled water
sodium hydrogen phosphate 1.8g in 100ml distilled water
mix to give 475ml at pH7.4
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paraformaldehyde 20g in 200ml distilled water
The two components can be stored separately at 4°C until required, overnight if 
necessary.
Mix buffered lysine and parafomaldehyde and make up volume to 1L with 0.1M 
phosphate buffer. Add 2.14g sodium periodate and allow to dissolve. Use 
immediately as does not keep.
7.2 Tissue processing protocols
7.2.1 Paraffin wax processing
Tissues to be prepared for paraffin blocks were passed through the following 
solutions:
1) 70% methylated spirit/5 % phenol 2 hr
2) 90% methylated spirit/5 % phenol 2 hr
3) methylated spirit 2 hr
4) ethanol/5 % phenol x3 2 hr, lhr x2
5) 1% celloidin in methyl benzoate* 4 hr
6) xylene x3 1 hr (x3)
7) paraffin wax x2 6 hr, 7 hr
*Necoloidine (Merck) solution for microscopy was considered as 100%. Add 
lml/100ml methyl benzoate.
7.2.2 Resin processing
Processing of tissues for resin blocks involved the following solutions:
i) isotonic cacodylate buffer 4°C 50 min
2) 1% osmium tetroxide in 
cacodylate buffer
room temperature 2 hr
3) isotonic cacodylate buffer 1 room temperature 30 min
4) 50% ethanol 40C 5 min
5) 50% ethanol 4°C 10 min
6) 70% ethanol 40C 5 min
7) 70% ethanol 40C 10 min
8) 80% ethanol 40C 5 min
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9) 80% ethanol 40C 10 min
10) 90% ethanol 40c 5 min
11) 90% ethanol 40C 10 min
12) ethanol 40c 20 min
13) ethanol 40C 20 min
14) propylene oxide room temperature 15 min
15) propylene oxide room temperature 15 min
16) 1:3 resin^ipropylene oxide room temperature 13 hr
17) 1:2 resin:propylene oxide room temperature 6 hr
18) 1:2 resin ipropylene oxide room temperature 18 hr
19) resin 30°C 4 hr
Processed samples were positioned in resin filled silicon moulds and left to 
polymerise overnight at 60°C.
7.2.2.1 ’isotonic sodium cacodylate buffer
sodium cacodylate 16.05g
sodium chloride 3.8g
calcium chloride 0.055g
magnesium chloride 0.102g
Make up to 1L with distilled water and adjust to pH7.2.
7.2.2.2 2Araldite resin
araldite CY212 30g resin
dodecanyl succinic 
anhydride (DDSA)
25.2g hardener
2,4,6-tri-
dimethylaminomethyl 
-phenol (DMP 30)
1.2ml accelerator
di-butyl phthalate 1.0ml plasticiser
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7.3 Staining protocols and stains
7.3.1 Haematoxylin and eosin
Paraffin sections were passed through the following solutions:
1) xylene 2 min
2) absolute alcohol 2 min
3) methylated spirit 2 min
4) water 2 min
5) Lugol’s iodine 1 min
6) water 1 min
7) 5% sodium thiosulphate 1 min
8) water 1 min
9) Mayer ’ s haematoxylin 1 10 min
10) 1% acid alcohol 3 dips
11) water 2 min
12) Scot’s tap water substitute2 1 min
13) water 2 min
14) methylated spirit 10 sec
15 saturated alcoholic eosin 2 min
16) methylated spirit 2 min
17) absolute alcohol 2 min
18) histoclear 2 min
19) xylene 5 min
1 and 2 - see below
7.3.2 Haematoxylin
Sections for nuclear counterstaining were passed through:
i) water 2 min
2) Mayer’s haematoxylin 50 sec
3) water wash off excess
4) Scot’s tap water substitute 30 sec
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Dehydrate sections routinely before mounting in DPX.
7.3.2.1 -Mayer’s haematoxylin
haematoxylin 1 .Og
potassium alum lO.Og
sodium iodate 0.2g
made up in 1L distilled water. Bring to boiling point and allow to cool overnight. 
Then add lg  citric acid and 50g chloral hydrate.
1 3 2 .2  -Scot’s tap water 
sodium bicarbonate 3.5 g
magnesium sulphate 20.Og
in 1L distilled water.
7.3.3 Staining of tissues for electron microscopy
Thin resin sections for electronmicroscopy were stained as follows:
1) saturated uranyl acetate in 50% 
ethanol
5-15 min
2) 50% ethanol rinse
3) 50% ethanol rinse
4) distilled water rinse x 2
5) air dry
6) Reynold’s lead citrate* (Sodium 5-10 min
7) 1M sodium hydroxide rinse x 3
8) distilled water rinse x 5
7.3.3.1 ^Reynold’s lead citrate
lead nitrate 1.33g
sodium citrate 1.76g
Dissolve each in 15 ml water, mix together and shake vigorously for 1 min, then 
intermittently over the next 30 min. Add 8 ml 1M NaOH until the solution clears 
and make up the volume to 50 ml with water.
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7.3.3.2 Methylene blue/azur II
This was used for staining thick resin sections used for light microscopy.
Methylene blue 1%
azurll 1%
borax 1%
Each of the above is made up with distilled water. Equal volumes of each are mixed 
to give final staining solution.
7.4 Buffers
7.4.1 Tris buffered saline (TBS)
Tris pH7.5 3g
sodium chloride 8g
potassium chloride 0.2g
Dissolve in 800ml distilled water, adjust pH to 7.4 with HC1 and make up to 1L with 
further distilled water.
7.4.2 Phosphate buffered saline (PBS)
sodium chloride 8g
disodium hydrogen phosphate 1.44g
potassium dihydrogen phosphate 0.24g
potassium chloride 0.2g
Dissolve in 800ml distilled water, adjust pH to 7.4 with HC1 and make up to 1L with 
further distilled water.
7.4.3 Tris-EDTA buffer (TE)
To make lOmM Tris.Cl (pH8.0), ImM EDTA (pH8)
1M Tris pH8.0 500pl
0.5MEDTA lOOpl 
Add to 50ml distilled water.
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7.4.4 Gel running buffers
7.4.4.1 Tris acetate EDTA buffer xlO
0.04M Tris acetate, 0.001M EDTA.
tris base 48.4g
glacial acetic acid 11.4ml
0.5 M EDTA 20ml
made up to 1L in distilled water.
7.4.4.2 Tris borate EDTA buffer x5
tris base 54g
boric acid 27.5
0.5 M EDTA 20ml
made up to 1L in distilled water.
7.5 Loading dye
6x buffer for TAE/TBE conditions
30% glycerol (Sigma)
0.25% bromophenol blue
0.25% xylene cyanol FF (Sigma)
7.6 SSC (Sodium chloride/sodium citrate) X20
3M sodium chloride/0.3M sodium citrate
sodium chloride 1753g
sodium citrate 882g
made up to 10L with distilled water.
7.7 Bacteriological media
7.7.1 Luria-Bertani medium
tryptone (Oxoid) 10g
yeast extract (Oxoid) 5g
sodium chloride lOg
Add to 950ml distilled water, adjust to pH7.0 using about 0.2ml 5N sodium 
hydroxide. Make up to 1 L  with distilled water and sterilise by autoclaving for 20 
min at 1 5 1 b / i n ^ .  Store at 4 ° C .
7.7.2 SOC medium
tryptone (Oxoid) 20g
yeast extract (Oxoid) 5g 
sodium chloride 0.5g
Make up to 970ml in DW, add 10ml 250mM potassium chloride and adjust to pH7.0 
using about 0.2ml 5N sodium hydroxide. Autoclave for 20 min at 15l b / i n ^ . Cool to 
<60°C and add 20ml filter sterilised 1M glucose solution. Store at 4°C.
7.8 Tissue culture solutions
7.8.1 SD solution
soybean trypsin inhibitor (SD) (SIGMA) 0.52mg/ml
bovine pancreas DNAse (SIGMA) 0.04mg/ml
factor V bovine serum albumin (SIGMA). 3 mg/ml
Made up in L15/HBSS 1ml aliquots stored at -20°C.
7.8.2 SATO medium
Glucose lg/1
Glutamine (SIGMA) 2mM
Insulin (bovine) (SIGMA) lOpg/ml
Transferrin (human) (SIGMA) lOOpg/ml
BSA-pathocyte (ICN) 0.0286%
Progesterone (SIGMA) 0.2pM
Putrescine (SIGMA) O.lmM
Thyroxine (SIGMA) 0.45 pM
Selenite (SIGMA) 0.224pM
Tri-iodo-thyronine (SIGMA) 0.5pM
Made up in DMEM, 30ml aliquots stored at -20°C.
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7.8.3 Blocking buffer
2% bovine serum albumin (BSA/Fraction V) (BDH)
0.1% porcine skin gelatin/type A (Sigma)
2% normal goat serum (Scottish antibody production unit)
0.02% biotin (Sigma)
0 .1 .  saponin (Sigma)
Blocking buffer 2, used for dilution of antibodies, is identical to above except only 
contains 0.02% saponin.
7.8.4 Poly-L lysine coverslips
Coverslips were coated with poly-L lysine to encourage cell adhesion and were 
prepared as follows:
1. Wash in 70% ethanol
2. Rinse in distilled water
3. Soak in 1M nitric acid overnight
4. Rinse in distilled water
5. Rinse in absolute alcohol
6. Air dry on filter paper
7. Autoclave for 20 min and 151b/in2
8. Immerse in poly-L lysine (100jag/ml in SDW) (Sigma) for at least 30 min
9. Rinse in SDW x2
10.Air dry
Post-autoclaving, all procedures were carried out in a tissue culture hood. 
Coverslips were stored at -20°C after coating.
7.9 Protein analysis
7.9.1 Polyacrylamide gel composition
7.9.1.1 Acrylamide/bisacrylamide solution
acrylamide-bisacrylamide (30:0.8) 5 ml
Tris-Hcl 3M (pH 8.8) 3.75 ml
10% SDS 0.3 ml
1.5% ammonium persulphate 0.7 ml
water 20.25 ml
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7.9.1.2 Acrylamide/bisacrylamide solution
acrylamide-bisacrylamide (30:0.8) 20 ml
Tris-Hcl 3M (pH 8.8) 3.75 ml
10% SDS 0.3 ml
1.5% ammonium persulphate 0.7 ml
water 2.75 ml
7.9.1.3 Stacking gel
acrylamide-bisacrylamide (30:0.8) 2.5 ml
Tris-Hcl 0.125 M (pH 6.8) 5 ml
10% SDS 2 ml
1.5% ammonium persulphate 1 ml
water 11.3 ml
TEMED 0.015 ml
7.9.2 SDS-PAGE buffers
7.9.2.1 Discontinuous buffers
Resolving gel buffer: 0.375M Tris-HCl
Stacking gel buffer: 0.125M Tris-HCl
Reservoir buffer: 0.025M Tris-HCl, 0.192M glycine, 0.1% SDS
7.9.2.2 Sample buffer
0.0625M Tris-HCl (pH 6.8)
2% SDS
5% 2-mercaptoethanol 
10% glycerol
0.002% bromophenol blue
Table 10: A list of the full names of all loci in the interval of interest on 
chromosome 3. No gene appeared to have a specific role in the CNS based on 
data available through the MGD.
cM Symbol, Name
D3MU175. DNA segment. Massachusetts. Institute of Technology 175
41.0 D3MH282, DNA segment, Massachusetts, Institute of Technology 282
41.0 D3MH49. DNA segment. Massachusetts. Institute of Technology 49
41.0 D3MU74. DNA segment. Massachusetts. Institute of Technology 74
41.0 Lxn. latexin
41.1 D3Lerl. DNA segment. Chr 3, Le Rov 1
41.1 D3Ler2. DNA segment. Chr 3. Le Rov 2
41.2 D3Hun9. DNA segment, Chr 3, Hunter 9
41.3 D3Bvu6. DNA segment. Chr 3, Brigham Young, University 6
41.3 D3Ucla2. DNA segment. University of California at Los Angeles 2
41.3 Fgg, gamma-fibrinogen
41.3 lapis 1-7. intracistemal A particle, lymphocyte specific 1-7
41.3 Xmmv22. xenotropic-MCF leukemia virus 22
41.3 Xmmv65. xenotropic-MCF leukemia virus 65
41.4 D3Cphl. DNA segment. Chr 3. CEPH 1
41.4 D3Cph2. DNA segment. Chr 3. CEPH 2
41.4 ft, flaky tail
41.5 D3Mitl08.1, DNA Segment, Massachusetts Institute of Technology-
41.5 Pklr. pyruvate kinase liver and red blood cell
41.6 R n u lb l . U lb l small nuclear RNA
41.6 Rnulb2 . Ulb2 small nuclear RNA
41.7 Calll, calpactin I light chain
41.7 Capl, calcium binding protein, placental
41.7 D3Pas502. DNA segment. Chr 3. Pasteur Institute 502
41.7 Gba, acid beta glucosidase
41.7 Mix. metaxin
41.7 Pmv28. polvtropic murine leukemia virus 28
41.7 Rnulb3 . Ulb3 small nuclear RNA
41.8 Acrbl, acetylcholine receptor beta 2 neural
41.9 Pmv38, polvtropic murine leukemia virus 38
42.1 Il6ra. interleukin 6 receptor, alpha
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42.1 Lor. loricrin
42.1 soc. soft coat
42.2 D3HunlO, DNA segment. Chr 3. Hunter 10
42.2 D 3U fl. DNA segment. Chr 3. University of Florida 1
42.4 D3MH187. DNA segment. Massachusetts Institute of Technology 187
42.6 Bslap-rsl, bone gamma-carboxvglutamate protein, related sequence 1
42.6 Bglapl. bone gamma carboxvglutamate protein 1
42.6 Bglap2. bone gamma-carboxvglutamate protein 2
42.6 D3MU289.1. DNA Segment. Massachusetts Institute of Technologv-
42.6 Fdps. famesvl diphosphate synthetase
42.6 Fig. filaggrin
42.6 Lmna, lamin A
42.6 Thbs3. thrombospondin 3
42.65 Lpsb2. liver protein, selenium binding, 56 kDa
42.7 Gabpb2, GA repeat binding protein, beta 2
43.0 Rpl32-rs8, ribosomal protein L32 related sequence 8
43.2 D 3H unll. DNA segment. Chr 3. Hunter 11
43.4 Rpl32-ps, ribosomal protein L32 pseudo gene
43.6 Cacv. calcvclin
43.6 D3MH139. DNA segment. Massachusetts Institute of Technology 139
43.6 D3Tu51, DNA segment. Chr 3, Tubingen 51
43.6 M cll. myeloid cell leukemia sequence 1
43.78 D3MH370. DNA segment. Massachusetts Institute of Technology 370
44.1 D3Ncvsl2. DNA segment. National Cardiovascular Center. Shionogi 12
44.2 D3Hunl2. DNA segment. Chr 3. Hunter 12
44.8 D3MH357. DNA Segment. Massachusetts Institute of Technology 357
44.8 M u d . tumor-associated mucin 1
45.2 D3Hunl3. DNA segment. Chr 3, Hunter 13
45.2 D3MH14L DNA segment. Massachusetts Institute of Technology 141
45.2 D3M ill56. DNA segment. Massachusetts Institute of Technology 156
45.2 D3MH232. DNA segment, Massachusetts Institute of Technology 232
45.2 D3MH28. DNA segment, Massachusetts Institute of Technology 28
45.2 D3MH29, DNA segment, Massachusetts Institute of Technology 29
45.2 D3MU311. DNA Segment, Massachusetts Institute of Technology 311
45.2 D3MU341. DNA Segment. Massachusetts Institute of Technology 341
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45.2 D3Mit76. DNA segment, Massachusetts Institute of Technology 76
45.2 D3MU99. DNA segment, Massachusetts Institute of Technology 99
45.2 F cgrl. Fc receptor, IgG, high affinity I
45.2 Hist2. histone gene complex 2
45.2 Iapls2-28. intracistemal A particle, lymphocyte specific 2-28
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8. Abbreviations
pi microlitre
pm micrometer
APES 3-aminopropyltriethoxy-silane
BAC bacterial artificial chromosome
BALB BALB/cJ
bFGF basic fibroblast growth factor
BNF buffered neutral paraformaldehyde
C57 C57BL/6J
cAMP 3’,5’-cyclic AMP
CAST Mus musculus castaneus
CIAP calf intestinal alkaline phosphatase
cM centimorgan
CNP 2’ ,3 ’,cyclic nucleotide 3 ’-phosphodiesterase
CNS central nervous system
CNTF ciliary neurotrophic factor
ct curly tail
DAB 3,4,4’,4’,-tetraminobiphenyl hydrochloride
DAPI 4’,6-diamidino-2-phenylindole
DEPC diethyl pyrocarbonate
dl downless
DM20 the small isoform of from the Pip gene
DNA deoxyribonucleic acid
EGF epidermal growth factor
EM electron microscopy
EST expressed sequence tag
EUCIB European Collaborative Interspecific Backcross
FCS foetal calf serum
FITC fluorescein isothiocyanate
g grams
GalC galactocerebroside
GFAP glial fibrillary acidic protein
golli-mbp gene of oligodnedrocyte lineage
H&E haematoxylin and eosin
HBSS Hanks buffered salt solution
hh hedgehog
hr hour
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hsh hindshaker
IGF insulin-like growth factor
IL6 interleukin 6
IPL intraperiod line
ISH in situ hybridisation
K+ potassium
kDa kiloDalton
L-MAG large isoform of the myelin associated glycoprotein
LIF leukaemia inhibitory facotr
LM light microscopy
LOD logarithm of odds
M molar
MAG myelin-associated glycoprotein
MAL myelin and lymphocyte protein
MBP myelin basic protein
Mbpshi shiverer
Mfrpshi-mld myelin deficient
md-rat myelin deficient rat
MDL major dense line
Mg^+ magnesium
MGD Mouse Genome Database
Mgjsl-con Steel contrasted
min minute
Min multiple intestinal neoplasia mutation
MOBP myelin-associated oligodendrocytic basic protein
MOG myelin/oligodendrocyte glycoprotein
MOSP myelin oligodendrocyte specific protein
mRNA messenger ribonucleic acid
NaCl sodium chloride
NaOH sodium hydroxide
n h 4+ ammonia
0-2A oligodendrocyte type-2 astrocyte
°C degrees centigrade
Omgp oligodendrocyte-myelin glycoprotein
OSP oligodendrocyte specific protein
P postnatal age (days)
PI phage 1
PAP peroxidase-anti-peroxidase
PBS phosphate buffered saline
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PCR polymerase chain reaction
PDGF platelet derived growth factor
PDGFRa platelet derived growth factor a  receptor
PLP proteolipid protein
PLPJP jimpy
PLPiP~rsh rumpshaker
Plpmsd myelin synthesis deficient
PMD Pelizaeus Merzbacher disease
PNS peripheral nervous system
POA pre-oligodendrocyte antigen
pt paralytic tremor rabbit
qk quaking
R-mAb Ranscht monoclonal antibody
RFLP restriction fragment length polymorphism
RNA ribonucleic acid
RNAseA ribonuclease A
rpm revolutions per minute
S-MAG small isoform of the myelin associated glycoprotein
SDS sodium dodecyl sulphate
SDS-PAGE sodium dodecyl suplphate polyacrylamide gel electrophoresis
SDW sterile distilled water
sec second
sh-pup shaking pup
Shh sonic hedgehog
SSC sodium chloride/sodium citrate
SSLP simple sequence length polymorphism
T Brachury
TAE tris acetate EDTA
TBE tris borate EDTA
TBS tris buffered saline
TEMED N,N,N,N ’ ,tetramethy lethy lenediamine
t f  tufted
TXR Texas red
Ugt8 UDP-glucuronosyltransferase 8
UV ultraviolet
WT wild type
YAC yeast artificial chromosome
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